<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Physiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id><journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id><journal-title-group><journal-title>Frontiers in Physiology</journal-title></journal-title-group><issn pub-type="epub">1664-042X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6046402</article-id><article-id pub-id-type="doi">10.3389/fphys.2018.00814</article-id><article-categories><subj-group subj-group-type="heading"><subject>Physiology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Physiological and Biological Responses to Short-Term Intermittent Hypobaric Hypoxia Exposure: From Sports and Mountain Medicine to New Biomedical Applications</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Viscor</surname><given-names>Gin&#x000e9;s</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/290344/overview"/></contrib><contrib contrib-type="author"><name><surname>Torrella</surname><given-names>Joan R.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/546792/overview"/></contrib><contrib contrib-type="author"><name><surname>Corral</surname><given-names>Luisa</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/577637/overview"/></contrib><contrib contrib-type="author"><name><surname>Ricart</surname><given-names>Antoni</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Javierre</surname><given-names>Casimiro</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/288671/overview"/></contrib><contrib contrib-type="author"><name><surname>Pages</surname><given-names>Teresa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/523899/overview"/></contrib><contrib contrib-type="author"><name><surname>Ventura</surname><given-names>Josep L.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/314961/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Physiology Section, Department of Cell Biology, Physiology and Immunology, Faculty of Biology, Universitat de Barcelona</institution>, <addr-line>Barcelona</addr-line>, <country>Spain</country></aff><aff id="aff2"><sup>2</sup><institution>Exercise Physiology Unit, Department of Physiological Sciences, Faculty of Medicine and Health Sciences, Universitat de Barcelona, L'Hospitalet de Llobregat</institution>, <addr-line>Barcelona</addr-line>, <country>Spain</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Rodrigo Del Rio, Pontificia Universidad Cat&#x000f3;lica de Chile, Chile</p></fn><fn fn-type="edited-by"><p>Reviewed by: Cheryl Heesch, University of Missouri, United States; Simona Mrakic-Sposta, Istituto di Bioimmagini e Fisiologia Molecolare, Italy</p></fn><corresp id="c001">*Correspondence: Gin&#x000e9;s Viscor <email>gviscor@ub.edu</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Integrative Physiology, a section of the journal Frontiers in Physiology</p></fn></author-notes><pub-date pub-type="epub"><day>09</day><month>7</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>9</volume><elocation-id>814</elocation-id><history><date date-type="received"><day>16</day><month>2</month><year>2018</year></date><date date-type="accepted"><day>11</day><month>6</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Viscor, Torrella, Corral, Ricart, Javierre, Pages and Ventura.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Viscor, Torrella, Corral, Ricart, Javierre, Pages and Ventura</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>In recent years, the altitude acclimatization responses elicited by short-term intermittent exposure to hypoxia have been subject to renewed attention. The main goal of short-term intermittent hypobaric hypoxia exposure programs was originally to improve the aerobic capacity of athletes or to accelerate the altitude acclimatization response in alpinists, since such programs induce an increase in erythrocyte mass. Several model programs of intermittent exposure to hypoxia have presented efficiency with respect to this goal, without any of the inconveniences or negative consequences associated with permanent stays at moderate or high altitudes. Artificial intermittent exposure to normobaric hypoxia systems have seen a rapid rise in popularity among recreational and professional athletes, not only due to their unbeatable cost/efficiency ratio, but also because they help prevent common inconveniences associated with high-altitude stays such as social isolation, nutritional limitations, and other minor health and comfort-related annoyances. Today, intermittent exposure to hypobaric hypoxia is known to elicit other physiological response types in several organs and body systems. These responses range from alterations in the ventilatory pattern to modulation of the mitochondrial function. The central role played by hypoxia-inducible factor (HIF) in activating a signaling molecular cascade after hypoxia exposure is well known. Among these targets, several growth factors that upregulate the capillary bed by inducing angiogenesis and promoting oxidative metabolism merit special attention. Applying intermittent hypobaric hypoxia to promote the action of some molecules, such as angiogenic factors, could improve repair and recovery in many tissue types. This article uses a comprehensive approach to examine data obtained in recent years. We consider evidence collected from different tissues, including myocardial capillarization, skeletal muscle fiber types and fiber size changes induced by intermittent hypoxia exposure, and discuss the evidence that points to beneficial interventions in applied fields such as sport science. Short-term intermittent hypoxia may not only be useful for healthy people, but could also be considered a promising tool to be applied, with due caution, to some pathophysiological states.</p></abstract><kwd-group><kwd>intermittent hypoxia</kwd><kwd>erythropoiesis</kwd><kwd>angiogenesis</kwd><kwd>cardioprotection</kwd><kwd>bronchial asthma</kwd><kwd>neuroprotection</kwd><kwd>circulating stem cells</kwd><kwd>regenerative medicine</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">Ministerio de Econom&#x000ed;a y Competitividad<named-content content-type="fundref-id">10.13039/501100003329</named-content></funding-source><award-id rid="cn001">DEP2010-22205-C02-01</award-id><award-id rid="cn001">DEP2013 48334-C2-1P</award-id></award-group></funding-group><counts><fig-count count="0"/><table-count count="7"/><equation-count count="0"/><ref-count count="198"/><page-count count="20"/><word-count count="16838"/></counts></article-meta></front><body><sec id="s1"><title>Intermittent hypoxia: concept and historical background</title><p>The term &#x0201c;intermittent hypoxia&#x0201d; is widely used and applies to a wide spectrum of situations that range from alpine expeditions to obstructive sleep apnea (OSA). However, in physiological terms, there are often few similarities between these conditions (Viscor et al., <xref rid="B177" ref-type="bibr">2014</xref>). Although the same physiological responses are elicited by the same sensors and signaling pathways, the varied intensity and duration of the hypoxia switches different mechanisms on and off at different times, thus making the final physiological changes induced in the whole organism highly variable. In addition, a high variability in human tolerance to hypoxia has been reported, and it is now known to vary throughout the lives of individuals (Canou&#x000ef;-Poitrine et al., <xref rid="B29" ref-type="bibr">2014</xref>; Richalet and Lhuissier, <xref rid="B138" ref-type="bibr">2015</xref>). As a consequence, specialists have engaged in an interesting discussion about how to measure and define hypoxic &#x0201c;dosage&#x0201d; (Serebrovskaya et al., <xref rid="B156" ref-type="bibr">2008</xref>; Garvican-Lewis et al., <xref rid="B63" ref-type="bibr">2016</xref>). In general, three different types of intermittent hypoxia can be considered:</p><list list-type="alpha-lower"><list-item><p>Episodic intermittent hypoxia, which consists of successive short episodes of hypoxia with variable intensity. This may be present in permanent situations such as OSA, in transitory situations such as surgical ischemia-reperfusion (to one or several organs) and in some sporting activities such as parachuting and extreme skiing, in which the subject may not even notice the hypoxia.</p></list-item><list-item><p>Intervallic intermittent hypoxia, which is characterized by long periods of normoxia interspersed with periods of hypoxia, as seen in frequent alpine expeditions and trekking at altitude, mountain rescue teams, regular intercontinental commercial flight crews (when in flight, commercial airplane cabins are usually regulated at pressures equivalent to a moderate altitude of about 2,000 m above sea level), and even astronauts at the International Space Station or future extraplanetary missions.</p></list-item><list-item><p>Chronic intermittent hypoxia, which affects individuals who work under shift systems characterized by work at moderate or high altitudes alternating with periods of rest at sea level. This last model is common in the Andes region and in the Central Asian mining industry, but is also found in contractors for astronomical observatories, the military and customs, and police and border control personnel in many high-elevation countries.</p></list-item></list><p>The concept of &#x0201c;hypoxic training&#x0201d; was coined during the 1930s in the academic environment of the former Soviet Union, and was considered a useful therapeutic tool after it was shown to have beneficial effects on a number of different pathologies, even though the mechanisms involved in these favorable effects were unclear (Agadzhanyan and Torshin, <xref rid="B1" ref-type="bibr">1986</xref>; Serebrovskaya, <xref rid="B158" ref-type="bibr">2002</xref>). For instance, it was reported to have a beneficial effect on hypertension and cardiovascular diseases (Aleshin et al., <xref rid="B3" ref-type="bibr">1993</xref>). Later, new experimental studies corroborated some of these findings and provided a fresh insight through enhanced plasma lipid profiles (Tin'kov and Aksenov, <xref rid="B167" ref-type="bibr">2002</xref>). Nowadays in former Soviet States, hypoxic training is systematically applied as a non-pharmacological strategy for treating a wide range of alterations, including chronic lung disease, bronchial asthma, hypertension, diabetes mellitus, Parkinson's disease, emotional disorders and radiation toxicity, and for the prophylactic treatment of some occupational diseases (Ge et al., <xref rid="B65" ref-type="bibr">1994</xref>; Xi and Serebrovskaya, <xref rid="B187" ref-type="bibr">2012</xref>). In Western countries, intermittent hypoxia exposure programs were first applied in the field of sports medicine to improve aerobic capacity and for pre-acclimatization to altitude (Richalet et al., <xref rid="B135" ref-type="bibr">1992</xref>; Levine and Stray-Gundersen, <xref rid="B93" ref-type="bibr">1997</xref>; Rodr&#x000ed;guez et al., <xref rid="B142" ref-type="bibr">1999</xref>; Stray-Gundersen and Levine, <xref rid="B162" ref-type="bibr">1999</xref>; Casas M. et al., <xref rid="B31" ref-type="bibr">2000</xref>; Ricart et al., <xref rid="B134" ref-type="bibr">2000</xref>).</p><p>Our group took an in-depth look at the physiological responses to intermittent exposure to hypobaric hypoxia (IEHH) in hypobaric (low barometric pressure) chambers. A detailed study of the precise mechanisms that underlie these adaptive responses (erythropoiesis, angiogenesis and the release of circulating stem cells) in humans and in an experimental rodent model encouraged us to explore the possibilities of applying IEHH programs with biomedical and therapeutic purposes (Panisello et al., <xref rid="B128" ref-type="bibr">2007</xref>, <xref rid="B127" ref-type="bibr">2008</xref>; Esteva et al., <xref rid="B56" ref-type="bibr">2009</xref>; Viscor et al., <xref rid="B176" ref-type="bibr">2009</xref>; Corral et al., <xref rid="B42" ref-type="bibr">2014b</xref>). Thus, we recently demonstrated the efficacy of applying IEHH programs (passive exposure only or combined with exercise protocols) in the recovery of a range of injuries (Corral et al., <xref rid="B41" ref-type="bibr">2014a</xref>; N&#x000fa;&#x000f1;ez-Espinosa et al., <xref rid="B122" ref-type="bibr">2014</xref>; Rizo-Roca et al., <xref rid="B140" ref-type="bibr">2017a</xref>,<xref rid="B141" ref-type="bibr">b</xref>). These results are consistent with the new paradigm that proposes biphasic effects in the response to hypoxia (hormesis); that is, its harmful or beneficial effects depend on the frequency and severity of the hypoxic challenge to the organism or tissue in question (Navarrete-Opazo and Mitchell, <xref rid="B115" ref-type="bibr">2014</xref>).</p></sec><sec id="s2"><title>Biological effects of intermittent hypoxia exposure</title><p>The molecular mechanisms involved in the response to hypoxia at the cellular level are relatively well understood (F&#x000e1;bi&#x000e1;n et al., <xref rid="B57" ref-type="bibr">2016</xref>; Bhattarai et al., <xref rid="B19" ref-type="bibr">2017</xref>; Koyasu et al., <xref rid="B88" ref-type="bibr">2017</xref>). However, the complexity of the interactions between the divergent signaling pathways and the time frame of the various processes on different tissues and organs, together with the significant individual variability in humans' susceptibility to hypoxia (Rathat et al., <xref rid="B131" ref-type="bibr">1992</xref>), pose formidable challenges to researching the potential benefits of regular programs involving exposure to real or simulated altitudes. This paper presents a series of examples of how intermittent exposure to hypoxia can benefit certain patients, although it is not intended to be an exhaustive list. Obviously, these programs must always be applied with due caution and under rigorous clinical controls, as with any pharmacological treatment.</p><sec><title>Erythropoiesis</title><p>Table <xref rid="T1" ref-type="table">1</xref> lists several representative studies of the favorable effects of intermittent hypoxia exposure by increasing erythropoiesis. A detailed report on the rate of erythropoietin (EPO) formation and plasma lifetime in humans in response to acute hypobaric hypoxia exposure in a hypobaric chamber was first provided by the group led by Christian Bauer in Zurich (Eckardt et al., <xref rid="B53" ref-type="bibr">1989</xref>). Later, the pivotal role of hypoxia-inducible factor 1 (HIF-1) in the transcriptional response of EPO to hypoxia was also described (Wang and Semenza, <xref rid="B179" ref-type="bibr">1993</xref>). These seminal works and many subsequent studies sparked an interest in applying IEHH programs to increase erythrocyte mass as a way of improving the aerobic capacity of athletes. Recombinant human erythropoietin (rHuEPO) opened up a new chapter in the correction of uremic anemia due to chronic renal failure (Egrie et al., <xref rid="B54" ref-type="bibr">1986</xref>; London et al., <xref rid="B98" ref-type="bibr">1989</xref>; Najean et al., <xref rid="B113" ref-type="bibr">1989</xref>), but also led to unethical use in sports medicine. The celebration of the 1968 Summer Olympics held in Mexico City (2,250 m above sea level) aroused interest in studying the effects of altitude on human performance. The reduced performance in sporting events with a high aerobic component was evident, while participants in competitions with a clear anaerobic character saw no decline in their performance, and some even beat their records (Di Prampero et al., <xref rid="B49" ref-type="bibr">1970</xref>). As a consequence, stays at high altitude and other artificial hypoxia exposure strategies in athletes were subject to intense study; a wide range of strategies, from permanent stays at moderate or high geographic altitudes (Antezana et al., <xref rid="B9" ref-type="bibr">1994</xref>; Richalet et al., <xref rid="B136" ref-type="bibr">1994</xref>) to different patterns of intermittent exposure (Levine and Stray-Gundersen, <xref rid="B93" ref-type="bibr">1997</xref>; Chapman et al., <xref rid="B32" ref-type="bibr">1998</xref>; Rodr&#x000ed;guez et al., <xref rid="B142" ref-type="bibr">1999</xref>; Casas M. et al., <xref rid="B31" ref-type="bibr">2000</xref>; Karlsen et al., <xref rid="B82" ref-type="bibr">2001</xref>; Stray-Gundersen et al., <xref rid="B163" ref-type="bibr">2001</xref>; Ge et al., <xref rid="B66" ref-type="bibr">2002</xref>; Lundby et al., <xref rid="B99" ref-type="bibr">2007</xref>; Richalet and Gore, <xref rid="B137" ref-type="bibr">2008</xref>) were examined. Noticeable differences in protocols and hypoxia exposure methods led to intense debate on the usefulness of intermittent hypoxia exposure for elite athletes, given that hypoxic dose and interindividual variability represent two of the main constraints (Chapman et al., <xref rid="B32" ref-type="bibr">1998</xref>; Casas H. et al., <xref rid="B30" ref-type="bibr">2000</xref>; Julian et al., <xref rid="B80" ref-type="bibr">2004</xref>; Gore et al., <xref rid="B68" ref-type="bibr">2006</xref>; Wilber et al., <xref rid="B184" ref-type="bibr">2007</xref>; Truijens et al., <xref rid="B168" ref-type="bibr">2008</xref>; Rodr&#x000ed;guez et al., <xref rid="B143" ref-type="bibr">2015</xref>). In parallel, there was rising interest in understanding the non-erythropoietic effects of EPO. The discovery of multi-tissue erythropoietin receptor expression provided an insight into erythropoietin (EPO) activity that went beyond its role in the regulation of red blood cell production, including a key role in cardioprotection, brain development and neuroprotection, through a coordinated response against tissue oxygen shortage (Noguchi et al., <xref rid="B120" ref-type="bibr">2007</xref>; Arcasoy, <xref rid="B10" ref-type="bibr">2008</xref>; Burger et al., <xref rid="B23" ref-type="bibr">2009</xref>; Chateauvieux et al., <xref rid="B33" ref-type="bibr">2011</xref>; Jia et al., <xref rid="B79" ref-type="bibr">2012</xref>; Zhang Y. et al., <xref rid="B194" ref-type="bibr">2014b</xref>), thus contributing to ischemic preconditioning, an interesting and important property of organ survival that could also prove very useful for new biomedical applications.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Examples of the effects of intermittent hypoxia exposure on erythropoiesis.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Subjects</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Hypoxia time</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Hypoxia method</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Hypoxia dosage</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Outcome</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Healthy men (<italic>n</italic> = 6)</td><td valign="top" align="left" rowspan="1" colspan="1">5.5 h</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">3,000&#x02013;4,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;EPO</td><td valign="top" align="left" rowspan="1" colspan="1">Eckardt et al., <xref rid="B53" ref-type="bibr">1989</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Alpinists (<italic>n</italic> = 10; 4 w + 6 m)</td><td valign="top" align="left" rowspan="1" colspan="1">10 d</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">6,542 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Hct &#x02191;[Hb]</td><td valign="top" align="left" rowspan="1" colspan="1">Richalet et al., <xref rid="B136" ref-type="bibr">1994</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Competitive (<italic>n</italic> = 13; 4 w + 9 m)</td><td valign="top" align="left" rowspan="1" colspan="1">4 h TL/d for 4 wk</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude (LH-TL) <break/>Altitude (LH-TH)</td><td valign="top" align="left" rowspan="1" colspan="1">1,250/2,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Hct &#x02191;[Hb] &#x02191;RBC<sub>mass</sub></td><td valign="top" align="left" rowspan="1" colspan="1">Levine and Stray-Gundersen, <xref rid="B93" ref-type="bibr">1997</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Competitive (<italic>n</italic> = 39; 12 w + 27 m)</td><td valign="top" align="left" rowspan="1" colspan="1">30 h (14 d)</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude (LH-TL) <break/>Altitude (LH-TH)</td><td valign="top" align="left" rowspan="1" colspan="1">1,200&#x02013;1,400 m/2,500&#x02013;3,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;EPO</td><td valign="top" align="left" rowspan="1" colspan="1">Chapman et al., <xref rid="B32" ref-type="bibr">1998</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Alpinists (<italic>n</italic> = 17; 3 w + 14 m)</td><td valign="top" align="left" rowspan="1" colspan="1">3&#x02013;5 h/d for 9 d</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">4,000&#x02013;5,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Hct &#x02191;[Hb] &#x02191;RBC</td><td valign="top" align="left" rowspan="1" colspan="1">Rodr&#x000ed;guez et al., <xref rid="B142" ref-type="bibr">1999</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Elite alpinists (<italic>n</italic> = 6; 1 w + 5 m)<break/> Alpinists (<italic>n</italic> = 17; 3 w + 14 m)<break/> Novice men (<italic>n</italic> = 8)</td><td valign="top" align="left" rowspan="1" colspan="1">3&#x02013;5 h/d for 17 d<break/> 3&#x02013;5 h/d for 9 d<break/> 1.5 h/d &#x000d7; 3 d/wk for 3 wk</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">4,000&#x02013;5,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Hct &#x02191;[Hb] &#x02191;RBC <break/>(all protocols)</td><td valign="top" align="left" rowspan="1" colspan="1">Casas H. et al., <xref rid="B30" ref-type="bibr">2000</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Elite runners (<italic>n</italic> = 26; 9 w + 17 m)</td><td valign="top" align="left" rowspan="1" colspan="1">4 wk (4 h TL/d)</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude LH-TL</td><td valign="top" align="left" rowspan="1" colspan="1">1,225/2,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;EPO &#x02191;Hct &#x02191;[Hb]</td><td valign="top" align="left" rowspan="1" colspan="1">Stray-Gundersen et al., <xref rid="B163" ref-type="bibr">2001</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Healthy people (<italic>n</italic> = 48; 16 w + 32 m)</td><td valign="top" align="left" rowspan="1" colspan="1">24 h</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">1,780m <break/>2,085m <break/>2,454m <break/>2,800m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;EPO (6 h) &#x02193;EPO (24 h) <break/>&#x02191;EPO (6 h) &#x02193;EPO (24 h) <break/>&#x02191;EPO (6 h) &#x02191;EPO (24 h <break/>&#x02191;EPO (6 h) &#x02191;EPO (24 h)</td><td valign="top" align="left" rowspan="1" colspan="1">Ge et al., <xref rid="B66" ref-type="bibr">2002</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Competitive (<italic>n</italic> = 17; 3 w + 14 m)</td><td valign="top" align="left" rowspan="1" colspan="1">(IHT 5:5) 70 min/d (5 d/wk) for 4 wk</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.12 (&#x02248;4,400 m) <break/>FiO<sub>2</sub> = 0.11 (&#x02248;5,200 m) <break/>FiO<sub>2</sub> = 0.10 (&#x02248;5,800 m) <break/>FiO<sub>2</sub> = 0.10 (&#x02248;5,800 m)</td><td valign="top" align="left" rowspan="1" colspan="1">No changes</td><td valign="top" align="left" rowspan="1" colspan="1">Julian et al., <xref rid="B80" ref-type="bibr">2004</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Competitive (<italic>n</italic> = 23; 12 w + 11 m)</td><td valign="top" align="left" rowspan="1" colspan="1">3 h/d &#x000d7; 5 d/wk for 4 wk</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">4,000&#x02013;5,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;EPO (3 h after)</td><td valign="top" align="left" rowspan="1" colspan="1">Gore et al., <xref rid="B68" ref-type="bibr">2006</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Competitive (<italic>n</italic> = 87; 28 w + 59 m)</td><td valign="top" align="left" rowspan="1" colspan="1">4 wk (&#x02265;22 h) <break/>4 wk (12&#x02013;16 h)</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude <break/>HC</td><td valign="top" align="left" rowspan="1" colspan="1">2,000&#x02013;2,500 m <break/>2,500&#x02013;3,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;EPO</td><td valign="top" align="left" rowspan="1" colspan="1">Wilber et al., <xref rid="B184" ref-type="bibr">2007</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Elite athletes (<italic>n</italic> = 41) <break/>XC Skiers (<italic>n</italic> = 11) <break/>Swimmers (<italic>n</italic> = 18) <break/>Runners (<italic>n</italic> = 12)</td><td valign="top" align="left" rowspan="1" colspan="1">18 nights <break/>13 nights <break/>18 nights</td><td valign="top" align="left" rowspan="1" colspan="1">NH and Altitude <break/> (LH-TL)</td><td valign="top" align="left" rowspan="1" colspan="1">1,200/ <break/>/2,500&#x02013;3,500 m <break/>/2,500&#x02013;3,000 m <break/>/2,500&#x02013;3,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;[Hb] <break/>&#x02191;Hct &#x02191;[Hb] <break/>&#x02191;[Hb]</td><td valign="top" align="left" rowspan="1" colspan="1">Richalet and Gore, <xref rid="B137" ref-type="bibr">2008</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Trained rats</td><td valign="top" align="left" rowspan="1" colspan="1">4 h/d &#x000d7; 5 d/wk for 2 wk</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">4,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;[Hb]&#x02191;Hct &#x02191;RBC</td><td valign="top" align="left" rowspan="1" colspan="1">N&#x000fa;&#x000f1;ez-Espinosa et al., <xref rid="B122" ref-type="bibr">2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male trained triathletes (<italic>n</italic> = 18) <break/>-Normoxia (<italic>n</italic> = 9) <break/>-Hypoxia (<italic>n</italic> = 9)</td><td valign="top" align="left" rowspan="1" colspan="1">1 h/d &#x000d7; 2 d/wk for 7 wk</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.145-0.15 (&#x02248;2,800&#x02013;2,500 m)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;[Hb] &#x02191;RBC</td><td valign="top" align="left" rowspan="1" colspan="1">Ramos-Campo et al., <xref rid="B129" ref-type="bibr">2015</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Elite swimmers <break/>(<italic>n</italic> = 54; 30w+24m)</td><td valign="top" align="left" rowspan="1" colspan="1">3 or 4 wk</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude <break/>LH-TH vs. LL-TL vs. LH-TH+TL</td><td valign="top" align="left" rowspan="1" colspan="1">690/2,320 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;tHb<sub>mass</sub> for LH-TH and LH-TH+TL</td><td valign="top" align="left" rowspan="1" colspan="1">Rodr&#x000ed;guez et al., <xref rid="B143" ref-type="bibr">2015</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male well-trained triathletes (<italic>n</italic> = 28) <break/>-HH (<italic>n</italic> = 11) <break/>-NH (<italic>n</italic> = 10) <break/>-Normoxia (<italic>n</italic> = 7)</td><td valign="top" align="left" rowspan="1" colspan="1">230 h for 18 d <break/>238 h for 18 d</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude (LH-TL) <break/> NH (LH-TL)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;1,200/2,250m <break/>1,150 m/(&#x02248;2,250 m)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Hb<sub>mass</sub> (similar in NH &#x00026; HH)</td><td valign="top" align="left" rowspan="1" colspan="1">Hauser et al., <xref rid="B74" ref-type="bibr">2016</xref></td></tr></tbody></table><table-wrap-foot><p><italic>Altitude, geographic altitude; EPO, serum or plasma erythropietin levels; FiO<sub>2</sub>, Fraction of inspired oxygen; [Hb], Blood hemoglobin concentration; Hb<sub>mass</sub>, whole body hemoglobin mass; HC, Hypobaric Chamber; Hct, Hematocrit; IHT(5:5), intermittent hypoxic training, alternating 5 min hypoxia with 5 min normoxia along the session; LH-TH, Living High-Training High; LH-TL, Living High-Training Low; NH, normobaric hypoxia; RBC, red blood cell count; RBC<sub>mass</sub>, whole body erythrocytic mass</italic>.</p></table-wrap-foot></table-wrap></sec><sec><title>Angiogenesis and muscle capillarization</title><p>In Table <xref rid="T2" ref-type="table">2</xref>, some examples of the effects of intermittent hypoxia exposure on angiogenesis, vascular remodeling, muscle capillarization and hypertension are presented. In addition to its erythropoietic role, HIF-1 is the main mediator of angiogenesis in response to hypoxic conditions (Rey and Semenza, <xref rid="B132" ref-type="bibr">2010</xref>) and has been considered a potential therapeutic target in many diseases. Two different strategies have been applied: HIF-1 upregulation for ischemic diseases (Li et al., <xref rid="B94" ref-type="bibr">2014</xref>) and HIF-1 inhibition for cancer and endometriosis (Zhou et al., <xref rid="B196" ref-type="bibr">2012</xref>; Bhattarai et al., <xref rid="B19" ref-type="bibr">2017</xref>). Multiple angiogenic factors have been tested in the past; however, therapies that use only one proangiogenic agent to elicit angiogenesis were shown to be insufficient (Hirota and Semenza, <xref rid="B76" ref-type="bibr">2006</xref>). Therefore, the addition of non-pharmacological treatments based on hypoxia-induced angiogenesis may be a successful strategy (Zimna and Kurpisz, <xref rid="B198" ref-type="bibr">2015</xref>).</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Examples of the effects of intermittent hypoxia exposure on angiogenesis, vascular remodeling, muscle capillarization, and hypertension.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Subjects</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Time of hypoxia</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Hypoxia method</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Hypoxia dosage</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Outcome</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Healthy (<italic>n</italic> = 32 m) <break/>14 normoxic (SL) <break/>18 hypoxic (&#x02248;2,500 m)</td><td valign="top" align="left" rowspan="1" colspan="1">3 cycling/wk for 4 wk</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.16 (&#x02248;2,500 m)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Lipid peroxidation during hipoxia</td><td valign="top" align="left" rowspan="1" colspan="1">Bailey et al., <xref rid="B14" ref-type="bibr">2001</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Males (<italic>n</italic> = 16) Double blind groups <break/>8 healthy <break/>8 prior myocardial infarction</td><td valign="top" align="left" rowspan="1" colspan="1">IHT <break/>3&#x02013;4 &#x000d7; (3&#x02013;5:3) <break/>15 sessions in 3 wk</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.14&#x02013;0.10 (&#x02248;3,500&#x02013;&#x02248;5,800 m)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Aerobic capacity &#x02191;exercise tolerance (without differences in patients)</td><td valign="top" align="left" rowspan="1" colspan="1">Burtscher et al., <xref rid="B26" ref-type="bibr">2004</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Sedentary male rats</td><td valign="top" align="left" rowspan="1" colspan="1">4 h/d, 5 d/wk for 22 d</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">5,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Capillary density <break/> &#x02193;Diffusion distances for slow fibres</td><td valign="top" align="left" rowspan="1" colspan="1">Panisello et al., <xref rid="B127" ref-type="bibr">2008</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Overweight to obese subjects group (<italic>n</italic> = 24)</td><td valign="top" align="left" rowspan="1" colspan="1">4 wk training under hypoxia at 65% VO<sub>2</sub>max</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.15 (&#x02248;2,760 m)</td><td valign="top" align="left" rowspan="1" colspan="1">Better physical fitness, metabolic risk markers, and body composition</td><td valign="top" align="left" rowspan="1" colspan="1">Wiesner et al., <xref rid="B182" ref-type="bibr">2010</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male Wistar rats (hyperlipidemia induced by 8 wk high-fat diet)</td><td valign="top" align="left" rowspan="1" colspan="1">3 &#x000d7; (10 s:10 s) ischemia/reperfusion preceding 180 min reperfusion</td><td valign="top" align="left" rowspan="1" colspan="1">Ischemic postconditioning</td><td valign="top" align="left" rowspan="1" colspan="1">Ischemia: 30 min LAD occlusion followed by 180 min of reperfusion</td><td valign="top" align="left" rowspan="1" colspan="1">Up-regulation of HIF-1&#x003b1; can be cardioprotective</td><td valign="top" align="left" rowspan="1" colspan="1">Li et al., <xref rid="B94" ref-type="bibr">2014</xref></td></tr></tbody></table><table-wrap-foot><p><italic>FiO<sub>2</sub>, Fraction of inspired oxygen; HC, Hypobaric Chamber; HIF, hypoxia inducible factor; NH, Normobaric hypoxia; IHT, Intermittent hypoxic training alternating hypoxia with normoxia along the session; LAD, left anterior descending coronary artery; VO<sub>2</sub>max, maximal oxygen consumption capacity</italic>.</p></table-wrap-foot></table-wrap><p>The physiological response elicited by hypoxia at moderate altitude exposure (1,800&#x02013;3,000 m) is low, but increases when combined with exercise, with additional specific responses that are not observed when similar exercise levels are carried out in normoxia (B&#x000e4;rtsch et al., <xref rid="B16" ref-type="bibr">2008</xref>). Moreover, even greater adaptations are obtained when the hypoxic intervention is accompanied by high-intensity training (Faiss et al., <xref rid="B59" ref-type="bibr">2013</xref>; Sanchez and Borrani, <xref rid="B148" ref-type="bibr">2018</xref>).</p><p>Although altitude is generally associated with increased health risks in most patients and elderly individuals, several studies have reported therapeutic benefits associated with exercising in mild hypoxia in a variety of alterations (Bailey et al., <xref rid="B14" ref-type="bibr">2001</xref>; Burtscher et al., <xref rid="B26" ref-type="bibr">2004</xref>; Wiesner et al., <xref rid="B182" ref-type="bibr">2010</xref>). As exercising in moderate hypoxia seems to play a valuable role as an additional &#x0201c;therapeutic strategy,&#x0201d; albeit one with both benefits and risks, new insights on this paradigm are now increasing. Some critical analysis and guidelines for hypertensive, obese and elderly individuals have recently been proposed (Millet et al., <xref rid="B110" ref-type="bibr">2016</xref>). These concluded that intermittent hypoxic training seems to be well tolerated by most patients, in a similar way to healthy individuals, and that hypoxia and exercise may have additive or synergistic effects, probably mediated by several factors, including nitric oxide, angiogenesis and &#x0201c;altitude anorexia,&#x0201d; thereby paving the way for researchers to identify the optimal individual combination of exercise and hypoxia.</p></sec><sec><title>Cardiac remodeling</title><p>Aerobic exercise activities have traditionally been widely recommended for preventing disease and promoting health. Today, resistance training is usually included in physical activity counseling, even for older adults and people with a range of cardiac conditions (Haskell et al., <xref rid="B72" ref-type="bibr">2007</xref>; Nelson et al., <xref rid="B118" ref-type="bibr">2007</xref>; Heuschmann et al., <xref rid="B75" ref-type="bibr">2010</xref>), and there is solid evidence of different echocardiographic repercussions (Kenney et al., <xref rid="B83" ref-type="bibr">2012</xref>). The cardioprotective effects of chronic intermittent hypoxia have been extensively studied, and their positive effect has shown to be related to preservation of mitochondrial function and inhibition of potassium channels sensitive to ATP (mitoKATP) present in the sarcoplasmic and mitochondrial membranes (Ost&#x000e1;dal et al., <xref rid="B126" ref-type="bibr">1989</xref>; Asemu et al., <xref rid="B13" ref-type="bibr">1999</xref>, <xref rid="B12" ref-type="bibr">2000</xref>; Chouabe et al., <xref rid="B37" ref-type="bibr">2004</xref>; Ostadal and Kolar, <xref rid="B125" ref-type="bibr">2007</xref>). Additional myocardial remodeling data were reported by our group using a model of IEHH (Panisello et al., <xref rid="B128" ref-type="bibr">2007</xref>). Both chronic and intermittent exposure models supported the potential beneficial effects of acute exposure in coronary patients reported in pioneering studies conducted by Peruvian cardiologist Emilio Marticorena (Marticorena, <xref rid="B104" ref-type="bibr">1993</xref>; Marticorena et al., <xref rid="B105" ref-type="bibr">2001</xref>; Reynafarje and Marticorena, <xref rid="B133" ref-type="bibr">2002</xref>; Valle et al., <xref rid="B172" ref-type="bibr">2006</xref>). In rodents, it has been demonstrated that endurance exercise training and IEHH modulate cardiac mitochondria to a protective phenotype characterized by decreased induction of mitochondrial permeability transition pore and apoptotic signaling (Magalh&#x000e3;es et al., <xref rid="B100" ref-type="bibr">2013</xref>, <xref rid="B101" ref-type="bibr">2014</xref>). However, there are no studies on humans on cardiac remodeling that combine hypoxia and exercise, other than those dealing with OSA models. There have been extensive studies on patients suffering from this syndrome, and several pieces of evidence may be found in the literature: the progression and reversibility of atrial remodeling following stretch release may help prevent atrial fibrillation (Thanigaimani et al., <xref rid="B166" ref-type="bibr">2017</xref>), the important prognostic information of right-sided heart dysfunction (Kusunose et al., <xref rid="B90" ref-type="bibr">2016</xref>) and the evidence that OSA is associated independently with decreasing left ventricular systolic function and reduced right ventricular function (Korcarz et al., <xref rid="B87" ref-type="bibr">2016</xref>). Nevertheless, this cardiac remodeling in OSA patients &#x02013;individuals characterized by sustained systemic acidosis, hypercapnia and cerebral vasodilation&#x02013; might not be present during intermittent hypoxia exposure in healthy subjects, in which alkalosis and hypocapnia, both induced by the hyperventilation caused by adrenergic drive, are evident and probably lead to cerebral vascular constriction and reduced effects of hypoxic insult (Viscor et al., <xref rid="B177" ref-type="bibr">2014</xref>). Consequently, some of the changes and/or adaptive responses found in these pathological conditions must be interpreted with caution. In conclusion, there is no solid evidence for pernicious cardiac remodeling, but rather the opposite, after intermittent hypoxia in healthy individuals, whether accompanied by physical exercise or not. Table <xref rid="T3" ref-type="table">3</xref> contrasts the deteriorated cardiac function in OSA patients in comparison to several studies demonstrating, both in experimental animal models and human coronary patients, the positive effects of intermittent hypoxia exposure on cardiac function.</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Examples of the positive effects of intermittent hypoxia exposure on cardiac pathologies.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Subjects</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Time of hypoxia</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Hypoxia method</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Hypoxia dosage</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Outcome</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Acclimatized rats (4 d&#x02212;12 wk)</td><td valign="top" align="left" rowspan="1" colspan="1">8 h/d &#x000d7; 5 d/wk (12 wk)</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">Sea level &#x02013; 7,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Pulmonary hypertension</td><td valign="top" align="left" rowspan="1" colspan="1">Ost&#x000e1;dal et al., <xref rid="B126" ref-type="bibr">1989</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Coronary patients (<italic>n</italic> = 5)</td><td valign="top" align="left" rowspan="1" colspan="1">8 walks (in 4 wk)</td><td valign="top" align="left" rowspan="1" colspan="1">Progressive Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">900&#x02013;5,200 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Cardiac function</td><td valign="top" align="left" rowspan="1" colspan="1">Marticorena, <xref rid="B104" ref-type="bibr">1993</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats</td><td valign="top" align="left" rowspan="1" colspan="1">4 h/d (3 wk)</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">5,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Ischemia</td><td valign="top" align="left" rowspan="1" colspan="1">Asemu et al., <xref rid="B13" ref-type="bibr">1999</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats</td><td valign="top" align="left" rowspan="1" colspan="1">4 or 8 h/d (3 or 6 wk)</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">5,000 or 7,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0201c;Dose dependent&#x0201d; opposite effects</td><td valign="top" align="left" rowspan="1" colspan="1">Asemu et al., <xref rid="B12" ref-type="bibr">2000</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Coronary patients (<italic>n</italic> = 8)</td><td valign="top" align="left" rowspan="1" colspan="1">4 h/wk (13 wk)</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">4,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Cardiac function &#x02191;NO</td><td valign="top" align="left" rowspan="1" colspan="1">Marticorena et al., <xref rid="B105" ref-type="bibr">2001</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Guinea pigs</td><td valign="top" align="left" rowspan="1" colspan="1">Chronic vs. sea-level</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">4,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Efficiency in generate ATP</td><td valign="top" align="left" rowspan="1" colspan="1">Reynafarje and Marticorena, <xref rid="B133" ref-type="bibr">2002</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats</td><td valign="top" align="left" rowspan="1" colspan="1">20 d</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">4,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Aging remodeling</td><td valign="top" align="left" rowspan="1" colspan="1">Chouabe et al., <xref rid="B37" ref-type="bibr">2004</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Coronary patients (<italic>n</italic> = 6)</td><td valign="top" align="left" rowspan="1" colspan="1">4 h/wk (14 wk)</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">2,400&#x02013;4,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Myocardial perfusion</td><td valign="top" align="left" rowspan="1" colspan="1">Valle et al., <xref rid="B172" ref-type="bibr">2006</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats</td><td valign="top" align="left" rowspan="1" colspan="1">4 h/d &#x000d7; 5 d/wk (22 d)</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">5,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Myocardial capillaries</td><td valign="top" align="left" rowspan="1" colspan="1">Panisello et al., <xref rid="B128" ref-type="bibr">2007</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats</td><td valign="top" align="left" rowspan="1" colspan="1">5 h/d (5 wk)</td><td valign="top" align="left" rowspan="1" colspan="1">HC + exercise</td><td valign="top" align="left" rowspan="1" colspan="1">6,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Cardiac function</td><td valign="top" align="left" rowspan="1" colspan="1">Magalh&#x000e3;es et al., <xref rid="B100" ref-type="bibr">2013</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats</td><td valign="top" align="left" rowspan="1" colspan="1">5 h/d (5 wk)</td><td valign="top" align="left" rowspan="1" colspan="1">HC + exercise</td><td valign="top" align="left" rowspan="1" colspan="1">6,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Heart mitochondrial function after DOXO treatment</td><td valign="top" align="left" rowspan="1" colspan="1">Magalh&#x000e3;es et al., <xref rid="B101" ref-type="bibr">2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OSA patients</td><td valign="top" align="left" rowspan="1" colspan="1">Chronic</td><td valign="top" align="left" rowspan="1" colspan="1">OSA</td><td valign="top" align="left" rowspan="1" colspan="1">OSA</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Ventricular function</td><td valign="top" align="left" rowspan="1" colspan="1">Korcarz et al., <xref rid="B87" ref-type="bibr">2016</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">OSA patients</td><td valign="top" align="left" rowspan="1" colspan="1">Chronic</td><td valign="top" align="left" rowspan="1" colspan="1">OSA</td><td valign="top" align="left" rowspan="1" colspan="1">OSA</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Ventricular function</td><td valign="top" align="left" rowspan="1" colspan="1">Kusunose et al., <xref rid="B90" ref-type="bibr">2016</xref></td></tr></tbody></table><table-wrap-foot><p><italic>Altitude, geographic altitude; DOXO, Doxorubicin treatment; HC, Hypobaric Chamber; NO, nitric oxide; OSA, Obstructive sleep apnea</italic>.</p></table-wrap-foot></table-wrap></sec><sec><title>Treatment of bronchial asthma</title><p>Despite modern advances in the treatments, bronchial asthma continues being a potentially severe illness. All treatments focus on the improvement of bronchial obstruction, but nowadays we do not have an etiological definitive treatment. Bronchial asthma generates great dependence on a variety of medications and therefore frequently submits the patient to derived complications (Chiu et al., <xref rid="B36" ref-type="bibr">1981</xref>; Fairfax et al., <xref rid="B58" ref-type="bibr">1999</xref>; van der Woude et al., <xref rid="B173" ref-type="bibr">2001</xref>; Salpeter et al., <xref rid="B147" ref-type="bibr">2006</xref>). The Experts Committee of the United States Food &#x00026; Drug Administration published a consensus document about the risks of the antiasthma medications, some of them potentially lethal (DeNoon, <xref rid="B48" ref-type="bibr">2008</xref>).</p><p>For that reason, every procedure that could diminish pharmacological dependence among asthmatic patients should be considered a benefit. IEHH programs represent a realistic possibility to apply a minimally aggressive non-pharmacological approach that would reduce bronchial obstruction and pharmacological dependence in these patients.</p><p>As early as the nineteenth century there was social wisdom and medical knowledge that respiratory illnesses may improve in the mountains. The sanatoriums for respiratory patients, traditionally, were located at moderate altitude in the mountains. Notable examples were the Dutch Asthma Center, Davos, Clavadel, at 1,686 m over the sea level (Switzerland) and the Istituto Pio XII, Misurina, Auronzo at 1,756 m (Italy) devoted to childhood bronchial asthma. The first medical reference we found about bronchial asthma and altitude is an inquiry between the doctors of Davos referring that 133 among their 143 patients with bronchial asthma that spent their holidays in this mountain town, did not present any acute episode of asthma and that 81% reported persistent improvement of the illness (Turban and Spengler, <xref rid="B171" ref-type="bibr">1906</xref>).</p><p>Moreover, different epidemiological studies showed the beneficial effects of living at moderate altitude in the prevalence and severity of bronchial asthma (van Velzen et al., <xref rid="B174" ref-type="bibr">1996</xref>; Yangzong et al., <xref rid="B190" ref-type="bibr">2006</xref>; Droma et al., <xref rid="B52" ref-type="bibr">2007</xref>; Kiechl-Kohlendorfer et al., <xref rid="B85" ref-type="bibr">2007</xref>; Sy et al., <xref rid="B165" ref-type="bibr">2007</xref>). However, acute hypoxia exposure, as occurs with acute altitude exposure, as in many other stress situations, can induce an asthmatic episode of bronchoconstriction. On the other hand, when the acclimatization process advances, the asthmatic illness improved or even disappeared (Allegra et al., <xref rid="B4" ref-type="bibr">1995</xref>; Christie et al., <xref rid="B38" ref-type="bibr">1995</xref>; Cogo et al., <xref rid="B39" ref-type="bibr">1997</xref>, <xref rid="B40" ref-type="bibr">2004</xref>; Gourgoulianis et al., <xref rid="B69" ref-type="bibr">2001</xref>; Karagiannidis et al., <xref rid="B81" ref-type="bibr">2006</xref>; Schultze-Werninghaus, <xref rid="B152" ref-type="bibr">2006</xref>, <xref rid="B153" ref-type="bibr">2008</xref>). Regrettably, this improvement vanished upon returning to the sea level.</p><p>The triad altitude exposure-hypoxia-acclimatization produces a number of physiological changes, some of which are accepted as related to the improvement of bronchial asthma: (a) a different breathing control pattern (Harrison et al., <xref rid="B71" ref-type="bibr">2002</xref>; Serebrovskaya et al., <xref rid="B157" ref-type="bibr">2003</xref>), (b) mitochondrial changes that optimize oxygen metabolism during the normal acclimatization process (Levett et al., <xref rid="B92" ref-type="bibr">2012</xref>), and (c) the decrease in free radicals and the associated anti-inflammatory and immunosuppressive effects (Meehan, <xref rid="B107" ref-type="bibr">1987</xref>; Simon et al., <xref rid="B159" ref-type="bibr">1994</xref>; Serebrovskaya et al., <xref rid="B157" ref-type="bibr">2003</xref>; Ohta et al., <xref rid="B123" ref-type="bibr">2011</xref>; Oliver et al., <xref rid="B124" ref-type="bibr">2013</xref>).</p><p>Since bronchial asthma improves with acclimatization to altitude and IEHH stimulates the acclimatization process (Rodr&#x000ed;guez et al., <xref rid="B142" ref-type="bibr">1999</xref>, <xref rid="B145" ref-type="bibr">2000</xref>; Casas H. et al., <xref rid="B30" ref-type="bibr">2000</xref>; Casas M. et al., <xref rid="B31" ref-type="bibr">2000</xref>; Ib&#x000e1;&#x000f1;ez et al., <xref rid="B78" ref-type="bibr">2000</xref>; Ricart et al., <xref rid="B134" ref-type="bibr">2000</xref>), it could be hypothesized that IEHH improves bronchial asthma. In fact, some medical studies have shown the usefulness of intermittent hypoxia exposure as a treatment for bronchial asthma (Harrison et al., <xref rid="B71" ref-type="bibr">2002</xref>; Serebrovskaya et al., <xref rid="B157" ref-type="bibr">2003</xref>). However, due to the different techniques and protocols used to produce the hypoxia and the wide dispersion of data, further research is required to design more effective protocols for intermittent hypoxia exposure that could prove useful in treating this disease. The ultimate objective of such treatments must be to reduce bronchial obstruction and the dependence on potentially dangerous drugs. Moreover, if protocols demonstrate a good response in bronchial asthma mitigation, they could also be useful for treating other illnesses with inflammatory backdrop. Table <xref rid="T4" ref-type="table">4</xref> summarizes some of the results that demonstrate a favorable effect of exposure to hypoxia on the symptoms of bronchial asthma.</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Examples of the application of intermittent hypoxia exposure on bronchial asthma patients.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Subjects</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Time of hypoxia</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Hypoxia method</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Hypoxia dosage</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Outcome</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Asthmatic (<italic>n</italic> = 143)</td><td valign="top" align="left" rowspan="1" colspan="1">1&#x02013;3 mo (living at Davos)</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">1,686 m</td><td valign="top" align="left" rowspan="1" colspan="1">Improvement in 133 patients</td><td valign="top" align="left" rowspan="1" colspan="1">Turban and Spengler, <xref rid="B171" ref-type="bibr">1906</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Asthmatic (<italic>n</italic> = 14)</td><td valign="top" align="left" rowspan="1" colspan="1">5 weeks (living at Davos)</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">1,686 m</td><td valign="top" align="left" rowspan="1" colspan="1">Improvement in patients with HDM IgE-meditated allergy</td><td valign="top" align="left" rowspan="1" colspan="1">Simon et al., <xref rid="B159" ref-type="bibr">1994</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Asthmatic (<italic>n</italic> = 11)</td><td valign="top" align="left" rowspan="1" colspan="1">Mt Rosa &#x00026; near Mt Everest BC (after 3&#x02013;6 d trekking)</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">4,559 and 5,050 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Bronchial responsiveness to hypoosmolar aerosol 72 h after arrival</td><td valign="top" align="left" rowspan="1" colspan="1">Allegra et al., <xref rid="B4" ref-type="bibr">1995</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Asthmatic (<italic>n</italic> = 14)</td><td valign="top" align="left" rowspan="1" colspan="1">1 mo (living at Davos)</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">1,686 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Airway responsiveness to histamine after return to SL in children with atopic asthma at altitude</td><td valign="top" align="left" rowspan="1" colspan="1">Christie et al., <xref rid="B38" ref-type="bibr">1995</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Asthmatic (<italic>n</italic> = 16)</td><td valign="top" align="left" rowspan="1" colspan="1">1 mo (living at Davos)</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">1,560 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Airways inflammation</td><td valign="top" align="left" rowspan="1" colspan="1">van Velzen et al., <xref rid="B174" ref-type="bibr">1996</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Asthmatic (<italic>n</italic> = 11)</td><td valign="top" align="left" rowspan="1" colspan="1">3 d trekking from 2,800 to 5,050 m</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">5,050 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Bronchial response</td><td valign="top" align="left" rowspan="1" colspan="1">Cogo et al., <xref rid="B39" ref-type="bibr">1997</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Children (<italic>n</italic> = 874) <break/>Epidemiologic study</td><td valign="top" align="left" rowspan="1" colspan="1">Chronic</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">SL &#x02013; 1,200 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Prevalence &#x02193;morbidity of bronchial asthma in children at altitude</td><td valign="top" align="left" rowspan="1" colspan="1">Gourgoulianis et al., <xref rid="B69" ref-type="bibr">2001</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Athletes (<italic>n</italic> = 40; 20 asthmatic)</td><td valign="top" align="left" rowspan="1" colspan="1">IHT 6 &#x000d7; (5:5) 15 sessions in 3 wk</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02248;6,800 m</td><td valign="top" align="left" rowspan="1" colspan="1">Improvement in symptoms <break/>&#x02193;Medication use</td><td valign="top" align="left" rowspan="1" colspan="1">Harrison et al., <xref rid="B71" ref-type="bibr">2002</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Central Tibet epidemiologic study</td><td valign="top" align="left" rowspan="1" colspan="1">Permanent stay</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">3,000&#x02013;4,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Prevalence<break/> &#x02191;Risk due to western lifestyle</td><td valign="top" align="left" rowspan="1" colspan="1">Yangzong et al., <xref rid="B190" ref-type="bibr">2006</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Asthmatics (<italic>n</italic> = 11)</td><td valign="top" align="left" rowspan="1" colspan="1">3 wk (living at Davos)</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">1,686 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;local airway inflammation</td><td valign="top" align="left" rowspan="1" colspan="1">Karagiannidis et al., <xref rid="B81" ref-type="bibr">2006</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Asmathics (<italic>n</italic> = 296) <break/>Retrospective review</td><td valign="top" align="left" rowspan="1" colspan="1">2 wk&#x02212;9 mo</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">1,500&#x02013;1,800 m</td><td valign="top" align="left" rowspan="1" colspan="1">Beneficial effect, in particular in steroid-dependent patients</td><td valign="top" align="left" rowspan="1" colspan="1">Schultze-Werninghaus, <xref rid="B152" ref-type="bibr">2006</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Epidemiologic ISAAC&#x02013;HWO study <break/>13&#x02013;14 y old children (<italic>n</italic> = 3,196)</td><td valign="top" align="left" rowspan="1" colspan="1">Chronic (living in Lhasa)</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">3,658 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Prevalence (Asthma prevalence in Lhasa was the lowest worldwide in ISAAC study)</td><td valign="top" align="left" rowspan="1" colspan="1">Droma et al., <xref rid="B52" ref-type="bibr">2007</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Epidemiologic study <break/>Hospitalized asthmatic children <break/>6&#x02013;11 y old (<italic>n</italic> = 305)</td><td valign="top" align="left" rowspan="1" colspan="1">Chronic</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">450&#x02013;1,800 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Risk of hospitalization for atopic asthma</td><td valign="top" align="left" rowspan="1" colspan="1">Kiechl-Kohlendorfer et al., <xref rid="B85" ref-type="bibr">2007</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Epidemiologic study (<italic>n</italic> = 9984)</td><td valign="top" align="left" rowspan="1" colspan="1">Chronic</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">1,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Prevalence <break/>&#x02193;Asthma-like symptoms</td><td valign="top" align="left" rowspan="1" colspan="1">Sy et al., <xref rid="B165" ref-type="bibr">2007</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Asthmatics (<italic>n</italic> = 428) <break/>Retrospective review</td><td valign="top" align="left" rowspan="1" colspan="1">3 wk&#x02212;9 mo</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">1,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">Beneficial effects beyond the effects of allergen avoidance</td><td valign="top" align="left" rowspan="1" colspan="1">Schultze-Werninghaus, <xref rid="B153" ref-type="bibr">2008</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mice (<italic>in vivo</italic>; lymphoid organs)</td><td valign="top" align="left" rowspan="1" colspan="1">2 h</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.08 <break/>FiO<sub>2</sub> = 0.21 <break/>FiO<sub>2</sub> = 1</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;T cell activation <break/>T cell activation <italic>in vivo</italic> is dependent on localization and decrease with hypoxia</td><td valign="top" align="left" rowspan="1" colspan="1">Ohta et al., <xref rid="B123" ref-type="bibr">2011</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mountaineers (<italic>n</italic> = 27)</td><td valign="top" align="left" rowspan="1" colspan="1">Alpine activities 11&#x02013;18 d over 3,777 m</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">3,777 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Development of new immunity in humans</td><td valign="top" align="left" rowspan="1" colspan="1">Oliver et al., <xref rid="B124" ref-type="bibr">2013</xref></td></tr></tbody></table><table-wrap-foot><p><italic>Altitude, geographic altitude; BC, Base camp; FiO<sub>2</sub>, Fraction of inspired oxygen; HC, Hypobaric Chamber; HDM, house dust mite; IHT, Intermittent hypoxic training alternating hypoxia with normoxia along the session; ISSAC, International Study of Asthma and Allergies in Childhood; WHO, World Health Organization</italic>.</p></table-wrap-foot></table-wrap></sec><sec><title>Neurological impact of hypoxic exposure</title><p>Hypobaric hypoxic exposure at altitude, usually long-term, results in several pathophysiological and psychological conditions associated with the nervous system. The term high altitude deterioration (HAD) was first used by members of early Mount Everest expeditions to denote the deterioration in mental and physical condition due to prolonged time spent at high altitudes (Ward, <xref rid="B180" ref-type="bibr">1954</xref>). It is well known among climbers that staying at extreme altitudes for long periods is deleterious (Milledge, <xref rid="B109" ref-type="bibr">2003</xref>). Manifestations vary depending on the altitude reached and the individual's hypoxia tolerance, but include acute and chronic mountain sickness, memory loss and high-altitude cerebral edema (Lieberman et al., <xref rid="B95" ref-type="bibr">1994</xref>; Hornbein, <xref rid="B77" ref-type="bibr">2001</xref>; West et al., <xref rid="B181" ref-type="bibr">2013</xref>). Acute mountain sickness generally occurs 6 to 12 h after an unacclimatized person ascends to 2,500 m or higher (B&#x000e4;rtsch and Swenson, <xref rid="B15" ref-type="bibr">2013</xref>). As a result, cognitive function may be impaired under hypoxia (Viru&#x000e9;s-Ortega et al., <xref rid="B175" ref-type="bibr">2006</xref>), although the physiological changes that occur during acclimatization prevent mountain sickness. Given the acclimatization-like responses triggered by intermittent hypoxic exposure, it offers protection against severe hypoxia exposure damage and has been reported to produce beneficial effects (Kushwah et al., <xref rid="B89" ref-type="bibr">2016</xref>). Our group reported how short-term (3-h sessions on three consecutive days) IEHH with surface muscle electrostimulation increased the concentration of circulating progenitor cells in the peripheral blood of humans (Viscor et al., <xref rid="B176" ref-type="bibr">2009</xref>). However, we were unable to reproduce these results later in healthy patients and those with traumatic brain injuries (Corral et al., <xref rid="B41" ref-type="bibr">2014a</xref>,<xref rid="B42" ref-type="bibr">b</xref>), thus raising doubts about the potential role of hypoxia exposure in the release of stem cells to circulation and its involvement in the tissue regeneration process. In any case, the translation of the physiological effects of IEHH to humans is not straightforward in the field of neurology.</p><p>The brain's protective mechanisms involved in intermittent exposure to hypoxia have been widely studied using experimental animal models, and numerous beneficial effects have been reported. Intermittent hypoxia facilitates the proliferation of neural stem cells <italic>in situ</italic> in the subventricular zone and dentate gyrus of rat brains (Zhu et al., <xref rid="B197" ref-type="bibr">2005</xref>; Ross et al., <xref rid="B146" ref-type="bibr">2012</xref>). Xu et al. (<xref rid="B189" ref-type="bibr">2007</xref>) described a time-dependent migration of neural progenitor cells (NPC), promoted by hypoxia-induced astrocytes, thereby suggesting a role for astrocytes in NPC replacement therapy in the central nervous system. Intermittent hypoxia stimulated hippocampal angiogenesis and neurogenesis and improved short-term memory indices in control mice; and, in brain-injured mice, it reduced injury size and prevented memory impairments (Bouslama et al., <xref rid="B22" ref-type="bibr">2015</xref>). It was recently reported that activation of HIF-1 is involved in hyperglycemia-aggravated blood-brain barrier disruption in an ischemic stroke model (Zhang et al., <xref rid="B195" ref-type="bibr">2016b</xref>). Moreover, glycemic control by insulin abolished HIF-1&#x003b1; upregulation in diabetic animals and reduced blood-brain barrier permeability and brain infarction (Zhang et al., <xref rid="B195" ref-type="bibr">2016b</xref>). Acute intermittent hypoxia can trigger spinal plasticity associated with sustained increases in respiratory, somatic and/or autonomic motor output (Streeter et al., <xref rid="B164" ref-type="bibr">2017</xref>).</p><p>In rats, intermittent hypobaric hypoxia preconditioning caused a reduction in the degree of brain injury following ischemia-reperfusion by reducing hippocampal neuronal apoptosis by local upregulation of neuroglobin and Bcl-2 expression (Wu et al., <xref rid="B186" ref-type="bibr">2015</xref>). Neuroglobin is an intracellular monomer hemoprotein that was discovered by Burmester et al. (<xref rid="B25" ref-type="bibr">2000</xref>) and is expressed in the central and peripheral nervous system, cerebrospinal fluid, retina and some endocrine areas of the brain (Burmester and Hankeln, <xref rid="B24" ref-type="bibr">2004</xref>). It reversibly binds oxygen with a higher affinity than normal adult hemoglobin, and plays a critical role in brain tissue protection facing a possible oxygen delivery shortage (Ascenzi et al., <xref rid="B11" ref-type="bibr">2016</xref>). Bcl-2 is an anti-apoptotic protein localized in the outer membrane of the mitochondria; overexpression of Bcl-2 in neurons can inhibit neuron apoptosis induced by ischemia-reperfusion injury by maintaining the integrity of mitochondria (Xing et al., <xref rid="B188" ref-type="bibr">2008</xref>; Zhang et al., <xref rid="B191" ref-type="bibr">2008</xref>).</p><p>Kushwah et al. (<xref rid="B89" ref-type="bibr">2016</xref>) also explored the ameliorating potential of intermittent hypoxia against the detrimental effects of unpredictable chronic mild stress (UCMS) on anxiety and depression-like behavior in rats, through the enhancement of neurogenesis in the hippocampus, a response mediated by brain derived neurotrophic factor (BDNF). In the postischemic rat brain, intermittent hypoxia intervention rescued ischemia-induced spatial learning and memory impairment by inducing hippocampal neurogenesis and functional synaptogenesis via BDNF expression (Tsai et al., <xref rid="B170" ref-type="bibr">2013</xref>).</p><p>Nowadays, intermittent hypoxia exposure is known to enhance neurogenesis at multiple stages. Notch1 is a transcription factor in the neuron's membrane that regulates several stages of neurogenesis and promotes differentiation of progenitor cells into astroglia. Notch1 is activated by hypoxia <italic>in vivo</italic>, and such activation has been shown to be required for hypoxia-induced neurogenesis (Zhang K. et al., <xref rid="B192" ref-type="bibr">2014a</xref>). Chronic IEHH pretreatment can reduce cerebral ischemic injury, which, as similarly reported for myocardium (see above), is mediated through upregulation of the expression and activity of mitochondrial membrane ATP-sensitive potassium channel (mitoKATP) (Zhang et al., <xref rid="B193" ref-type="bibr">2016a</xref>). As is well known, hypoxia inducible factor-1 (HIF-1) is the key transcription factor that controls early adaptive responses to the lack of oxygen in mammalian cells. HIF-1&#x003b1; and HIF-1&#x003b2; expression was measured during acclimatization to hypobaric hypoxia in the rat cerebral cortex, and neurons, astrocytes, ependymal cells and possibly endothelial cells were the cell types that expressed HIF-1&#x003b1; (Ch&#x000e1;vez et al., <xref rid="B34" ref-type="bibr">2000</xref>). Thus, the vascular remodeling and metabolic changes triggered during prolonged hypoxia may restore normal oxygen delivery levels to brain tissue (Agani et al., <xref rid="B2" ref-type="bibr">2002</xref>; Chavez and LaManna, <xref rid="B35" ref-type="bibr">2002</xref>).</p><p>Finally, there is solid evidence of the beneficial effects of intermittent hypoxia exposure on spinal cord neural tissue repair. Complete or incomplete spinal cord injuries are characterized by spared synaptic pathways below the level of the injury. Intermittent hypoxia elicits plasticity in the spinal cord and strengthens these spared synaptic pathways, expressed as respiratory and somatic functional recovery in both experimental animals and humans with traumatic spinal cord injury (Navarrete-Opazo et al., <xref rid="B117" ref-type="bibr">2015</xref>, <xref rid="B114" ref-type="bibr">2017a</xref>,<xref rid="B116" ref-type="bibr">b</xref>; Dougherty et al., <xref rid="B51" ref-type="bibr">2017</xref>; Trumbower et al., <xref rid="B169" ref-type="bibr">2017</xref>). Table <xref rid="T5" ref-type="table">5</xref> lists studies reporting beneficial neurological impact after a wide range of intermittent hypoxia exposure protocols.</p><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Examples of the effects of intermittent hypoxia exposure with favorable neurological impact.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Subjects</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Time of hypoxia</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Hypoxia method</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Hypoxia dosage</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Outcome</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats</td><td valign="top" align="left" rowspan="1" colspan="1">6 h, 12 h, or 1, 4, 7, 14, or 21 d</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">BP = 380 Torr <break/>(&#x02248;5,500 m)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Hct <break/>&#x02191;GLUT-1 &#x02191;VEGF <break/>&#x02191;brain HIF-1&#x003b1; until 14 d <break/>&#x02193;brain HIF-1&#x003b1; at 21 d</td><td valign="top" align="left" rowspan="1" colspan="1">Ch&#x000e1;vez et al., <xref rid="B34" ref-type="bibr">2000</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cell culture</td><td valign="top" align="left" rowspan="1" colspan="1">4 h</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">1%O <sub>2</sub> + 5%CO<sub>2</sub> + N<sub>2</sub></td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;HIF-1&#x003b1; (NO interferes expression)</td><td valign="top" align="left" rowspan="1" colspan="1">Agani et al., <xref rid="B2" ref-type="bibr">2002</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats (male)</td><td valign="top" align="left" rowspan="1" colspan="1">11&#x02013;13 min</td><td valign="top" align="left" rowspan="1" colspan="1">Ischemia</td><td valign="top" align="left" rowspan="1" colspan="1">Ischemia after cardiac arrest</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;HIF-1&#x003b1; 12 h&#x02212;7 d <break/>&#x02191;IGF-1</td><td valign="top" align="left" rowspan="1" colspan="1">Chavez and LaManna, <xref rid="B35" ref-type="bibr">2002</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats (male) (3 groups)</td><td valign="top" align="left" rowspan="1" colspan="1">4 h/d for 2 wk</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">3,000 m <break/>5,000 m <break/>Control normoxic</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;BrdU-labeled cells in SVZ and DG (NPC) in rat brain</td><td valign="top" align="left" rowspan="1" colspan="1">Zhu et al., <xref rid="B197" ref-type="bibr">2005</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Astrocytes and NPC culture from brain cortex of newborn rats</td><td valign="top" align="left" rowspan="1" colspan="1">6, 12, 18, and 24 h</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">1%O<sub>2</sub> + 5%CO<sub>2</sub> + N<sub>2</sub> (astrocytes)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Migration of NPC by hypoxia-induced astrocytes (maximal at 18 h)</td><td valign="top" align="left" rowspan="1" colspan="1">Xu et al., <xref rid="B189" ref-type="bibr">2007</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Neuronal cultures of 16&#x02013;18 days old fetuses of Sprague&#x02013;Dawley rats</td><td valign="top" align="left" rowspan="1" colspan="1">6 h &#x0201c;ischemia&#x0201d; <break/>48 h &#x0201c;reperfusion&#x0201d;</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">Anoxic atmosphere (5%CO<sub>2</sub> + 95%N<sub>2</sub>)</td><td valign="top" align="left" rowspan="1" colspan="1">Mitochondrial dysfunction &#x00026; ER stress &#x021d2; neuronal apoptosis <break/>&#x02191;Bcl-2 &#x021d2;&#x02193;Apoptosis</td><td valign="top" align="left" rowspan="1" colspan="1">Zhang et al., <xref rid="B191" ref-type="bibr">2008</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats (<italic>n</italic> = 122) <break/>-Ischemia MCA <italic>n</italic> = 42 <break/>-Ischemia MCA + post-cond <italic>n</italic> = 42 <break/>-Control group <italic>n</italic> = 40</td><td valign="top" align="left" rowspan="1" colspan="1">60 min MCA ischemia post-cond (60 min after reperfusion): reperfusion for 30 s, MCA occluded for 5 cycles &#x000d7; 30 s</td><td valign="top" align="left" rowspan="1" colspan="1">Ischemia <break/>(MCA occlusion)</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown (ischemia)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Bcl-2 &#x02191;Hsp70 &#x02193;Cytochrome <italic>c</italic>
<break/> &#x02193;Bax translocation to the mitochondria &#x02193;Caspase-3 <break/>&#x02193;Infarct volume &#x02193;Oxidative stress <break/>&#x02191;Neurologic scores</td><td valign="top" align="left" rowspan="1" colspan="1">Xing et al., <xref rid="B188" ref-type="bibr">2008</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Neonatal mice: acute IH and control group</td><td valign="top" align="left" rowspan="1" colspan="1">40 min 20 &#x000d7; (1:1)</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.10 (10% O<sub>2</sub>)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;SVZ derived NPC <italic>in vitro</italic></td><td valign="top" align="left" rowspan="1" colspan="1">Ross et al., <xref rid="B146" ref-type="bibr">2012</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats (<italic>n</italic> = 55) <break/>Groups: with or without MCAO and/or IH, and/or zidovudine</td><td valign="top" align="left" rowspan="1" colspan="1">4 h/d for 7 d</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.12 (12% O<sub>2</sub>)</td><td valign="top" align="left" rowspan="1" colspan="1">Post brain ischemia: <break/>&#x02191;Synaptogenesis via BDNF <break/> &#x02191;Neurogenesis <break/>&#x02191;Spatial learning and memory</td><td valign="top" align="left" rowspan="1" colspan="1">Tsai et al., <xref rid="B170" ref-type="bibr">2013</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">TBI medical history human males. <break/>4 groups: <break/>-Exercise and SES (<italic>n</italic> = 5) <break/> -Cycling (<italic>n</italic> = 5) <break/>-IHH and SES (<italic>n</italic> = 6) <break/>-Control (<italic>n</italic> = 5)</td><td valign="top" align="left" rowspan="1" colspan="1">2 h/d &#x000d7; 3 d/wk for 12 wk</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">4,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;CPC <break/>No changes in psychological tests <break/> &#x02191;Aerobic capacity or workload</td><td valign="top" align="left" rowspan="1" colspan="1">Corral et al., <xref rid="B41" ref-type="bibr">2014a</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mice (wildtype vs. Notch1 KO)</td><td valign="top" align="left" rowspan="1" colspan="1">4 h/d during consecutive 28 d</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">2,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Notch1 <break/> &#x02191;Hypoxia induced neurogenesis</td><td valign="top" align="left" rowspan="1" colspan="1">Zhang K. et al., <xref rid="B192" ref-type="bibr">2014a</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Newborn mice with brain injury <break/>3 Groups (<italic>n</italic> = 373) <break/>-Hypoxia separated from the mother <break/>-Normoxia separated from the mother <break/>Control with mother</td><td valign="top" align="left" rowspan="1" colspan="1">20 events/h, 6 h/d from postnatal day 6 (P6) to P10</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.08 (8% O<sub>2</sub>)</td><td valign="top" align="left" rowspan="1" colspan="1">Control mice: <break/>&#x02191;Hippocampal angiogenesis <break/>&#x02191;Neurogenesis <break/>&#x02191;Short-term memory indices <break/>Brain-injured mice: <break/>&#x02193;Injury size <break/>&#x02193;Memory impairments</td><td valign="top" align="left" rowspan="1" colspan="1">Bouslama et al., <xref rid="B22" ref-type="bibr">2015</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats (<italic>n</italic> = 48) hypocampal CA1 region. 4 groups with or without ischemia-reperfusion and IHH</td><td valign="top" align="left" rowspan="1" colspan="1">Hypoxia for 4 d once a day I/R 8 min</td><td valign="top" align="left" rowspan="1" colspan="1"><italic>In vivo</italic>
<break/>I/R</td><td valign="top" align="left" rowspan="1" colspan="1">Unknown (ischemia)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Surviving cells in the hippocampal CA1 in IHH+IR <break/>&#x02191;Bcl-2</td><td valign="top" align="left" rowspan="1" colspan="1">Wu et al., <xref rid="B186" ref-type="bibr">2015</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats with C2 medular hemisection (<italic>n</italic> = 32)</td><td valign="top" align="left" rowspan="1" colspan="1">IHT 10 &#x000d7; (5:5) intervals (total 95 min) for 7 d</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.105 (10.5% O<sub>2</sub>)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Breathing capacity <break/> &#x02191;Contralateral diaphragm (adenosine dependent) <break/>&#x02212;2&#x000b0; intercostal muscle (adenosine independent)</td><td valign="top" align="left" rowspan="1" colspan="1">Navarrete-Opazo et al., <xref rid="B117" ref-type="bibr">2015</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats (male) with Chronic Mild Stress induced depression (<italic>n</italic> = 60) and controls (<italic>n</italic> = 20)</td><td valign="top" align="left" rowspan="1" colspan="1">4 h/d for 2 wk</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">5,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">Avoid neuronal loss <break/>&#x02191;Neurogenesis <break/> &#x02191;BDNF&#x02013;TrkB signaling</td><td valign="top" align="left" rowspan="1" colspan="1">Kushwah et al., <xref rid="B89" ref-type="bibr">2016</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats (<italic>n</italic> = 195) 6 groups with chronic 5 wk stress and/or IHH or IMIP or antagonist of mitoKATP</td><td valign="top" align="left" rowspan="1" colspan="1">6 h/d for 28 days</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">5,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Expression and activity of mitoK<sub>ATP</sub>
<break/> &#x02193;Cerebral ischemia injury <break/>&#x02193;UCMS</td><td valign="top" align="left" rowspan="1" colspan="1">Zhang et al., <xref rid="B193" ref-type="bibr">2016a</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats with C2 medular hemisection (<italic>n</italic> = 27) with or without hypoxia + adenosine inhibitor</td><td valign="top" align="left" rowspan="1" colspan="1">8 wk post-lesion 5 min<break/> hypoxia, 5-min<break/> normoxic 10 times<break/> (95 min) 7 d, AIH 3/wk 8 wk</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.105 (10.5% O<sub>2</sub>)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Tidal volume and bilateral diaphragm activity (enhanced by adenosine receptor inhibitor) for 4 wk</td><td valign="top" align="left" rowspan="1" colspan="1">Navarrete-Opazo et al., <xref rid="B116" ref-type="bibr">2017b</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats with spinal C2 hemisection. <break/>1) 7d after lesion <break/>2) 7wk after lesion <break/>+ serotonin receptor antagonist</td><td valign="top" align="left" rowspan="1" colspan="1">IHT 10 &#x000d7; (5:5) intervals (total 110 min)</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.105 (10.5% O<sub>2</sub>)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Breathing capacity <break/>Serotonin independent in acute (2wk) and serotonin dependent in chronic (8wk)</td><td valign="top" align="left" rowspan="1" colspan="1">Dougherty et al., <xref rid="B51" ref-type="bibr">2017</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Humans incomplete spinal cord injured (<italic>n</italic> = 35): <break/>IH + BWSTT (<italic>n</italic> = 18) <break/> NX + BWSTT (<italic>n</italic> = 17)</td><td valign="top" align="left" rowspan="1" colspan="1">IHT 15 &#x000d7; (1.5:1.5) intervals for 5<break/> consecutive d + 3 d/wk for 3 wk</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.09 (9% O<sub>2</sub>)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Walking recovery and endurance <break/>(up to 5wk)</td><td valign="top" align="left" rowspan="1" colspan="1">Navarrete-Opazo et al., <xref rid="B114" ref-type="bibr">2017a</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats (<italic>n</italic> = 12)</td><td valign="top" align="left" rowspan="1" colspan="1">IHT 3 &#x000d7; (5:5)</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.11 (11% O<sub>2</sub>) alternating with hyperoxia FiO<sub>2</sub> = 0.5 (O<sub>2</sub> 50%)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;or&#x02193;in firing rate of midcervical interneurons altering connectivity</td><td valign="top" align="left" rowspan="1" colspan="1">Streeter et al., <xref rid="B164" ref-type="bibr">2017</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Men with chronic incomplete spinal cord injury (<italic>n</italic> = 6) (double-blind, crossover study)</td><td valign="top" align="left" rowspan="1" colspan="1">IHT 15 &#x000d7; (1.5:1) intervals for 5 consecutive d + hand opening practice</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.09 (9% O<sub>2</sub>)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Hand dexterity, function, or opening in all participants</td><td valign="top" align="left" rowspan="1" colspan="1">Trumbower et al., <xref rid="B169" ref-type="bibr">2017</xref></td></tr></tbody></table><table-wrap-foot><p><italic>In IHT protocols hypoxia was alternated with room air (FiO<sub>2</sub> = 0.209) if nothing else is indicated. AIH, acute intermittent hypoxia; BDNF, brain derived neurotrophic factor; Bcl-2, B cell lymphoma/leukemia-2; BP, barometric pressure; BrdU, 5-Bromo-2-deoxyuridine-5-monophosphate; BWSTT, body weight-supported treadmill training; CAO, carotid artery occlusion; CIHH, chronic intermittent hypobaric hypoxia; CPC, circulating progenitor cells; DG, dentate gyrus; FiO<sub>2</sub>, Fraction of inspired oxygen; GLUT-1, glucose transporter-1; HC, Hypobaric Chamber; Hct, hematocrit; HIF, Hypoxia inducible factor; Hsp70, heat shock protein70; IGF-1, insulin-like growth factor-1; IH, intermittent hypoxia; IHH, intermittent hypobaric hypoxia; IHT, intervallic hypoxic training alternating hypoxia and normoxia along the session; IMIP, imipramine; I/R, ischemia-reperfusion; KO, knockout mutant; MCA, medium cerebral artery; MCAO, middle cerebral artery occlusion; NH, normobaric hypoxia; NO, nitric oxide; NPC, neural progenitor cells; NX, normoxia (placebo); ER, endoplasmic reticulum; TBI, traumatic brain injury; UCMS, Unpredictable Chronic Mild Stress; VEGF, vascular endothelial growth factor; SES, surface electrical stimulation; SVZ, subventricular zone</italic>.</p></table-wrap-foot></table-wrap></sec><sec><title>Other pathological conditions where the use of intermittent hypoxia exposure has potential therapeutic value</title><p>Since the altitude-hypoxia-acclimatization triad is known to have some antioxidant, anti-inflammatory and immunosuppressive effects (Meehan, <xref rid="B107" ref-type="bibr">1987</xref>; Meehan et al., <xref rid="B108" ref-type="bibr">1988</xref>; Ohta et al., <xref rid="B123" ref-type="bibr">2011</xref>; Oliver et al., <xref rid="B124" ref-type="bibr">2013</xref>), a benefit in some other pathologies related to immune response, such as psoriasis, atopy, arthritis or autoimmune pneumonitis can be expected. This is still a controversial field with no extensive clinical studies available, although some medical descriptive studies point to potential future research opportunities (Singh et al., <xref rid="B160" ref-type="bibr">1977</xref>; Vocks et al., <xref rid="B178" ref-type="bibr">1999</xref>; Engst and Vocks, <xref rid="B55" ref-type="bibr">2000</xref>; Steiner, <xref rid="B161" ref-type="bibr">2009</xref>).</p><p>Intermittent exposure to both normobaric and hypobaric hypoxia has been related to some protective effects (Cai et al., <xref rid="B28" ref-type="bibr">2003</xref>; Costa et al., <xref rid="B43" ref-type="bibr">2013</xref>) and beneficial outcomes in several pathological conditions, especially in those related to metabolic syndrome (Marquez et al., <xref rid="B103" ref-type="bibr">2013</xref>; Leone and Lalande, <xref rid="B91" ref-type="bibr">2017</xref>; Serebrovska et al., <xref rid="B154" ref-type="bibr">2017</xref>). The possible role of intermittent hypoxia on body weight control has also attracted considerable attention. In addition to improving exercise performance and diet control, intermittent exposure protocols to normobaric and hypobaric hypoxia have been applied in an attempt to potentiate weight loss, showing in some cases positive short-term results (Haufe et al., <xref rid="B73" ref-type="bibr">2008</xref>; Netzer et al., <xref rid="B119" ref-type="bibr">2008</xref>; Lippl et al., <xref rid="B96" ref-type="bibr">2010</xref>; Wiesner et al., <xref rid="B182" ref-type="bibr">2010</xref>; Cabrera-Aguilera et al., <xref rid="B27" ref-type="bibr">in press</xref>). However, a long-term study failed to demonstrate permanent body weight reduction after IEHH (Gatterer et al., <xref rid="B64" ref-type="bibr">2015</xref>), suggesting that additional research is needed to clarify the discrepancies reported in this field.</p><p>In summary, recent reports call for increased attention to the potential benefits of the application of intermittent hypoxia protocols in several clinical areas (Dale et al., <xref rid="B44" ref-type="bibr">2014</xref>; Mateika et al., <xref rid="B106" ref-type="bibr">2015</xref>). It is likely that future studies will yield important new information regarding potential therapeutic uses of intermittent hypoxia. Table <xref rid="T6" ref-type="table">6</xref> lists a non-exhaustive but representative sample of studies reporting favorable impact of intermittent hypoxia exposure in other pathological conditions.</p><table-wrap id="T6" position="float"><label>Table 6</label><caption><p>Examples of the effects of intermittent hypoxia exposure with favorable impact in other pathological conditions.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Subjects</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Time of hypoxia</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Hypoxia method</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Hypoxia dosage</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Outcome</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Epidemiological study (1965&#x02013;1972) in 20,000 altitude native men vs. to 130,700 lowlanders (760 m)</td><td valign="top" align="left" rowspan="1" colspan="1">Chronic</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">3,692&#x02013;5,538 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Diseases <break/>&#x02193;Morbidity rates</td><td valign="top" align="left" rowspan="1" colspan="1">Singh et al., <xref rid="B160" ref-type="bibr">1977</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats (<italic>n</italic> = 24)</td><td valign="top" align="left" rowspan="1" colspan="1">8 h/d for 30 d</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">5,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Resistance to epileptogenic action of penicillin</td><td valign="top" align="left" rowspan="1" colspan="1">Agadzhanyan and Torshin, <xref rid="B1" ref-type="bibr">1986</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Healthy men (<italic>n</italic> = 7) (operation Everest II)</td><td valign="top" align="left" rowspan="1" colspan="1">40 d</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">7,620 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;T cell function <break/>&#x02193;PHA-stimulated thymidine uptake</td><td valign="top" align="left" rowspan="1" colspan="1">Meehan, <xref rid="B107" ref-type="bibr">1987</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Healthy men (<italic>n</italic> = 8) (operation Everest II)</td><td valign="top" align="left" rowspan="1" colspan="1">4 weeks <break/>5 d at 2,286m <break/>28 d at 7,620 m (gradually) peaks 1&#x02013;4 h at 8,839 m</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">2,286 m <break/>7,620 m <break/>8,839 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Phytohemagglutinin-stimulated thymidine uptake and protein synthesis in mononuclear cells <break/> &#x02191;Monocytes <break/>&#x02191;Plasma IgM &#x00026; IgA <break/>&#x02193;T-cell activation</td><td valign="top" align="left" rowspan="1" colspan="1">Meehan et al., <xref rid="B108" ref-type="bibr">1988</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Essential hypertension patients</td><td valign="top" align="left" rowspan="1" colspan="1">30 min/d, 5 d/wk for 3 wks</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">3,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;BP &#x02193;Blood vol &#x02193;[Na]serum &#x02191;Microcirculation &#x02191;PO<sub>2</sub> tissue &#x02193;cholesterol</td><td valign="top" align="left" rowspan="1" colspan="1">Aleshin et al., <xref rid="B3" ref-type="bibr">1993</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Tibetan natives at moderate (M) and high (H) altitudes</td><td valign="top" align="left" rowspan="1" colspan="1">Chronic</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">M: 2,000&#x02013;3,000 m <break/>H: 4,000&#x02013;4,700 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;HR &#x02193;HVR &#x02193;V<sub>E</sub>max <break/>in group at H altitude</td><td valign="top" align="left" rowspan="1" colspan="1">Ge et al., <xref rid="B65" ref-type="bibr">1994</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Psoriasis affected patients (<italic>n</italic> = 76)</td><td valign="top" align="left" rowspan="1" colspan="1">4 wk</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">1,560 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Psoriasis <break/>no changes in plasma cortisol</td><td valign="top" align="left" rowspan="1" colspan="1">Vocks et al., <xref rid="B178" ref-type="bibr">1999</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Neurodermitis patients (<italic>n</italic> = 31,438)</td><td valign="top" align="left" rowspan="1" colspan="1">4 wk</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">1,560 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Dermatosis <break/>&#x02193;Psoriasis &#x02193;ECP</td><td valign="top" align="left" rowspan="1" colspan="1">Engst and Vocks, <xref rid="B55" ref-type="bibr">2000</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Coronary patients (<italic>n</italic> = 46)</td><td valign="top" align="left" rowspan="1" colspan="1">22 sessions 3 h/d</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">3,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Total cholesterol <break/>&#x02191;HDL &#x02193;LDL &#x02193;VLDL &#x02193;TG</td><td valign="top" align="left" rowspan="1" colspan="1">Tin'kov and Aksenov, <xref rid="B167" ref-type="bibr">2002</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mice (<italic>n</italic> = 9)</td><td valign="top" align="left" rowspan="1" colspan="1">IHT 5 &#x000d7; (6:6)</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.06</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;EPO; &#x02191;heart HIF-1&#x003b1;</td><td valign="top" align="left" rowspan="1" colspan="1">Cai et al., <xref rid="B28" ref-type="bibr">2003</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Obese subjects (BMI &#x0003e; 27) (<italic>n</italic> = 20) <break/>-Hypoxia (<italic>n</italic> = 10; 8 w + 2 m) <break/> -Sham (<italic>n</italic> = 10; 8 w + 2 m)</td><td valign="top" align="left" rowspan="1" colspan="1">1.5 h/d, 3 d/wk for 8 wk exercising at 60% VO<sub>2</sub>max</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.15 (&#x02248;2,500 m) <break/>FiO<sub>2</sub> = 0.201 (&#x02248;450 m)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;BMI and &#x02191;BW loss &#x02193;cholesterol &#x02193;TG and &#x02193;LDL</td><td valign="top" align="left" rowspan="1" colspan="1">Netzer et al., <xref rid="B119" ref-type="bibr">2008</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Healthy men (<italic>n</italic> = 20) <break/>-Hypoxia (<italic>n</italic> = 10) <break/>-Normoxia (<italic>n</italic> = 10)</td><td valign="top" align="left" rowspan="1" colspan="1">1 h/d, 3 d/wk for 4 wk exercising at 3 mmol/L Lac HR</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.15 (&#x02248;2,760 m) <break/> FiO<sub>2</sub> = 0.21 (&#x02248;SL)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Body fat content &#x02193;TG &#x02193;HOMA-Index fasting insulin and &#x02193;AUCins</td><td valign="top" align="left" rowspan="1" colspan="1">Haufe et al., <xref rid="B73" ref-type="bibr">2008</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Atopic dermatitis and psoriasis patients (mini-review)</td><td valign="top" align="left" rowspan="1" colspan="1">12 d&#x02212;4 wk</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">1,560 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Symptoms</td><td valign="top" align="left" rowspan="1" colspan="1">Steiner, <xref rid="B161" ref-type="bibr">2009</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Obese men (<italic>n</italic> = 20)</td><td valign="top" align="left" rowspan="1" colspan="1">1 week</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">2,650 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;BW &#x02191;BMR &#x02193;Food intake &#x02191;Basal leptin &#x02193;diastolic BP</td><td valign="top" align="left" rowspan="1" colspan="1">Lippl et al., <xref rid="B96" ref-type="bibr">2010</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Overweight to obese subjects (<italic>n</italic> = 24)</td><td valign="top" align="left" rowspan="1" colspan="1">4 wk training under hypoxia at 65% VO<sub>2</sub>max</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.15 (&#x02248;2,760 m)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Physical fitness <break/>&#x02193;Metabolic risk markers <break/>&#x02191;Body composition</td><td valign="top" align="left" rowspan="1" colspan="1">Wiesner et al., <xref rid="B182" ref-type="bibr">2010</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mice (<italic>in vivo</italic>; lymphoid organs)</td><td valign="top" align="left" rowspan="1" colspan="1">Acute 2 h exposure</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.08 <break/>FiO<sub>2</sub> = 0.21 <break/>FiO<sub>2</sub> = 1 (variable in organs: thymus &#x0003c; lymphoid nodes &#x0003c; spleen)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;T-cell activation in better oxygenated tissues. <break/>T-cell activation <italic>in vivo</italic> is dependent on localization and decrease with hypoxia</td><td valign="top" align="left" rowspan="1" colspan="1">Ohta et al., <xref rid="B123" ref-type="bibr">2011</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mice (WT vs. KO)</td><td valign="top" align="left" rowspan="1" colspan="1">Myoblast cell culture</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">5 vs. 21%</td><td valign="top" align="left" rowspan="1" colspan="1">Endogenous EPO promotes satellite activation and functional recovery after muscle injury</td><td valign="top" align="left" rowspan="1" colspan="1">Jia et al., <xref rid="B79" ref-type="bibr">2012</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats (<italic>n</italic> = 8)</td><td valign="top" align="left" rowspan="1" colspan="1">3 h/d for 6 d</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">5,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">Injured excitotoxic brain: <break/> &#x02191;EPO &#x02193;Lipid peroxidation <break/>&#x02193;Apoptotic cell death</td><td valign="top" align="left" rowspan="1" colspan="1">Costa et al., <xref rid="B43" ref-type="bibr">2013</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Healthy adult sedentary men (<italic>n</italic> = 28)</td><td valign="top" align="left" rowspan="1" colspan="1">2 &#x000d7; 20 min/d &#x000d7; 3 d/wk for 10 weeks</td><td valign="top" align="left" rowspan="1" colspan="1">HC <break/>(CVAC) <break/>5 fluctuations/min</td><td valign="top" align="left" rowspan="1" colspan="1">Progressive: <break/>SL - 3,048 m (wk 1) <break/>SL - 6,096 m (wk 5&#x02013;10)</td><td valign="top" align="left" rowspan="1" colspan="1">No changes in Hct, [Hb], cholesterol and insulin <break/>&#x02193;Fasting plasma glucose <break/> &#x02193;Plasma glucose in response to oral glucose tolerance test</td><td valign="top" align="left" rowspan="1" colspan="1">Marquez et al., <xref rid="B103" ref-type="bibr">2013</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Recreationally active mountaineers (<italic>n</italic> = 10; 3 w + 7 m)</td><td valign="top" align="left" rowspan="1" colspan="1">28 h</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">3,777 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Immune response</td><td valign="top" align="left" rowspan="1" colspan="1">Oliver et al., <xref rid="B124" ref-type="bibr">2013</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Obese patients (BMI &#x0003e; 30 kg/m<sup>2</sup>) (<italic>n</italic> = 16; 4 w + 12 m)</td><td valign="top" align="left" rowspan="1" colspan="1">52 sess of 90 min (8 mo)</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">Exercise: 3,500 m <break/>Rest: 4,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">No added effects by hypoxia to those provoked by moderate intensity exercise</td><td valign="top" align="left" rowspan="1" colspan="1">Gatterer et al., <xref rid="B64" ref-type="bibr">2015</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Prediabetic adult patients (<italic>n</italic> = 11; 6 w + 5 m)</td><td valign="top" align="left" rowspan="1" colspan="1">3 sess/wk for 3 wk</td><td valign="top" align="left" rowspan="1" colspan="1">NH (IHT 5:5)</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.12 (&#x02248;4,400 m)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;mRNA expression of HIF-1&#x003b1; and target genes <break/>&#x02193;Fasting plasma glucose <break/>&#x02193;Plasma glucose response to 2 h post-oral glucose tolerance test</td><td valign="top" align="left" rowspan="1" colspan="1">Serebrovska et al., <xref rid="B154" ref-type="bibr">2017</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Trained rats (<italic>n</italic> = 78) <break/>-Basal (<italic>n</italic> = 6) <break/>-Hypoxia (<italic>n</italic> = 24) <break/>-Hypoxia + LAE (<italic>n</italic> = 24) <break/>-Normoxia (<italic>n</italic> = 24)</td><td valign="top" align="left" rowspan="1" colspan="1">4 h/d for 14 d</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">4,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">m. soleus: <break/>&#x02191;Histological muscle damage recovery <break/>No change in fiber types <break/>&#x02193;Fiber size <break/>&#x02191;Capillarisation <break/>&#x02191;VEGF expression <break/> &#x02191;Citrate synthase activity <break/>&#x02191;PGC-1&#x003b1;</td><td valign="top" align="left" rowspan="1" colspan="1">Rizo-Roca et al., <xref rid="B140" ref-type="bibr">2017a</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Trained Rats (<italic>n</italic> = 78) <break/>-Basal (<italic>n</italic> = 6) <break/>-Hypoxia (<italic>n</italic> = 24) <break/>-Hypoxia + LAE (<italic>n</italic> = 24) <break/>-Normoxia (<italic>n</italic> = 24)</td><td valign="top" align="left" rowspan="1" colspan="1">4 h/d for 14 d</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">4,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">m. soleus: <break/>&#x02191;Mitochondrial biogenesis markers <break/>&#x02191;Mitochondrial dynamics markers <break/>&#x02193;Oxidative stress <break/>&#x02193;Apoptotic signalling</td><td valign="top" align="left" rowspan="1" colspan="1">Rizo-Roca et al., <xref rid="B141" ref-type="bibr">2017b</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Rats (<italic>n</italic> = 28) <break/>-Normoxia sedentary (<italic>n</italic> = 7) <break/>-Normoxia + EET (<italic>n</italic> = 7) <break/>-Hypoxia sedentary (<italic>n</italic> = 7) <break/>-Hypoxia + EET (<italic>n</italic> = 7)</td><td valign="top" align="left" rowspan="1" colspan="1">5 h/d for 4 wk</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">6,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;Food intake <break/>&#x02193;Body weight gain <break/> &#x02193;Oxygen consumption <break/>Additive effect of IHH+EET</td><td valign="top" align="left" rowspan="1" colspan="1">Cabrera-Aguilera et al., <xref rid="B27" ref-type="bibr">in press</xref></td></tr></tbody></table><table-wrap-foot><p><italic>3 mmol/L Lac HR, heart rate corresponding to the 3 mmol/L lactate value in the FiO<sub>2</sub>-specific incremental test; Altitude, geographic altitude; AMS, acute mountain sickness; AUCins, Insulin response (area under curve) to oral glucose tolerance test; BMI, body mass index; BMR, basal metabolic rate; BP, arterial blood pressure; BW; body weight; CVAC, Cyclic Variations in Altitude Conditioning; ECP, eosinophil cationic protein; EET, endurance exercise training; EPO, Erythropietin; FiO<sub>2</sub>, Fraction of inspired oxygen; [Hb], Blood hemoglobin concentration; HC, Hypobaric Chamber; Hct, Hematocrit; HDL, high density lipoproteins; IHT, Intermittent hypoxic training alternating hypoxia with normoxia along the exposure protocol; HOMA-Index, homeostatic model assessment index of insulin resistance; HR, Heart rate; HVR, hypoxic ventilatory response; IHH, intermittent hypobaric hypoxia; IHT (6:6), intermittent hypoxic training, alternating 6 min hypoxia with 6 min normoxia along the session; LAE, light aerobic exercise; LDL, low density lipoproteins; NH, normobaric hypoxia; TG, plasma triglycerides; V<sub>E</sub>max; maximal exercise pulmonary ventilation; VLDL, very low density lipoproteins</italic>.</p></table-wrap-foot></table-wrap></sec></sec><sec id="s3"><title>Intermittent hypoxia in sport</title><p>The benefits of intermittent hypoxia programs in competitive sport are still a subject of scientific debate. Table <xref rid="T7" ref-type="table">7</xref> shows several examples of intermittent hypoxia exposure effect on the improvement of human physical performance. A prior consideration to bear in mind when dealing with this topic is that two inherent factors justify the diversity of results in the field of elite sport: (a) the narrow margin of improvement detectable in elite athletes; and (b) the limitation in the sample size when performing studies with this population. Both factors contribute to reduced statistical power in most of these studies.</p><table-wrap id="T7" position="float"><label>Table 7</label><caption><p>Examples of the intermittent hypoxia exposure on the improvement of human physical performance.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Subjects</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Time of hypoxia</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Hypoxia method</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Hypoxia dosage</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>Outcome</bold></th><th valign="top" align="left" rowspan="1" colspan="1"><bold>References</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Elite alpinists (<italic>n</italic> = 5; 1 w + 4 m)</td><td valign="top" align="left" rowspan="1" colspan="1">1 wk chronic + 38 h for 4 d</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude + HC</td><td valign="top" align="left" rowspan="1" colspan="1">4,350&#x02013;4,807 m (1 wk at Mt Blanc) <break/>5,000&#x02013;8,500 m (4 d at HC)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;SaO<sub>2</sub> during HT <break/> &#x02191;Altitude acclimatization</td><td valign="top" align="left" rowspan="1" colspan="1">Richalet et al., <xref rid="B135" ref-type="bibr">1992</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Competitive (<italic>n</italic> = 39, 12 w + 27 m)</td><td valign="top" align="left" rowspan="1" colspan="1">4 wk</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">LH-TL <break/>1,250/2,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;VO<sub>2</sub>max</td><td valign="top" align="left" rowspan="1" colspan="1">Levine and Stray-Gundersen, <xref rid="B93" ref-type="bibr">1997</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Competitive (<italic>n</italic> = 39; 12 w + 27 m)</td><td valign="top" align="left" rowspan="1" colspan="1">14 d</td><td valign="top" align="left" rowspan="1" colspan="1">LH-TL <break/>LH-TH</td><td valign="top" align="left" rowspan="1" colspan="1">1,200&#x02013;1,400 m/2,500&#x02013;3,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;VO<sub>2</sub>max <break/>&#x02191;VO<sub>2</sub>max</td><td valign="top" align="left" rowspan="1" colspan="1">Chapman et al., <xref rid="B32" ref-type="bibr">1998</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Alpinists (<italic>n</italic> = 17)</td><td valign="top" align="left" rowspan="1" colspan="1">3&#x02013;5 h/d for 9 d</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">4,000&#x02013;5,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">Vo<sub>2</sub>max &#x02191;Lact/Vel</td><td valign="top" align="left" rowspan="1" colspan="1">Rodr&#x000ed;guez et al., <xref rid="B142" ref-type="bibr">1999</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Competitive (<italic>n</italic> = 126, 37 w + 89 m)</td><td valign="top" align="left" rowspan="1" colspan="1">4 wk</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude</td><td valign="top" align="left" rowspan="1" colspan="1">LH-TL <break/>1,250/2,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Vo<sub>2</sub>max in responders</td><td valign="top" align="left" rowspan="1" colspan="1">Stray-Gundersen and Levine, <xref rid="B162" ref-type="bibr">1999</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Alpinists (<italic>n</italic> = 9)</td><td valign="top" align="left" rowspan="1" colspan="1">2 h/d 14 d</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">5,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;V<sub>E</sub> &#x02191;SaO<sub>2</sub> during exercise at 5,000m</td><td valign="top" align="left" rowspan="1" colspan="1">Ricart et al., <xref rid="B134" ref-type="bibr">2000</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Elite athletes (<italic>n</italic> = 18; 2 w + 16 m) <break/>-Hypoxia (<italic>n</italic> = 8; 2 w + 6 m) <break/>-Control (<italic>n</italic> = 10; 10 m)</td><td valign="top" align="left" rowspan="1" colspan="1">10 d</td><td valign="top" align="left" rowspan="1" colspan="1">NH <break/>(LH-TL)</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.158 (&#x02248;2,200 m)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;400-m race time <break/>&#x02191;resting blood pH</td><td valign="top" align="left" rowspan="1" colspan="1">Nummela and Rusko, <xref rid="B121" ref-type="bibr">2000</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Elite alpinists (<italic>n</italic> = 6)</td><td valign="top" align="left" rowspan="1" colspan="1">3&#x02013;5 h/d for 17 d</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">4,000&#x02013;5,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;TtE &#x02191;Lact/Vel</td><td valign="top" align="left" rowspan="1" colspan="1">Casas M. et al., <xref rid="B31" ref-type="bibr">2000</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Competitive (<italic>n</italic> = 23; 11 w + 12 m) <break/>-Hypoxia (<italic>n</italic> = 11) <break/>-Normoxia (<italic>n</italic> = 12)</td><td valign="top" align="left" rowspan="1" colspan="1">3 h/d, 5 d/wk for 4 wk</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">4,000&#x02013;5,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">Marginal &#x02191;VO<sub>2</sub>max (<italic>p</italic> &#x0003c; 0.07) but only in swimmers</td><td valign="top" align="left" rowspan="1" colspan="1">Rodr&#x000ed;guez et al., <xref rid="B144" ref-type="bibr">2007</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Elite athletes (<italic>n</italic> = 41) <break/>-XC Skiers (<italic>n</italic> = 11) <break/>-Swimmers (<italic>n</italic> = 18) <break/>-Runners (<italic>n</italic> = 12)</td><td valign="top" align="left" rowspan="1" colspan="1">18 nights <break/>13 nights <break/>18 nights</td><td valign="top" align="left" rowspan="1" colspan="1">NH and Altitude <break/>(LH-TL)</td><td valign="top" align="left" rowspan="1" colspan="1">1,200m/ <break/>/2,500&#x02013;3,500 m <break/>/2,500&#x02013;3,000 m <break/>/2,500&#x02013;3,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;VO<sub>2</sub>max <break/>&#x02191;VO<sub>2</sub>max <break/>&#x02191;VO<sub>2</sub>max</td><td valign="top" align="left" rowspan="1" colspan="1">Richalet and Gore, <xref rid="B137" ref-type="bibr">2008</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Competitive (<italic>n</italic> = 28; 11 w + 17 m)</td><td valign="top" align="left" rowspan="1" colspan="1">3 h/d, 5 d/wk for 4 wk</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">4,000&#x02013;5,500 m</td><td valign="top" align="left" rowspan="1" colspan="1">No changes in submaximal economy</td><td valign="top" align="left" rowspan="1" colspan="1">Truijens et al., <xref rid="B168" ref-type="bibr">2008</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Meta-Analysis of 51 studies on elite and sub-elite athletes</td><td valign="top" align="left" rowspan="1" colspan="1">Diverse</td><td valign="top" align="left" rowspan="1" colspan="1">Natural vs. artificial altitude (no discrimination between artificial NH or HH)</td><td valign="top" align="left" rowspan="1" colspan="1">Diverse</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Maximal endurance power output after natural and brief intermittent artificial LH-TL</td><td valign="top" align="left" rowspan="1" colspan="1">Bonetti and Hopkins, <xref rid="B20" ref-type="bibr">2009</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Randomized, placebo-controlled, double-blind study (<italic>n</italic> = 40; 18 w + 22 m)</td><td valign="top" align="left" rowspan="1" colspan="1">3 &#x000d7; 70 min/wk for 3 wk exercising + 4 &#x000d7; 90 min passive for 1 wk</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">2,500 m (wk-1) <break/>3,000 m (wk-2) <break/>3,500 m (wk-3) <break/>4,500 m (wk-4)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;AMS 1st d at 3,611 m <break/>&#x02245;AMS 2nd d at 4,559 m</td><td valign="top" align="left" rowspan="1" colspan="1">Schommer et al., <xref rid="B151" ref-type="bibr">2010</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Healthy men (<italic>n</italic> = 26) <break/>Randomized, placebo-controlled, double-blind study</td><td valign="top" align="left" rowspan="1" colspan="1">1 h/d for 1 wk</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.126 (&#x02248;4,500 m)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;AMS after 8 h at FIo<sub>2</sub> = 0.113 (&#x02248;5,300 m)</td><td valign="top" align="left" rowspan="1" colspan="1">Wille et al., <xref rid="B185" ref-type="bibr">2012</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Female netballer players (<italic>n</italic> = 30) <break/>-Hypoxic training <break/>-Vascular occlusion training <break/>-Control</td><td valign="top" align="left" rowspan="1" colspan="1">0&#x02013;90&#x000b0; bilateral knee extension and flexion <break/>3 sess/wk for 5 wk</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = variable to maintain SpO<sub>2</sub>&#x02248;80%</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;MVC<sub>3</sub>
<break/>&#x02191;MVC<sub>30</sub>
<break/>&#x02191;Reps<sub>20</sub></td><td valign="top" align="left" rowspan="1" colspan="1">Manimmanakorn et al., <xref rid="B102" ref-type="bibr">2013</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">USARIEM Retrospective review (<italic>n</italic> = 170; 37 w + 133 m)</td><td valign="top" align="left" rowspan="1" colspan="1">Several</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude, HC and NH</td><td valign="top" align="left" rowspan="1" colspan="1">4,300 m</td><td valign="top" align="left" rowspan="1" colspan="1">HC or altitude much more effective than NH for &#x02193;AMS and &#x02191;performance during acute altitude exposure</td><td valign="top" align="left" rowspan="1" colspan="1">Fulco et al., <xref rid="B62" ref-type="bibr">2013</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Healthy unacclimatized men (<italic>n</italic> = 42) <break/>-Hypoxia (<italic>n</italic> = 21) <break/>-Normoxia (<italic>n</italic> = 21)</td><td valign="top" align="left" rowspan="1" colspan="1">Sleep for 14 consecutive nights</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> &#x02248; 0.145 (&#x02248;2,600 m)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;AMS after 20 h at FIo<sub>2</sub> = 0.12 (&#x02248;4,500 m)</td><td valign="top" align="left" rowspan="1" colspan="1">Dehnert et al., <xref rid="B47" ref-type="bibr">2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Healthy men (<italic>n</italic> = 16) <break/>-Hypoxia (<italic>n</italic> = 9) <break/>-Normoxia (<italic>n</italic> = 7)</td><td valign="top" align="left" rowspan="1" colspan="1">Resistance training <break/>2 sess/wk for 8 wk (16 sessions in total)</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.144 (&#x02248;3,000 m)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Muscular endurance <break/>&#x02191;VEGF &#x02191;Capillary-to-fiber ratio</td><td valign="top" align="left" rowspan="1" colspan="1">Kon et al., <xref rid="B86" ref-type="bibr">2014</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male elite athletes (<italic>n</italic> = 12) <break/>-Hypoxia (<italic>n</italic> = 6) <break/>-Normoxia (<italic>n</italic> = 6)</td><td valign="top" align="left" rowspan="1" colspan="1">CST <break/>3 sess/wk for 4 wk (27 h in total)</td><td valign="top" align="left" rowspan="1" colspan="1">HC</td><td valign="top" align="left" rowspan="1" colspan="1">3,000 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Anaerobic performance</td><td valign="top" align="left" rowspan="1" colspan="1">&#x000c1;lvarez-Herms et al., <xref rid="B6" ref-type="bibr">2015a</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Elite swimmers <break/>(<italic>n</italic> = 54; 30 w + 24 m)</td><td valign="top" align="left" rowspan="1" colspan="1">3 or 4 wk</td><td valign="top" align="left" rowspan="1" colspan="1">Altitude <break/>LH-TH vs. LL-TL vs. LH-TH+TL</td><td valign="top" align="left" rowspan="1" colspan="1">690/2,320 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02193;TT for LH-TH+TL</td><td valign="top" align="left" rowspan="1" colspan="1">Rodr&#x000ed;guez et al., <xref rid="B143" ref-type="bibr">2015</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male trained triathletes (<italic>n</italic> = 18) <break/>-Hypoxia (<italic>n</italic> = 9) <break/>-Normoxia (<italic>n</italic> = 9)</td><td valign="top" align="left" rowspan="1" colspan="1">1 h/d &#x000d7; 2 d/wk for 7 wk</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.145&#x02013;0.15 (&#x02248;2,800&#x02013;2,500 m)</td><td valign="top" align="left" rowspan="1" colspan="1">No differences in aerobic performance</td><td valign="top" align="left" rowspan="1" colspan="1">Ramos-Campo et al., <xref rid="B129" ref-type="bibr">2015</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male well-trained triathletes (<italic>n</italic> = 16)</td><td valign="top" align="left" rowspan="1" colspan="1">18 d</td><td valign="top" align="left" rowspan="1" colspan="1">NH and Altitude <break/>LH-TL</td><td valign="top" align="left" rowspan="1" colspan="1">1,100/2,250 m</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;VO<sub>2</sub>max <break/>&#x02193;3-km run time</td><td valign="top" align="left" rowspan="1" colspan="1">Saugy et al., <xref rid="B149" ref-type="bibr">2016</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Well-trained (<italic>n</italic> = 16)</td><td valign="top" align="left" rowspan="1" colspan="1">Acute exposure during HIIE jump test</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.165 (&#x02248;1,900 m) <break/>FiO<sub>2</sub> = 0.135 (&#x02248;3,500 m)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;Effort perception</td><td valign="top" align="left" rowspan="1" colspan="1">&#x000c1;lvarez-Herms et al., <xref rid="B7" ref-type="bibr">2016</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Well-trained men (<italic>n</italic> = 16)</td><td valign="top" align="left" rowspan="1" colspan="1">Acute exposure during <break/>5 &#x000d7; 3 45&#x000b0; leg press and bench press at 85% 1RM test</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.165 (&#x02248;1,900 m)</td><td valign="top" align="left" rowspan="1" colspan="1">Serum &#x02191;Lactate &#x02191;GH</td><td valign="top" align="left" rowspan="1" colspan="1">Filopoulos et al., <xref rid="B61" ref-type="bibr">2017</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Male endurance-trained (<italic>n</italic> = 15) <break/>-Hypoxia (<italic>n</italic> = 9) <break/>-Normoxia (<italic>n</italic> = 6)</td><td valign="top" align="left" rowspan="1" colspan="1">IHT <break/>6 &#x000d7; (5:5) at 80&#x02013;85% of vVO<sub>2</sub>max <break/>3 sess/wk for 6 wk</td><td valign="top" align="left" rowspan="1" colspan="1">NH</td><td valign="top" align="left" rowspan="1" colspan="1">FiO<sub>2</sub> = 0.106 (&#x02248;5,000 m) (wk 1&#x02013;2) <break/>FiO<sub>2</sub> = 0.114 (&#x02248;5,500 m) <break/>(wk 3&#x02013;6)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02191;TtE at 95% VO<sub>2</sub>max</td><td valign="top" align="left" rowspan="1" colspan="1">Sanchez and Borrani, <xref rid="B148" ref-type="bibr">2018</xref></td></tr></tbody></table><table-wrap-foot><p><italic>1RM, one repetition maximum; Altitude, geographical altitude; AMS, acute mountain sickness; CST, circuit strength training; FiO<sub>2</sub>, Fraction of inspired oxygen; HC, Hypobaric Chamber; HIIE, high intensity intervallic exercise; HT, hypoxic test (at 4,800 m equivalent attitude); IHT, Intermittent hypoxic training alternating hypoxia during exercise with normoxia during recovery between sets; Lact/Vel, Lactate/Velocity curve (up-arrow means right shift); LH-TL, Living High-Training Low; LH-TH, Living High-Training High; MVC<sub>3</sub>, 3 s maximal voluntary contraction; MVC<sub>30</sub>, 30 s maximal voluntary contraction; NH, Normobaric hypoxia; TtE, Time to exhaustion; Reps<sub>20</sub>, maximal number of repetitions at 20% 1RM; TT, time trial; USARIEM, United States Army Research Institute of Environmental Medicine; VO<sub>2</sub>max, maximal oxygen consumption capacity</italic>.</p></table-wrap-foot></table-wrap><p>Other sources of variability are the wide range of exposure patterns, differing hypoxic doses (or altitude), and the kind of hypoxia (hypobaric or normobaric), as is discussed below. The living high-training low (LH-TL) pattern (Levine and Stray-Gundersen, <xref rid="B93" ref-type="bibr">1997</xref>) is the most widespread training schedule, although sometimes the reverse model, living low-training-high (LL-TH), is also applied, especially when artificial hypoxia is used. Moreover, studies evaluating training at altitude during permanent stays are also very usual.</p><p>In addition to other reports cited in precedent sections, a high number of studies have consistently found positive effects of IEHH programs to improve exercise performance. Thus, 4 weeks of LH-TL improved sea-level running performance in trained runners (Levine and Stray-Gundersen, <xref rid="B93" ref-type="bibr">1997</xref>). Short-term intermittent hypobaric hypoxia (in a hypobaric chamber) improved the aerobic performance capacity in healthy subjects (Rodr&#x000ed;guez et al., <xref rid="B142" ref-type="bibr">1999</xref>). Intermittent hypobaric hypoxia combined with low-intensity exercise induced altitude acclimation, improved lactate threshold and ventilatory anaerobic threshold in healthy subjects (Casas M. et al., <xref rid="B31" ref-type="bibr">2000</xref>). Normobaric hypoxia increased the growth hormone response to maximal resistance exercise in trained men (Filopoulos et al., <xref rid="B61" ref-type="bibr">2017</xref>). Finally, a reduction in the severity of acute mountain sickness was also reported after several intermittent normobaric hypoxia protocols (Schommer et al., <xref rid="B151" ref-type="bibr">2010</xref>; Wille et al., <xref rid="B185" ref-type="bibr">2012</xref>; Dehnert et al., <xref rid="B47" ref-type="bibr">2014</xref>).</p><p>In contrast, other studies did not detect significant improvements in exercise performance. Four weeks of IEHH did not improve oxygen transport in trained swimmers and runners (Rodr&#x000ed;guez et al., <xref rid="B144" ref-type="bibr">2007</xref>) nor did it change the submaximal economy in a group of well-trained athletes (Truijens et al., <xref rid="B168" ref-type="bibr">2008</xref>). Seven weeks of normobaric hypoxia training in triathletes, caused an improvement in hematological parameters but not in the aerobic performance (Ramos-Campo et al., <xref rid="B129" ref-type="bibr">2015</xref>). Finally, a recent systematic review and meta-analysis did not reveal a significant benefit of resistance training in hypoxia compared to the same training in normoxia (Ramos-Campo et al., <xref rid="B130" ref-type="bibr">2018</xref>).</p><p>In general, it is commonly accepted that the application of intermittent hypoxia exposure has beneficial effects for competitive sport in the same way as for the biomedical field. As discussed above, the wide difference in effects that have been reported in the literature can be explained by individual susceptibility and the diversity of intermittent hypoxia patterns applied (Debevec and Mekljavic, <xref rid="B45" ref-type="bibr">2013</xref>). The adaptive or maladaptive responses can be due to differences in the frequency, severity or duration of hypoxic episodes (Serebrovska et al., <xref rid="B155" ref-type="bibr">2016</xref>). Factors such as age, sex or genotypic variability may also contribute to varying results (Almendros et al., <xref rid="B5" ref-type="bibr">2014</xref>). A review of relevant publications between 1980 and 2015 concluded that evidence regarding the effects of altitude training on athletic performance is weak but that the natural stay at altitude combined with a live high-train low training strategy may provide the best protocol for enhancing endurance performance in elite and subelite athletes (Khodaee et al., <xref rid="B84" ref-type="bibr">2016</xref>), thus confirming similar findings in a previous study (Bonetti and Hopkins, <xref rid="B20" ref-type="bibr">2009</xref>). Finally, a recently published meta-analysis on the effect of natural or simulated altitude training in team-sport athletes conclude that hypoxic intervention appears to be a worthwhile training strategy for improvement in team-sport athletes, with enhanced performance over control groups persisting for at least 4 weeks post-intervention (Hamlin et al., <xref rid="B70" ref-type="bibr">2018</xref>). Also, our recent data indicate that contractile activity seems to be necessary to trigger in skeletal muscle the adaptive responses induced by intermittent exposure to hypoxia (Rizo-Roca et al., <xref rid="B139" ref-type="bibr">2018</xref>).</p><p>Although most of the expected effects of altitude training and IEHH programs have been mainly aimed at improving aerobic capacity (Stray-Gundersen and Levine, <xref rid="B162" ref-type="bibr">1999</xref>; Wilber, <xref rid="B183" ref-type="bibr">2004</xref>), some reports also have described benefits for strength training at moderate hypoxia levels (Nummela and Rusko, <xref rid="B121" ref-type="bibr">2000</xref>; Manimmanakorn et al., <xref rid="B102" ref-type="bibr">2013</xref>; &#x000c1;lvarez-Herms et al., <xref rid="B8" ref-type="bibr">2015b</xref>, <xref rid="B7" ref-type="bibr">2016</xref>). The underlying mechanism of these responses remain to be clarified, but potential psychological benefits may be derived of the perception of increased effort during hypoxic training (&#x000c1;lvarez-Herms et al., <xref rid="B7" ref-type="bibr">2016</xref>). In addition, training during hypoxia may result in a greater increase in muscular endurance than the same training load performed in normoxia, probably because of increased angiogenesis in skeletal muscle level (Kon et al., <xref rid="B86" ref-type="bibr">2014</xref>), can be involved in those improvements.</p></sec><sec id="s4"><title>Normobaric vs. hypobaric hypoxia: the same stimulus?</title><p>When artificial methods of producing hypoxia exposure were first developed, no attention was paid to the differences between hypobaric (low barometric pressure) and normobaric (low oxygen content in an inhaled gas mixture) hypoxia. It seems evident that the same physiological effects are expected for a determined alveolar oxygen partial pressure, regardless of the technical means used. However, data in the literature present consistent discrepancies after applying hypobaric and normobaric hypoxia, which could be attributed to alterations in other environmental parameters that affect alveolar gas composition, such as carbon dioxide partial pressure, humidity and temperature. For instance, even for the same level of oxygen partial pressure, the atmospheric composition in a small hypoxic tent with low air turnover (limited by the flow capacity of the hypoxic device) can be very different from the air composition in a hypobaric chamber. Generally, the use of powerful vacuum pumps in hypobaric chamber systems guarantees sufficient renewal of the air inside the room, thus preventing carbon dioxide accumulation and a rise in air temperature and humidity, factors that could become unbalanced in small volume hypoxic tents, especially with exercising subjects inside. In a comparative study of hypobaric (low pressure chamber) and normobaric hypoxia (hypoxic tent) during a submaximal exercise test in the same subjects, differences were observed in some cardiorespiratory and heart rate variability parameters between the two artificial hypoxia systems used (Basualto-Alarc&#x000f3;n et al., <xref rid="B17" ref-type="bibr">2012</xref>).</p><p>An interesting and dynamic debate, which is beyond the scope of this review, is currently under way among altitude researchers concerning whether or not hypobaric hypoxia induces different responses from normobaric hypoxia (Girard, <xref rid="B67" ref-type="bibr">2012</xref>; Millet et al., <xref rid="B111" ref-type="bibr">2012</xref>; Hauser et al., <xref rid="B74" ref-type="bibr">2016</xref>; Saugy et al., <xref rid="B149" ref-type="bibr">2016</xref>). Some evidences demonstrate that there are different physiological responses and outcomes between exposure to normobaric and hypobaric hypoxia conditions (Savourey et al., <xref rid="B150" ref-type="bibr">2003</xref>; Fulco et al., <xref rid="B62" ref-type="bibr">2013</xref>; Millet et al., <xref rid="B112" ref-type="bibr">2013</xref>; Beidleman et al., <xref rid="B18" ref-type="bibr">2014</xref>; Debevec and Millet, <xref rid="B46" ref-type="bibr">2014</xref>; Boos et al., <xref rid="B21" ref-type="bibr">2016</xref>; DiPasquale, <xref rid="B50" ref-type="bibr">2017</xref>). For instance, it has been reported that the decrease in air density that accompanies the partial pressure drop of oxygen at geographic altitude affects the way in which explosive actions are executed and increases movement velocity and power during force-velocity bench presses in comparison to normobaric hypoxia (Feriche et al., <xref rid="B60" ref-type="bibr">2014</xref>).</p></sec><sec sec-type="conclusions" id="s5"><title>Conclusions</title><p>A growing body of knowledge supports the beneficial effects of natural or simulated altitude techniques on health outcomes (Navarrete-Opazo and Mitchell, <xref rid="B115" ref-type="bibr">2014</xref>; Millet et al., <xref rid="B110" ref-type="bibr">2016</xref>; Lizamore and Hamlin, <xref rid="B97" ref-type="bibr">2017</xref>). Future research should be oriented to: (1) gain more in-depth knowledge of the subcellular mechanisms involved in the hypoxic response at different tissue levels, (2) standardize hypoxia exposure methods and establish a universal method for measuring, and repeatedly applying, hypoxic dosage, (3) improve predictions of individual hypoxia tolerance to prevent possible negative consequences, (4) apply this new knowledge to the selection and education of altitude workers, (5) improve altitude acclimatization, altitude training camps and altitude competition events to benefit mountaineers, athletes and coaches, and finally (6) cautiously explore the application of IEHH in pathological conditions.</p></sec><sec id="s6"><title>Author contributions</title><p>GV, JV, AR, and LC contributed to the initial draft of the manuscript; GV and JT edited the document after contributions from all authors; All authors reviewed and approved the final version.</p><sec><title>Conflict of interest statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><ack><p>This study was supported in part by research grants DEP2010-22205-C02-01, DEP2010-2205-C02-02, DEP2013 48334-C2-1P, and DEP2013-48334-C2-2-P from the Plan Nacional de I+D+i (Spain's Ministry of Economy, Industry and Competitiveness). The authors thank Christopher Evans and Paula Weiss (Language Advisory Service, Universitat de Barcelona) for their help editing the manuscript.</p></ack><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agadzhanyan</surname><given-names>N. A.</given-names></name><name><surname>Torshin</surname><given-names>V. I.</given-names></name></person-group> (<year>1986</year>). <article-title>Effect of adaptation to hypoxia on resistance of rats to the epileptogenic action of penicillin</article-title>. <source>Bull. Exp. Biol. Med.</source>
<volume>102</volume>, <fpage>1669</fpage>&#x02013;<lpage>1671</lpage>. <pub-id pub-id-type="doi">10.1007/BF00840791</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agani</surname><given-names>F. H.</given-names></name><name><surname>Puchowicz</surname><given-names>M.</given-names></name><name><surname>Chavez</surname><given-names>J. C.</given-names></name><name><surname>Pichiule</surname><given-names>P.</given-names></name><name><surname>LaManna</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Role of nitric oxide in the regulation of HIF-1&#x003b1; expression during hypoxia</article-title>. <source>Am. J. Physiol. Cell Physiol.</source>
<volume>283</volume>, <fpage>C178</fpage>&#x02013;<lpage>C186</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00381.2001</pub-id><?supplied-pmid 12055086?><pub-id pub-id-type="pmid">12055086</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aleshin</surname><given-names>I. A.</given-names></name><name><surname>Kots</surname><given-names>I. I.</given-names></name><name><surname>Tverdokhlib</surname><given-names>V. P.</given-names></name><name><surname>Galiautdinov</surname><given-names>G. S.</given-names></name><name><surname>Vdovenko</surname><given-names>L. G.</given-names></name><name><surname>Zabirov</surname><given-names>M. R.</given-names></name><etal/></person-group>. (<year>1993</year>). <article-title>[The nondrug treatment of hypertension patients by their adaptation to periodic hypoxia in a barochamber]</article-title>. <source>Ter. Arkh.</source>
<volume>65</volume>, <fpage>23</fpage>&#x02013;<lpage>29</lpage>. <?supplied-pmid 8211795?><pub-id pub-id-type="pmid">8211795</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allegra</surname><given-names>L.</given-names></name><name><surname>Cogo</surname><given-names>A.</given-names></name><name><surname>Legnani</surname><given-names>D.</given-names></name><name><surname>Diano</surname><given-names>P. L.</given-names></name><name><surname>Fasano</surname><given-names>V.</given-names></name><name><surname>Negretto</surname><given-names>G. G.</given-names></name></person-group> (<year>1995</year>). <article-title>High altitude exposure reduces bronchial responsiveness to hypo-osmolar aerosol in lowland asthmatics</article-title>. <source>Eur. Respir. J.</source>
<volume>8</volume>, <fpage>1842</fpage>&#x02013;<lpage>1846</lpage>. <pub-id pub-id-type="doi">10.1183/09031936.95.08111842</pub-id><?supplied-pmid 8620949?><pub-id pub-id-type="pmid">8620949</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almendros</surname><given-names>I.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Gozal</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>The polymorphic and contradictory aspects of intermittent hypoxia</article-title>. <source>Am. J. Physiol. Lung Cell. Mol. Physiol.</source>
<volume>307</volume>, <fpage>L129</fpage>&#x02013;<lpage>L140</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.00089.2014</pub-id><?supplied-pmid 24838748?><pub-id pub-id-type="pmid">24838748</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000c1;lvarez-Herms</surname><given-names>J.</given-names></name><name><surname>Juli&#x000e0;-S&#x000e1;nchez</surname><given-names>S.</given-names></name><name><surname>Corbi</surname><given-names>F.</given-names></name><name><surname>Pag&#x000e8;s</surname><given-names>T.</given-names></name><name><surname>Viscor</surname><given-names>G.</given-names></name></person-group> (<year>2015a</year>). <article-title>A program of circuit resistance training under hypobaric hypoxia conditions improves the anaerobic performance of athletes</article-title>. <source>Sci. Sports</source>
<volume>31</volume>, <fpage>78</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.scispo.2015.08.005</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000c1;lvarez-Herms</surname><given-names>J.</given-names></name><name><surname>Juli&#x000e0;-S&#x000e1;nchez</surname><given-names>S.</given-names></name><name><surname>Gatterer</surname><given-names>H.</given-names></name><name><surname>Blank</surname><given-names>C.</given-names></name><name><surname>Corbi</surname><given-names>F.</given-names></name><name><surname>Pag&#x000e8;s</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Anaerobic training in hypoxia: A new approach to stimulate the rating of effort perception</article-title>. <source>Physiol. Behav.</source>
<volume>163</volume>, <fpage>37</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.physbeh.2016.04.035</pub-id><?supplied-pmid 27126970?><pub-id pub-id-type="pmid">27126970</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000c1;lvarez-Herms</surname><given-names>J.</given-names></name><name><surname>Juli&#x000e0;-S&#x000e1;nchez</surname><given-names>S.</given-names></name><name><surname>Hamlin</surname><given-names>M.</given-names></name><name><surname>Viscor</surname><given-names>G.</given-names></name></person-group> (<year>2015b</year>). <article-title>Strength training under hypoxic conditions</article-title>. <source>Physiol. Rep.</source>
<volume>3</volume>:<fpage>e12227</fpage>. <pub-id pub-id-type="doi">10.14814/phy2.12227</pub-id><?supplied-pmid 25602011?><pub-id pub-id-type="pmid">25602011</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antezana</surname><given-names>A. M.</given-names></name><name><surname>Kacimi</surname><given-names>R.</given-names></name><name><surname>Le Trong</surname><given-names>J. L.</given-names></name><name><surname>Marchal</surname><given-names>M.</given-names></name><name><surname>Abousahl</surname><given-names>I.</given-names></name><name><surname>Dubray</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>1994</year>). <article-title>Adrenergic status of humans during prolonged exposure to the altitude of 6,542 m</article-title>. <source>J. Appl. Physiol.</source>
<volume>76</volume>, <fpage>1055</fpage>&#x02013;<lpage>1059</lpage>. <pub-id pub-id-type="doi">10.1152/jappl.1994.76.3.1055</pub-id><?supplied-pmid 8005844?><pub-id pub-id-type="pmid">8005844</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arcasoy</surname><given-names>M. O.</given-names></name></person-group> (<year>2008</year>). <article-title>The non-haematopoietic biological effects of erythropoietin</article-title>. <source>Br. J. Haematol.</source>
<volume>141</volume>, <fpage>14</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2141.2008.07014.x</pub-id><?supplied-pmid 18324962?><pub-id pub-id-type="pmid">18324962</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ascenzi</surname><given-names>P.</given-names></name><name><surname>di Masi</surname><given-names>A.</given-names></name><name><surname>Leboffe</surname><given-names>L.</given-names></name><name><surname>Fiocchetti</surname><given-names>M.</given-names></name><name><surname>Nuzzo</surname><given-names>M. T.</given-names></name><name><surname>Brunori</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Neuroglobin: From structure to function in health and disease</article-title>. <source>Mol. Aspects Med.</source>
<volume>52</volume>, <fpage>1</fpage>&#x02013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.mam.2016.10.004</pub-id><?supplied-pmid 27825818?><pub-id pub-id-type="pmid">27825818</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asemu</surname><given-names>G.</given-names></name><name><surname>Neck&#x000e1;r</surname><given-names>J.</given-names></name><name><surname>Sz&#x000e1;rszoi</surname><given-names>O.</given-names></name><name><surname>Papousek</surname><given-names>F.</given-names></name><name><surname>Ost&#x000e1;dal</surname><given-names>B.</given-names></name><name><surname>Kolar</surname><given-names>F.</given-names></name></person-group> (<year>2000</year>). <article-title>Effects of adaptation to intermittent high altitude hypoxia on ischemic ventricular arrhythmias in rats</article-title>. <source>Physiol. Res.</source>
<volume>49</volume>, <fpage>597</fpage>&#x02013;<lpage>606</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.biomed.cas.cz/physiolres/pdf/49/49_597.pdf">http://www.biomed.cas.cz/physiolres/pdf/49/49_597.pdf</ext-link><?supplied-pmid 11191364?><pub-id pub-id-type="pmid">11191364</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asemu</surname><given-names>G.</given-names></name><name><surname>Papousek</surname><given-names>F.</given-names></name><name><surname>Ost&#x000e1;dal</surname><given-names>B.</given-names></name><name><surname>Kol&#x000e1;r</surname><given-names>F.</given-names></name></person-group> (<year>1999</year>). <article-title>Adaptation to high altitude hypoxia protects the rat heart against ischemia-induced arrhythmias. Involvement of mitochondrial K(ATP) channel</article-title>. <source>J. Mol. Cell. Cardiol.</source>
<volume>31</volume>, <fpage>1821</fpage>&#x02013;<lpage>1831</lpage>. <pub-id pub-id-type="doi">10.1006/jmcc.1999.1013</pub-id><?supplied-pmid 10525420?><pub-id pub-id-type="pmid">10525420</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bailey</surname><given-names>D. M.</given-names></name><name><surname>Davies</surname><given-names>B.</given-names></name><name><surname>Young</surname><given-names>I. S.</given-names></name></person-group> (<year>2001</year>). <article-title>Intermittent hypoxic training: implications for lipid peroxidation induced by acute normoxic exercise in active men</article-title>. <source>Clin. Sci.</source>
<volume>101</volume>, <fpage>465</fpage>&#x02013;<lpage>475</lpage>. <pub-id pub-id-type="doi">10.1042/cs1010465</pub-id><?supplied-pmid 11672451?><pub-id pub-id-type="pmid">11672451</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000e4;rtsch</surname><given-names>P.</given-names></name><name><surname>Swenson</surname><given-names>E. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Clinical practice: acute high-altitude illnesses</article-title>. <source>N. Engl. J. Med.</source>
<volume>368</volume>, <fpage>2294</fpage>&#x02013;<lpage>2302</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMcp1214870</pub-id><?supplied-pmid 23758234?><pub-id pub-id-type="pmid">23758234</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000e4;rtsch</surname><given-names>P.</given-names></name><name><surname>Dehnert</surname><given-names>C.</given-names></name><name><surname>Friedmann-Bette</surname><given-names>B.</given-names></name><name><surname>Tadibi</surname><given-names>V.</given-names></name></person-group> (<year>2008</year>). <article-title>Intermittent hypoxia at rest for improvement of athletic performance</article-title>. <source>Scand. J. Med. Sci. Sports</source>
<volume>18</volume>(<issue>Suppl. 1</issue>), <fpage>50</fpage>&#x02013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0838.2008.00832.x</pub-id><?supplied-pmid 18665952?><pub-id pub-id-type="pmid">18665952</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basualto-Alarc&#x000f3;n</surname><given-names>C.</given-names></name><name><surname>Rodas</surname><given-names>G.</given-names></name><name><surname>Galilea</surname><given-names>P. A.</given-names></name><name><surname>Riera</surname><given-names>J.</given-names></name><name><surname>Pag&#x000e9;s</surname><given-names>T.</given-names></name><name><surname>Ricart</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2012</year>). <article-title>Cardiorespiratory parameters during submaximal exercise under acute exposure to normobaric and hypobaric hypoxia</article-title>. <source>Apunt. Med. l'Esport</source>
<volume>47</volume>, <fpage>65</fpage>&#x02013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.apunts.2011.11.005</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beidleman</surname><given-names>B. A.</given-names></name><name><surname>Fulco</surname><given-names>C. S.</given-names></name><name><surname>Staab</surname><given-names>J. E.</given-names></name><name><surname>Andrew</surname><given-names>S. P.</given-names></name><name><surname>Muza</surname><given-names>S. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Cycling performance decrement is greater in hypobaric versus normobaric hypoxia</article-title>. <source>Extrem. Physiol. Med.</source>
<volume>3</volume>:<fpage>8</fpage>. <pub-id pub-id-type="doi">10.1186/2046-7648-3-8</pub-id><?supplied-pmid 24778792?><pub-id pub-id-type="pmid">24778792</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattarai</surname><given-names>D.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Lee</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A &#x0201c;structure-activity relationship&#x0201d; perspective</article-title>. <source>Med. Res. Rev.</source>
<volume>38</volume>, <fpage>1</fpage>&#x02013;<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1002/med.21477</pub-id><?supplied-pmid 29278273?><pub-id pub-id-type="pmid">29278273</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonetti</surname><given-names>D. L.</given-names></name><name><surname>Hopkins</surname><given-names>W. G.</given-names></name></person-group> (<year>2009</year>). <article-title>Sea-level exercise performance following adaptation to hypoxia: a meta-analysis</article-title>. <source>Sports Med.</source>
<volume>39</volume>, <fpage>107</fpage>&#x02013;<lpage>127</lpage>. <pub-id pub-id-type="doi">10.2165/00007256-200939020-00002</pub-id><?supplied-pmid 19203133?><pub-id pub-id-type="pmid">19203133</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boos</surname><given-names>C. J.</given-names></name><name><surname>O'Hara</surname><given-names>J. P.</given-names></name><name><surname>Mellor</surname><given-names>A.</given-names></name><name><surname>Hodkinson</surname><given-names>P. D.</given-names></name><name><surname>Tsakirides</surname><given-names>C.</given-names></name><name><surname>Reeve</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>A four-way comparison of cardiac function with normobaric normoxia, normobaric hypoxia, hypobaric hypoxia and genuine high altitude</article-title>. <source>PLoS ONE</source>
<volume>11</volume>:<fpage>e0152868</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0152868</pub-id><?supplied-pmid 27100313?><pub-id pub-id-type="pmid">27100313</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouslama</surname><given-names>M.</given-names></name><name><surname>Adla-Biassette</surname><given-names>H.</given-names></name><name><surname>Ramanantsoa</surname><given-names>N.</given-names></name><name><surname>Bourgeois</surname><given-names>T.</given-names></name><name><surname>Bollen</surname><given-names>B.</given-names></name><name><surname>Brissaud</surname><given-names>O.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Protective effects of intermittent hypoxia on brain and memory in a mouse model of apnea of prematurity</article-title>. <source>Front. Physiol.</source>
<volume>6</volume>:<fpage>313</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2015.00313</pub-id><?supplied-pmid 26582992?><pub-id pub-id-type="pmid">26582992</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burger</surname><given-names>D.</given-names></name><name><surname>Xenocostas</surname><given-names>A.</given-names></name><name><surname>Feng</surname><given-names>Q. P.</given-names></name></person-group> (<year>2009</year>). <article-title>Molecular basis of cardioprotection by erythropoietin</article-title>. <source>Curr. Mol. Pharmacol.</source>
<volume>2</volume>, <fpage>56</fpage>&#x02013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.2174/1874467210902010056</pub-id><?supplied-pmid 20021446?><pub-id pub-id-type="pmid">20021446</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burmester</surname><given-names>T.</given-names></name><name><surname>Hankeln</surname><given-names>T.</given-names></name></person-group> (<year>2004</year>). <article-title>Neuroglobin: a respiratory protein of the nervous system</article-title>. <source>News Physiol. Sci.</source>
<volume>19</volume>, <fpage>110</fpage>&#x02013;<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1152/nips.01513.2003</pub-id><?supplied-pmid 15143204?><pub-id pub-id-type="pmid">15143204</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burmester</surname><given-names>T.</given-names></name><name><surname>Weich</surname><given-names>B.</given-names></name><name><surname>Reinhardt</surname><given-names>S.</given-names></name><name><surname>Hankeln</surname><given-names>T.</given-names></name></person-group> (<year>2000</year>). <article-title>A vertebrate globin expressed in the brain</article-title>. <source>Nature</source>
<volume>407</volume>, <fpage>520</fpage>&#x02013;<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1038/35035093</pub-id><?supplied-pmid 11029004?><pub-id pub-id-type="pmid">11029004</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burtscher</surname><given-names>M.</given-names></name><name><surname>Pachinger</surname><given-names>O.</given-names></name><name><surname>Ehrenbourg</surname><given-names>I.</given-names></name><name><surname>G&#x000fc;nther</surname><given-names>M.</given-names></name><name><surname>Faulhaber</surname><given-names>M.</given-names></name><name><surname>Reinhard</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>Intermittent hypoxia increases exercise tolerance in elderly men with and without coronary artery disease</article-title>. <source>Int J Cardiol</source>. <volume>96</volume>, <fpage>247</fpage>&#x02013;<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2003.07.021</pub-id><?supplied-pmid 15262041?><pub-id pub-id-type="pmid">15262041</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabrera-Aguilera</surname><given-names>I.</given-names></name><name><surname>Rizo-Roca</surname><given-names>D.</given-names></name><name><surname>Marques</surname><given-names>E.</given-names></name><name><surname>Santocildes</surname><given-names>G.</given-names></name><name><surname>Pag&#x000e8;s</surname><given-names>T.</given-names></name><name><surname>Viscor</surname><given-names>G</given-names></name><etal/></person-group>. (<year>in press</year>). <article-title>Additive effects of intermittent hypobaric hypoxia endurance training on body weight, food intake, oxygen consumption in rats</article-title>. <source>High Alt. Med. Biol</source>. <pub-id pub-id-type="doi">10.1089/ham.2018.0013</pub-id><?supplied-pmid 29957064?><pub-id pub-id-type="pmid">29957064</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>Z.</given-names></name><name><surname>Manalo</surname><given-names>D. J.</given-names></name><name><surname>Wei</surname><given-names>G.</given-names></name><name><surname>Rodriguez</surname><given-names>E. R.</given-names></name><name><surname>Fox-Talbot</surname><given-names>K.</given-names></name><name><surname>Lu</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2003</year>). <article-title>Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury</article-title>. <source>Circulation</source>
<volume>108</volume>, <fpage>79</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.0000078635.89229.8A</pub-id><?supplied-pmid 12796124?><pub-id pub-id-type="pmid">12796124</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Canou&#x000ef;-Poitrine</surname><given-names>F.</given-names></name><name><surname>Veerabudun</surname><given-names>K.</given-names></name><name><surname>Larmignat</surname><given-names>P.</given-names></name><name><surname>Letournel</surname><given-names>M.</given-names></name><name><surname>Bastuji-Garin</surname><given-names>S.</given-names></name><name><surname>Richalet</surname><given-names>J.-P.</given-names></name></person-group> (<year>2014</year>). <article-title>Risk prediction score for severe high altitude illness: a cohort study</article-title>. <source>PLoS ONE</source>
<volume>9</volume>:<fpage>e100642</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0100642</pub-id><?supplied-pmid 25068815?><pub-id pub-id-type="pmid">25068815</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casas</surname><given-names>H.</given-names></name><name><surname>Casas</surname><given-names>M.</given-names></name><name><surname>Ricart</surname><given-names>A.</given-names></name><name><surname>Rama</surname><given-names>R.</given-names></name><name><surname>Ib&#x000e1;&#x000f1;ez</surname><given-names>J.</given-names></name><name><surname>Palacios</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>Efectiveness of three short intermittent hypobaric hypoxia protocols: hematological responses</article-title>. <source>J. Exerc. Physiol.</source>
<volume>3</volume>, <fpage>38</fpage>&#x02013;<lpage>45</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.asep.org/asep/asep/PAGES.PDF">http://www.asep.org/asep/asep/PAGES.PDF</ext-link></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casas</surname><given-names>M.</given-names></name><name><surname>Casas</surname><given-names>H.</given-names></name><name><surname>Pag&#x000e9;s</surname><given-names>T.</given-names></name><name><surname>Rama</surname><given-names>R.</given-names></name><name><surname>Ricart</surname><given-names>A.</given-names></name><name><surname>Ventura</surname><given-names>J. L.</given-names></name><etal/></person-group>. (<year>2000</year>). <article-title>Intermittent hypobaric hypoxia induces altitude acclimation and improves the lactate threshold</article-title>. <source>Aviat. Space. Environ. Med.</source>
<volume>71</volume>, <fpage>125</fpage>&#x02013;<lpage>30</lpage>. <?supplied-pmid 10685585?><pub-id pub-id-type="pmid">10685585</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapman</surname><given-names>R. F.</given-names></name><name><surname>Stray-Gundersen</surname><given-names>J.</given-names></name><name><surname>Levine</surname><given-names>B. D.</given-names></name></person-group> (<year>1998</year>). <article-title>Individual variation in response to altitude training</article-title>. <source>J. Appl. Physiol.</source>
<volume>85</volume>, <fpage>1448</fpage>&#x02013;<lpage>1456</lpage>. <pub-id pub-id-type="doi">10.1152/jappl.1998.85.4.1448</pub-id><?supplied-pmid 9760340?><pub-id pub-id-type="pmid">9760340</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chateauvieux</surname><given-names>S.</given-names></name><name><surname>Grigorakaki</surname><given-names>C.</given-names></name><name><surname>Morceau</surname><given-names>F.</given-names></name><name><surname>Dicato</surname><given-names>M.</given-names></name><name><surname>Diederich</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>Erythropoietin, erythropoiesis and beyond</article-title>. <source>Biochem. Pharmacol.</source>
<volume>82</volume>, <fpage>1291</fpage>&#x02013;<lpage>1303</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2011.06.045</pub-id><?supplied-pmid 21782802?><pub-id pub-id-type="pmid">21782802</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ch&#x000e1;vez</surname><given-names>J. C.</given-names></name><name><surname>Agani</surname><given-names>F.</given-names></name><name><surname>Pichiule</surname><given-names>P.</given-names></name><name><surname>LaManna</surname><given-names>J. C.</given-names></name></person-group> (<year>2000</year>). <article-title>Expression of hypoxia-inducible factor-1alpha in the brain of rats during chronic hypoxia</article-title>. <source>J. Appl. Physiol.</source>
<volume>89</volume>, <fpage>1937</fpage>&#x02013;<lpage>1942</lpage>. <pub-id pub-id-type="doi">10.1152/jappl.2000.89.5.1937</pub-id><?supplied-pmid 11053346?><pub-id pub-id-type="pmid">11053346</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chavez</surname><given-names>J. C.</given-names></name><name><surname>LaManna</surname><given-names>J. C.</given-names></name></person-group> (<year>2002</year>). <article-title>Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1</article-title>. <source>J. Neurosci.</source>
<volume>22</volume>, <fpage>8922</fpage>&#x02013;<lpage>8931</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-20-08922.2002</pub-id><?supplied-pmid 12388599?><pub-id pub-id-type="pmid">12388599</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>J. T.</given-names></name><name><surname>Wells</surname><given-names>I.</given-names></name><name><surname>Novey</surname><given-names>H. S.</given-names></name></person-group> (<year>1981</year>). <article-title>Incidence of fungal precipitins in patients treated with beclomethasone dipropionate aerosol</article-title>. <source>Ann. Allergy</source>
<volume>46</volume>, <fpage>137</fpage>&#x02013;<lpage>9</lpage>. <?supplied-pmid 7008662?><pub-id pub-id-type="pmid">7008662</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chouabe</surname><given-names>C.</given-names></name><name><surname>Ricci</surname><given-names>E.</given-names></name><name><surname>Amsellem</surname><given-names>J.</given-names></name><name><surname>Blaineau</surname><given-names>S.</given-names></name><name><surname>Dalmaz</surname><given-names>Y.</given-names></name><name><surname>Favier</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>Effects of aging on the cardiac remodeling induced by chronic high-altitude hypoxia in rat</article-title>. <source>Am. J. Physiol. Heart Circ. Physiol.</source>
<volume>287</volume>, <fpage>H1246</fpage>&#x02013;<lpage>H1253</lpage>. <pub-id pub-id-type="doi">10.1152/ajpheart.00199.2004</pub-id><?supplied-pmid 15142847?><pub-id pub-id-type="pmid">15142847</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christie</surname><given-names>P. E.</given-names></name><name><surname>Yntema</surname><given-names>J. L.</given-names></name><name><surname>Tagari</surname><given-names>P.</given-names></name><name><surname>Ysselstijn</surname><given-names>H.</given-names></name><name><surname>Ford-Hutchinson</surname><given-names>A. W.</given-names></name><name><surname>Lee</surname><given-names>T. H.</given-names></name></person-group> (<year>1995</year>). <article-title>Effect of altitude on urinary leukotriene (LT) E4 excretion and airway responsiveness to histamine in children with atopic asthma</article-title>. <source>Eur. Respir. J.</source>
<volume>8</volume>, <fpage>357</fpage>&#x02013;<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1183/09031936.95.08030357</pub-id><?supplied-pmid 7789477?><pub-id pub-id-type="pmid">7789477</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cogo</surname><given-names>A.</given-names></name><name><surname>Basnyat</surname><given-names>B.</given-names></name><name><surname>Legnani</surname><given-names>D.</given-names></name><name><surname>Allegra</surname><given-names>L.</given-names></name></person-group> (<year>1997</year>). <article-title>Bronchial asthma and airway hyperresponsiveness at high altitude</article-title>. <source>Respiration.</source>
<volume>64</volume>, <fpage>444</fpage>&#x02013;<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1159/000196721</pub-id><?supplied-pmid 9383820?><pub-id pub-id-type="pmid">9383820</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cogo</surname><given-names>A.</given-names></name><name><surname>Fischer</surname><given-names>R.</given-names></name><name><surname>Schoene</surname><given-names>R.</given-names></name></person-group> (<year>2004</year>). <article-title>Respiratory diseases and high altitude</article-title>. <source>High Alt. Med. Biol.</source>
<volume>5</volume>, <fpage>435</fpage>&#x02013;<lpage>444</lpage>. <pub-id pub-id-type="doi">10.1089/ham.2004.5.435</pub-id><?supplied-pmid 15671633?><pub-id pub-id-type="pmid">15671633</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corral</surname><given-names>L.</given-names></name><name><surname>Conde</surname><given-names>L.</given-names></name><name><surname>Guillam,&#x000f3;</surname><given-names>E.</given-names></name><name><surname>Blasi</surname><given-names>J.</given-names></name><name><surname>Juncadella</surname><given-names>M.</given-names></name><name><surname>Javierre</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2014a</year>). <article-title>Circulating progenitor cells during exercise, muscle electro-stimulation and intermittent hypobaric hypoxia in patients with traumatic brain injury: a pilot study</article-title>. <source>NeuroRehabilitation</source>
<volume>35</volume>, <fpage>763</fpage>&#x02013;<lpage>769</lpage>. <pub-id pub-id-type="doi">10.3233/NRE-141172</pub-id><?supplied-pmid 25318779?><pub-id pub-id-type="pmid">25318779</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corral</surname><given-names>L.</given-names></name><name><surname>Javierre</surname><given-names>C.</given-names></name><name><surname>Blasi</surname><given-names>J.</given-names></name><name><surname>Viscor</surname><given-names>G.</given-names></name><name><surname>Ricart</surname><given-names>A.</given-names></name><name><surname>Ventura</surname><given-names>J. L.</given-names></name></person-group> (<year>2014b</year>). <article-title>Combined intermittent hypobaric hypoxia and muscle electro-stimulation: a method to increase circulating progenitor cell concentration?</article-title>
<source>J. Transl. Med.</source>
<volume>12</volume>:<fpage>174</fpage>. <pub-id pub-id-type="doi">10.1186/1479-5876-12-174</pub-id><?supplied-pmid 24947505?><pub-id pub-id-type="pmid">24947505</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>D. C.</given-names></name><name><surname>Alva</surname><given-names>N.</given-names></name><name><surname>Trigueros</surname><given-names>L.</given-names></name><name><surname>Gamez</surname><given-names>A.</given-names></name><name><surname>Carbonell</surname><given-names>T.</given-names></name><name><surname>Rama</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Intermittent hypobaric hypoxia induces neuroprotection in kainate-induced oxidative stress in rats</article-title>. <source>J. Mol. Neurosci.</source>
<volume>50</volume>, <fpage>402</fpage>&#x02013;<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-012-9945-8</pub-id><?supplied-pmid 23288703?><pub-id pub-id-type="pmid">23288703</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname><given-names>E. A.</given-names></name><name><surname>Ben Mabrouk</surname><given-names>F.</given-names></name><name><surname>Mitchell</surname><given-names>G. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Unexpected benefits of intermittent hypoxia: enhanced respiratory and nonrespiratory motor function</article-title>. <source>Physiology (Bethesda).</source>
<volume>29</volume>, <fpage>39</fpage>&#x02013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1152/physiol.00012.2013</pub-id><?supplied-pmid 24382870?><pub-id pub-id-type="pmid">24382870</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debevec</surname><given-names>T.</given-names></name><name><surname>Mekljavic</surname><given-names>I. B.</given-names></name></person-group> (<year>2013</year>). <article-title>Short intermittent hypoxia for improvement of athletic performance: reality or a placebo? / Kratkotrajna intermitentna hipoksija za izboljsanje sportne sposobnosti: realnost ali placebo?</article-title>
<source>Kinesiol. Slov.</source>
<volume>19</volume>, <fpage>5</fpage>&#x02013;<lpage>28</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://search.proquest.com/openview/22ce1795696590210cf7a98ba0253a14/1?">https://search.proquest.com/openview/22ce1795696590210cf7a98ba0253a14/1?</ext-link></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debevec</surname><given-names>T.</given-names></name><name><surname>Millet</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>Discerning normobaric and hypobaric hypoxia: significance of exposure duration</article-title>. <source>J. Appl. Physiol.</source>
<volume>116</volume>:<fpage>1255</fpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00319.2013.5</pub-id><?supplied-pmid 24789886?><pub-id pub-id-type="pmid">24789886</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dehnert</surname><given-names>C.</given-names></name><name><surname>B&#x000f6;hm</surname><given-names>A.</given-names></name><name><surname>Grigoriev</surname><given-names>I.</given-names></name><name><surname>Menold</surname><given-names>E.</given-names></name><name><surname>B&#x000e4;rtsch</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>Sleeping in moderate hypoxia at home for prevention of acute mountain sickness (AMS): a placebo-controlled, randomized double-blind study</article-title>. <source>Wilderness Environ. Med.</source>
<volume>25</volume>, <fpage>263</fpage>&#x02013;<lpage>271</lpage>. <pub-id pub-id-type="doi">10.1016/j.wem.2014.04.004</pub-id><?supplied-pmid 24931591?><pub-id pub-id-type="pmid">24931591</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>DeNoon</surname><given-names>D. J.</given-names></name></person-group> (<year>2008</year>). <article-title>FDA panel asks: are asthma drugs safe?</article-title>
<source>Medscape WebMD, December 10th</source>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.medscape.com/viewarticle/585129">https://www.medscape.com/viewarticle/585129</ext-link> [Accessed December 27, 2017]</mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Prampero</surname><given-names>P. E.</given-names></name><name><surname>Pi&#x000f1;era Limas</surname><given-names>F.</given-names></name><name><surname>Sassi</surname><given-names>G.</given-names></name></person-group> (<year>1970</year>). <article-title>Maximal muscular power, aerobic and anaerobic, in 116 athletes performing at the XIXth olympic games in Mexico</article-title>. <source>Ergonomics</source>
<volume>13</volume>, <fpage>665</fpage>&#x02013;<lpage>674</lpage>. <pub-id pub-id-type="doi">10.1080/00140137008931192</pub-id><?supplied-pmid 5532299?><pub-id pub-id-type="pmid">5532299</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiPasquale</surname><given-names>D. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Moving the debate forward: are normobaric and hypobaric hypoxia interchangeable in the study of altitude?</article-title>
<source>Curr. Sports Med. Rep.</source>
<volume>16</volume>, <fpage>68</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1249/JSR.0000000000000337</pub-id><?supplied-pmid 28282350?><pub-id pub-id-type="pmid">28282350</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dougherty</surname><given-names>B. J.</given-names></name><name><surname>Terada</surname><given-names>J.</given-names></name><name><surname>Springborn</surname><given-names>S. R.</given-names></name><name><surname>Vinit</surname><given-names>S.</given-names></name><name><surname>MacFarlane</surname><given-names>P. M.</given-names></name><name><surname>Mitchell</surname><given-names>G. S.</given-names></name></person-group> (<year>2017</year>). <article-title>Daily acute intermittent hypoxia improves breathing function with acute and chronic spinal injury via distinct mechanisms</article-title>. <source>Respir. Physiol. Neurobiol.</source>. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1016/j.resp.2017.05.004</pub-id><?supplied-pmid 28549897?><pub-id pub-id-type="pmid">28549897</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Droma</surname><given-names>Y.</given-names></name><name><surname>Kunii</surname><given-names>O.</given-names></name><name><surname>Yangzom</surname><given-names>Y.</given-names></name><name><surname>Shan</surname><given-names>M.</given-names></name><name><surname>Pingzo</surname><given-names>L.</given-names></name><name><surname>Song</surname><given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>Prevalence and severity of asthma and allergies in schoolchildren in Lhasa, Tibet</article-title>. <source>Clin. Exp. Allergy</source>
<volume>37</volume>, <fpage>1326</fpage>&#x02013;<lpage>1333</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2222.2007.02781.x</pub-id><?supplied-pmid 17845413?><pub-id pub-id-type="pmid">17845413</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckardt</surname><given-names>K. U.</given-names></name><name><surname>Boutellier</surname><given-names>U.</given-names></name><name><surname>Kurtz</surname><given-names>A.</given-names></name><name><surname>Schopen</surname><given-names>M.</given-names></name><name><surname>Koller</surname><given-names>E. A.</given-names></name><name><surname>Bauer</surname><given-names>C.</given-names></name></person-group> (<year>1989</year>). <article-title>Rate of erythropoietin formation in humans in response to acute hypobaric hypoxia</article-title>. <source>J Appl Physiol.</source>
<volume>66</volume>, <fpage>1785</fpage>&#x02013;<lpage>1788</lpage>. <pub-id pub-id-type="doi">10.1152/jappl.1989.66.4.1785</pub-id><?supplied-pmid 2732171?><pub-id pub-id-type="pmid">2732171</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egrie</surname><given-names>J. C.</given-names></name><name><surname>Strickland</surname><given-names>T. W.</given-names></name><name><surname>Lane</surname><given-names>J.</given-names></name><name><surname>Aoki</surname><given-names>K.</given-names></name><name><surname>Cohen</surname><given-names>A. M.</given-names></name><name><surname>Smalling</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>1986</year>). <article-title>Characterization and biological effects of recombinant human erythropoietin</article-title>. <source>Immunobiology</source>
<volume>172</volume>, <fpage>213</fpage>&#x02013;<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1016/S0171-2985(86)80101-2</pub-id><?supplied-pmid 3542810?><pub-id pub-id-type="pmid">3542810</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engst</surname><given-names>R.</given-names></name><name><surname>Vocks</surname><given-names>E.</given-names></name></person-group> (<year>2000</year>). <article-title>[High-mountain climate therapy for skin diseases and allergies - Mode of action, therapeutic results, and immunologic effects]</article-title>. <source>Rehabilitation</source>
<volume>39</volume>, <fpage>215</fpage>&#x02013;<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1055/s-2000-5897</pub-id><?supplied-pmid 11008279?><pub-id pub-id-type="pmid">11008279</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esteva</surname><given-names>S.</given-names></name><name><surname>Panisello</surname><given-names>P.</given-names></name><name><surname>Torrella</surname><given-names>J. R.</given-names></name><name><surname>Pag&#x000e9;s</surname><given-names>T.</given-names></name><name><surname>Viscor</surname><given-names>G.</given-names></name></person-group> (<year>2009</year>). <article-title>Blood rheology adjustments in rats after a program of intermittent exposure to hypobaric hypoxia</article-title>. <source>High Alt. Med. Biol.</source>
<volume>10</volume>, <fpage>275</fpage>&#x02013;<lpage>281</lpage>. <pub-id pub-id-type="doi">10.1089/ham.2008.1086</pub-id><?supplied-pmid 19775218?><pub-id pub-id-type="pmid">19775218</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>F&#x000e1;bi&#x000e1;n</surname><given-names>Z.</given-names></name><name><surname>Taylor</surname><given-names>C. T.</given-names></name><name><surname>Nguyen</surname><given-names>L. K.</given-names></name></person-group> (<year>2016</year>). <article-title>Understanding complexity in the HIF signaling pathway using systems biology and mathematical modeling</article-title>. <source>J. Mol. Med. (Berl).</source>
<volume>94</volume>, <fpage>377</fpage>&#x02013;<lpage>390</lpage>. <pub-id pub-id-type="doi">10.1007/s00109-016-1383-6</pub-id><?supplied-pmid 26821588?><pub-id pub-id-type="pmid">26821588</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fairfax</surname><given-names>A. J.</given-names></name><name><surname>David</surname><given-names>V.</given-names></name><name><surname>Douce</surname><given-names>G.</given-names></name></person-group> (<year>1999</year>). <article-title>Laryngeal aspergillosis following high dose inhaled fluticasone therapy for asthma</article-title>. <source>Thorax</source>
<volume>54</volume>, <fpage>860</fpage>&#x02013;<lpage>861</lpage>. <pub-id pub-id-type="doi">10.1136/thx.54.9.860</pub-id><?supplied-pmid 10456978?><pub-id pub-id-type="pmid">10456978</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faiss</surname><given-names>R.</given-names></name><name><surname>Girard</surname><given-names>O.</given-names></name><name><surname>Millet</surname><given-names>G. P.</given-names></name></person-group> (<year>2013</year>). <article-title>Advancing hypoxic training in team sports: from intermittent hypoxic training to repeated sprint training in hypoxia</article-title>. <source>Br. J. Sports Med.</source>
<volume>47</volume> (<issue>Suppl. 1</issue>), <fpage>i45</fpage>&#x02013;<lpage>i50</lpage>. <pub-id pub-id-type="doi">10.1136/bjsports-2013-092741</pub-id><?supplied-pmid 24282207?><pub-id pub-id-type="pmid">24282207</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feriche</surname><given-names>B.</given-names></name><name><surname>Garc&#x000ed;a-Ramos</surname><given-names>A.</given-names></name><name><surname>Calder&#x000f3;n-Soto</surname><given-names>C.</given-names></name><name><surname>Drobnic</surname><given-names>F.</given-names></name><name><surname>Bonitch-G&#x000f3;ngora</surname><given-names>J. G.</given-names></name><name><surname>Galilea</surname><given-names>P. A.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Effect of acute exposure to moderate altitude on muscle power: hypobaric hypoxia vs</article-title>. <source>normobaric hypoxia. PLoS ONE</source>
<volume>9</volume>:<fpage>e114072</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0114072</pub-id><?supplied-pmid 25474104?><pub-id pub-id-type="pmid">25474104</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Filopoulos</surname><given-names>D.</given-names></name><name><surname>Cormack</surname><given-names>S. J.</given-names></name><name><surname>Whyte</surname><given-names>D. G.</given-names></name></person-group> (<year>2017</year>). <article-title>Normobaric hypoxia increases the growth hormone response to maximal resistance exercise in trained men</article-title>. <source>Eur. J. Sport Sci.</source>
<volume>17</volume>, <fpage>821</fpage>&#x02013;<lpage>829</lpage>. <pub-id pub-id-type="doi">10.1080/17461391.2017.1317834</pub-id><?supplied-pmid 28445110?><pub-id pub-id-type="pmid">28445110</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fulco</surname><given-names>C. S.</given-names></name><name><surname>Beidleman</surname><given-names>B. A.</given-names></name><name><surname>Muza</surname><given-names>S. R.</given-names></name></person-group> (<year>2013</year>). <article-title>Effectiveness of preacclimatization strategies for high-altitude exposure</article-title>. <source>Exerc. Sport Sci. Rev.</source>
<volume>41</volume>, <fpage>55</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1097/JES.0b013e31825eaa33</pub-id><?supplied-pmid 22653279?><pub-id pub-id-type="pmid">22653279</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garvican-Lewis</surname><given-names>L. A.</given-names></name><name><surname>Sharpe</surname><given-names>K.</given-names></name><name><surname>Gore</surname><given-names>C. J.</given-names></name></person-group> (<year>2016</year>). <article-title>Time for a new metric for hypoxic dose?</article-title>
<source>J. Appl. Physiol.</source>
<volume>121</volume>, <fpage>352</fpage>&#x02013;<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00579.2015</pub-id><?supplied-pmid 26917695?><pub-id pub-id-type="pmid">26917695</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatterer</surname><given-names>H.</given-names></name><name><surname>Haacke</surname><given-names>S.</given-names></name><name><surname>Burtscher</surname><given-names>M.</given-names></name><name><surname>Faulhaber</surname><given-names>M.</given-names></name><name><surname>Melmer</surname><given-names>A.</given-names></name><name><surname>Ebenbichler</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Normobaric Intermittent Hypoxia over 8 Months Does Not Reduce Body Weight and Metabolic Risk Factors-a Randomized, Single Blind, Placebo-Controlled Study in Normobaric Hypoxia and Normobaric Sham Hypoxia</article-title>. <source>Obes. Facts</source>
<volume>8</volume>, <fpage>200</fpage>&#x02013;<lpage>209</lpage>. <pub-id pub-id-type="doi">10.1159/000431157</pub-id><?supplied-pmid 26008855?><pub-id pub-id-type="pmid">26008855</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>R. L.</given-names></name><name><surname>Chen</surname><given-names>Q. H.</given-names></name><name><surname>He</surname><given-names>L. G.</given-names></name></person-group> (<year>1994</year>). <article-title>[Characteristics of hypoxic ventilatory response in Tibetan living at moderate and high altitudes]</article-title>. <source>Zhonghua Jie He He Hu Xi Za Zhi</source>
<volume>17</volume>, <fpage>364</fpage>&#x02013;<lpage>6</lpage>, 384. <?supplied-pmid 7712582?><pub-id pub-id-type="pmid">7712582</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ge</surname><given-names>R.</given-names></name><name><surname>Witkowski</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Alfrey</surname><given-names>C.</given-names></name><name><surname>Sivieri</surname><given-names>M.</given-names></name><name><surname>Karlsen</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2002</year>). <article-title>Determinants of erythropoietin release in response to short-term hypobaric hypoxia</article-title>. <source>J. Appl. Physiol.</source>
<volume>92</volume>, <fpage>2361</fpage>&#x02013;<lpage>2367</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00684.2001</pub-id><?supplied-pmid 12015348?><pub-id pub-id-type="pmid">12015348</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girard</surname><given-names>O.</given-names></name></person-group> (<year>2012</year>). <article-title>Comments on point:counterpoint: hypobaric hypoxia induces / does not induce different responses from normobaric hypoxia - Reduced air resistance with terrestrial altitude alters run sprint performance</article-title>. <source>J. Appl. Physiol. (Bethesda, MD</source> 1985) <volume>112</volume>:<fpage>1788</fpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00356.2012</pub-id><?supplied-pmid 22589492?><pub-id pub-id-type="pmid">22589492</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gore</surname><given-names>C. J.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>F. A.</given-names></name><name><surname>Truijens</surname><given-names>M. J.</given-names></name><name><surname>Townsend</surname><given-names>N. E.</given-names></name><name><surname>Stray-Gundersen</surname><given-names>J.</given-names></name><name><surname>Levine</surname><given-names>B. D.</given-names></name></person-group> (<year>2006</year>). <article-title>Increased serum erythropoietin but not red cell production after 4 wk of intermittent hypobaric hypoxia (4,000-5,500 m)</article-title>. <source>J. Appl. Physiol.</source>
<volume>101</volume>, <fpage>1386</fpage>&#x02013;<lpage>1393</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00342.2006</pub-id><?supplied-pmid 16794028?><pub-id pub-id-type="pmid">16794028</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gourgoulianis</surname><given-names>K. I.</given-names></name><name><surname>Brelas</surname><given-names>N.</given-names></name><name><surname>Hatziparasides</surname><given-names>G.</given-names></name><name><surname>Papayianni</surname><given-names>M.</given-names></name><name><surname>Molyvdas</surname><given-names>P. A.</given-names></name></person-group> (<year>2001</year>). <article-title>The influence of altitude in bronchial asthma</article-title>. <source>Arch. Med. Res.</source>
<volume>32</volume>, <fpage>429</fpage>&#x02013;<lpage>431</lpage>. <pub-id pub-id-type="doi">10.1016/S0188-4409(01)00302-2</pub-id><?supplied-pmid 11578758?><pub-id pub-id-type="pmid">11578758</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamlin</surname><given-names>M. J.</given-names></name><name><surname>Lizamore</surname><given-names>C. A.</given-names></name><name><surname>Hopkins</surname><given-names>W. G.</given-names></name></person-group> (<year>2018</year>). <article-title>The effect of natural or simulated altitude training on high-intensity intermittent running performance in team-sport athletes: a meta-analysis</article-title>. <source>Sports Med.</source>
<volume>48</volume>, <fpage>431</fpage>&#x02013;<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1007/s40279-017-0809-9</pub-id><?supplied-pmid 29129021?><pub-id pub-id-type="pmid">29129021</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harrison</surname><given-names>C. C.</given-names></name><name><surname>Fleming</surname><given-names>J. M.</given-names></name><name><surname>Giles</surname><given-names>L. C.</given-names></name></person-group> (<year>2002</year>). <article-title>Does interval hypoxic training affect the lung function of asthmatic athletes</article-title>. <source>New Zeal. J. Sport. Med.</source>
<volume>30</volume>, <fpage>64</fpage>&#x02013;<lpage>67</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://blm-altitude.com/blm/uploads/images/Gallery/Applications/Health-and-Wellness/Lung-Function-Asthmatic-Athletes.pdf">http://blm-altitude.com/blm/uploads/images/Gallery/Applications/Health-and-Wellness/Lung-Function-Asthmatic-Athletes.pdf</ext-link></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haskell</surname><given-names>W. L.</given-names></name><name><surname>Lee</surname><given-names>I.-M.</given-names></name><name><surname>Pate</surname><given-names>R. R.</given-names></name><name><surname>Powell</surname><given-names>K. E.</given-names></name><name><surname>Blair</surname><given-names>S. N.</given-names></name><name><surname>Franklin</surname><given-names>B. A.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association</article-title>. <source>Med. Sci. Sports Exerc.</source>
<volume>39</volume>, <fpage>1423</fpage>&#x02013;<lpage>1434</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.185649</pub-id><?supplied-pmid 17762377?><pub-id pub-id-type="pmid">17762377</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haufe</surname><given-names>S.</given-names></name><name><surname>Wiesner</surname><given-names>S.</given-names></name><name><surname>Engeli</surname><given-names>S.</given-names></name><name><surname>Luft</surname><given-names>F. C.</given-names></name><name><surname>Jordan</surname><given-names>J.</given-names></name></person-group> (<year>2008</year>). <article-title>Influences of normobaric hypoxia training on metabolic risk markers in human subjects</article-title>. <source>Med. Sci. Sports Exerc.</source>
<volume>40</volume>, <fpage>1939</fpage>&#x02013;<lpage>1944</lpage>. <pub-id pub-id-type="doi">10.1249/MSS.0b013e31817f1988</pub-id><?supplied-pmid 18845972?><pub-id pub-id-type="pmid">18845972</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hauser</surname><given-names>A.</given-names></name><name><surname>Schmitt</surname><given-names>L.</given-names></name><name><surname>Troesch</surname><given-names>S.</given-names></name><name><surname>Saugy</surname><given-names>J. J.</given-names></name><name><surname>Cejuela-Anta</surname><given-names>R.</given-names></name><name><surname>Faiss</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Similar hemoglobin mass response in hypobaric and normobaric hypoxia in athletes</article-title>. <source>Med. Sci. Sports Exerc.</source>
<volume>48</volume>, <fpage>734</fpage>&#x02013;<lpage>741</lpage>. <pub-id pub-id-type="doi">10.1249/MSS.0000000000000808</pub-id><?supplied-pmid 26540262?><pub-id pub-id-type="pmid">26540262</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heuschmann</surname><given-names>P.</given-names></name><name><surname>Hoffmann</surname><given-names>U.</given-names></name><name><surname>Piepoli</surname><given-names>M. F.</given-names></name><name><surname>Verschuren</surname><given-names>M.</given-names></name><name><surname>Halcox</surname><given-names>J.</given-names></name><name><surname>Reviewers</surname><given-names>D.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Secondary prevention through cardiac rehabilitation : physical activity counselling and exercise training Key components of the position paper from the Cardiac rehabilitation section of the European Association of Cardiovascular Prevention and Rehabilitation</article-title>. <source>Eur Heart J.</source>
<volume>31</volume>, <fpage>1967</fpage>&#x02013;<lpage>1976</lpage>. <pub-id pub-id-type="doi">10.1093/eurheartj/ehq236</pub-id><?supplied-pmid 20643803?><pub-id pub-id-type="pmid">20643803</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirota</surname><given-names>K.</given-names></name><name><surname>Semenza</surname><given-names>G. L.</given-names></name></person-group> (<year>2006</year>). <article-title>Regulation of angiogenesis by hypoxia-inducible factor 1</article-title>. <source>Crit. Rev. Oncol. Hematol.</source>
<volume>59</volume>, <fpage>15</fpage>&#x02013;<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1016/j.critrevonc.2005.12.003</pub-id><?supplied-pmid 16716598?><pub-id pub-id-type="pmid">16716598</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hornbein</surname><given-names>T. F.</given-names></name></person-group> (<year>2001</year>). <article-title>The high-altitude brain</article-title>. <source>J. Exp. Biol.</source>
<volume>204</volume>, <fpage>3129</fpage>&#x02013;<lpage>3132</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://jeb.biologists.org/content/204/18/3129.full.pdf">http://jeb.biologists.org/content/204/18/3129.full.pdf</ext-link><?supplied-pmid 11581326?><pub-id pub-id-type="pmid">11581326</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ib&#x000e1;&#x000f1;ez</surname><given-names>J.</given-names></name><name><surname>Casas</surname><given-names>H.</given-names></name><name><surname>Casas</surname><given-names>M.</given-names></name><name><surname>Rama</surname><given-names>R.</given-names></name><name><surname>Ricart</surname><given-names>A.</given-names></name><name><surname>Ventura</surname><given-names>J. L.</given-names></name><etal/></person-group> (<year>2000</year>). <article-title>L'exposition intermittente &#x000e0; l'hypoxie en caisson hypobarique: effets physiologiques et applications</article-title>. <source>M&#x000e9;decine du Sport</source>
<volume>74</volume>, <fpage>32</fpage>&#x02013;<lpage>34</lpage></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>Y.</given-names></name><name><surname>Suzuki</surname><given-names>N.</given-names></name><name><surname>Yamamoto</surname><given-names>M.</given-names></name><name><surname>Gassmann</surname><given-names>M.</given-names></name><name><surname>Noguchi</surname><given-names>C. T.</given-names></name></person-group> (<year>2012</year>). <article-title>Endogenous erythropoietin signaling facilitates skeletal muscle repair and recovery following pharmacologically induced damage</article-title>. <source>FASEB J.</source>
<volume>26</volume>, <fpage>2847</fpage>&#x02013;<lpage>2858</lpage>. <pub-id pub-id-type="doi">10.1096/fj.11-196618</pub-id><?supplied-pmid 22490927?><pub-id pub-id-type="pmid">22490927</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Julian</surname><given-names>C. G.</given-names></name><name><surname>Gore</surname><given-names>C. J.</given-names></name><name><surname>Wilber</surname><given-names>R. L.</given-names></name><name><surname>Daniels</surname><given-names>J. T.</given-names></name><name><surname>Fredericson</surname><given-names>M.</given-names></name><name><surname>Stray-Gundersen</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2004</year>). <article-title>Intermittent normobaric hypoxia does not alter performance or erythropoietic markers in highly trained distance runners</article-title>. <source>J. Appl. Physiol.</source>
<volume>96</volume>, <fpage>1800</fpage>&#x02013;<lpage>1807</lpage>. <pub-id pub-id-type="doi">10.1016/j.obhdp.2010.11.002</pub-id><?supplied-pmid 14672967?><pub-id pub-id-type="pmid">14672967</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karagiannidis</surname><given-names>C.</given-names></name><name><surname>Hense</surname><given-names>G.</given-names></name><name><surname>Rueckert</surname><given-names>B.</given-names></name><name><surname>Mantel</surname><given-names>P. Y.</given-names></name><name><surname>Ichters</surname><given-names>B.</given-names></name><name><surname>Blaser</surname><given-names>K.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>High-altitude climate therapy reduces local airway inflammation and modulates lymphocyte activation</article-title>. <source>Scand. J. Immunol.</source>
<volume>63</volume>, <fpage>304</fpage>&#x02013;<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-3083.2006.01739.x</pub-id><?supplied-pmid 16623931?><pub-id pub-id-type="pmid">16623931</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlsen</surname><given-names>T.</given-names></name><name><surname>Resaland</surname><given-names>G. K.</given-names></name><name><surname>Ri-Li</surname><given-names>G.</given-names></name><name><surname>Sivieri</surname><given-names>M.</given-names></name><name><surname>Witowski</surname><given-names>S.</given-names></name><name><surname>Yates</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Epo response to 24 hrs of artificial hypobaric hypoxia predicts epo response to natural altitude</article-title>. <source>Med. Sci. Sport. Exerc.</source>
<volume>33</volume>:<fpage>S98</fpage> Available online at: <ext-link ext-link-type="uri" xlink:href="https://journals.lww.com/acsm-msse/Fulltext/2001/05001/EPO_RESPONSE_TO_24_HRS_OF_ARTIFICIAL_HYPOBARIC.556.aspx">https://journals.lww.com/acsm-msse/Fulltext/2001/05001/EPO_RESPONSE_TO_24_HRS_OF_ARTIFICIAL_HYPOBARIC.556.aspx</ext-link></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kenney</surname><given-names>W. L.</given-names></name><name><surname>Wilmore</surname><given-names>J. H.</given-names></name><name><surname>Costill</surname><given-names>D. L.</given-names></name><name><surname>Wilmore</surname><given-names>J. H.</given-names></name></person-group> (<year>2012</year>). <source>Physiology of Sport and Exercise. 5th Edn</source>. <publisher-loc>Champaign IL</publisher-loc>: <publisher-name>Human Kinetics</publisher-name></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khodaee</surname><given-names>M.</given-names></name><name><surname>Grothe</surname><given-names>H. L.</given-names></name><name><surname>Seyfert</surname><given-names>J. H.</given-names></name><name><surname>VanBaak</surname><given-names>K.</given-names></name></person-group> (<year>2016</year>). <article-title>Athletes at high altitude</article-title>. <source>Sports Health</source>
<volume>8</volume>, <fpage>126</fpage>&#x02013;<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1177/1941738116630948</pub-id><?supplied-pmid 26863894?><pub-id pub-id-type="pmid">26863894</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiechl-Kohlendorfer</surname><given-names>U.</given-names></name><name><surname>Horak</surname><given-names>E.</given-names></name><name><surname>Mueller</surname><given-names>W.</given-names></name><name><surname>Strobl</surname><given-names>R.</given-names></name><name><surname>Haberland</surname><given-names>C.</given-names></name><name><surname>Fink</surname><given-names>F. M.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Living at high altitude and risk of hospitalisation for atopic asthma in children: results from a large prospective birth-cohort study</article-title>. <source>Arch. Dis. Child.</source>
<volume>92</volume>, <fpage>339</fpage>&#x02013;<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1136/adc.2006.106278</pub-id><?supplied-pmid 17376940?><pub-id pub-id-type="pmid">17376940</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kon</surname><given-names>M.</given-names></name><name><surname>Ohiwa</surname><given-names>N.</given-names></name><name><surname>Honda</surname><given-names>A.</given-names></name><name><surname>Matsubayashi</surname><given-names>T.</given-names></name><name><surname>Ikeda</surname><given-names>T.</given-names></name><name><surname>Akimoto</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Effects of systemic hypoxia on human muscular adaptations to resistance exercise training</article-title>. <source>Physiol. Rep.</source>
<volume>2</volume>, <fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.14814/phy2.12033</pub-id><?supplied-pmid 24907297?><pub-id pub-id-type="pmid">24907297</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Korcarz</surname><given-names>C. E.</given-names></name><name><surname>Peppard</surname><given-names>P. E.</given-names></name><name><surname>Young</surname><given-names>T. B.</given-names></name><name><surname>Chapman</surname><given-names>C. B.</given-names></name><name><surname>Hla</surname><given-names>K. M.</given-names></name><name><surname>Barnet</surname><given-names>J. H.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Effects of obstructive sleep apnea and obesity on cardiac remodeling: the wisconsin sleep cohort study</article-title>. <source>Sleep</source>
<volume>39</volume>, <fpage>1187</fpage>&#x02013;<lpage>1195</lpage>. <pub-id pub-id-type="doi">10.5665/sleep.5828</pub-id><?supplied-pmid 27091525?><pub-id pub-id-type="pmid">27091525</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koyasu</surname><given-names>S.</given-names></name><name><surname>Kobayashi</surname><given-names>M.</given-names></name><name><surname>Goto</surname><given-names>Y.</given-names></name><name><surname>Hiraoka</surname><given-names>M.</given-names></name><name><surname>Harada</surname><given-names>H.</given-names></name></person-group> (<year>2017</year>). <article-title>Regulatory mechanisms of hypoxia-inducible factor 1 activity: two decades of knowledge</article-title>. <source>Cancer Sci.</source>
<volume>109</volume>, <fpage>560</fpage>&#x02013;<lpage>571</lpage>. <pub-id pub-id-type="doi">10.1111/cas.13483</pub-id><?supplied-pmid 29285833?><pub-id pub-id-type="pmid">29285833</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kushwah</surname><given-names>N.</given-names></name><name><surname>Jain</surname><given-names>V.</given-names></name><name><surname>Deep</surname><given-names>S.</given-names></name><name><surname>Prasad</surname><given-names>D.</given-names></name><name><surname>Singh</surname><given-names>S. B.</given-names></name><name><surname>Khan</surname><given-names>N.</given-names></name></person-group> (<year>2016</year>). <article-title>Neuroprotective role of intermittent hypobaric hypoxia in unpredictable chronic mild stress induced depression in rats</article-title>. <source>PLoS ONE</source>
<volume>11</volume>:<fpage>e0149309</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0149309</pub-id><?supplied-pmid 26901349?><pub-id pub-id-type="pmid">26901349</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kusunose</surname><given-names>K.</given-names></name><name><surname>Phelan</surname><given-names>D.</given-names></name><name><surname>Seicean</surname><given-names>S.</given-names></name><name><surname>Seicean</surname><given-names>A.</given-names></name><name><surname>Collier</surname><given-names>P.</given-names></name><name><surname>Boden</surname><given-names>K. A.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Relation of echocardiographic characteristics of the right-sided heart with incident heart failure and mortality in patients with sleep-disordered breathing and preserved left ventricular ejection fraction</article-title>. <source>Am. J. Cardiol.</source>
<volume>118</volume>, <fpage>1268</fpage>&#x02013;<lpage>1273</lpage>. <pub-id pub-id-type="doi">10.1016/j.amjcard.2016.07.024</pub-id><?supplied-pmid 27553095?><pub-id pub-id-type="pmid">27553095</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leone</surname><given-names>R. J.</given-names></name><name><surname>Lalande</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Intermittent hypoxia as a means to improve aerobic capacity in type 2 diabetes</article-title>. <source>Med. Hypotheses</source>
<volume>100</volume>, <fpage>59</fpage>&#x02013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.mehy.2017.01.010</pub-id><?supplied-pmid 28236850?><pub-id pub-id-type="pmid">28236850</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levett</surname><given-names>D. Z.</given-names></name><name><surname>Radford</surname><given-names>E. J.</given-names></name><name><surname>Menassa</surname><given-names>D. A.</given-names></name><name><surname>Graber</surname><given-names>E. F.</given-names></name><name><surname>Morash</surname><given-names>A. J.</given-names></name><name><surname>Hoppeler</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Acclimatization of skeletal muscle mitochondria to high-altitude hypoxia during an ascent of Everest</article-title>. <source>FASEB J.</source>
<volume>26</volume>, <fpage>1431</fpage>&#x02013;<lpage>1441</lpage>. <pub-id pub-id-type="doi">10.1096/fj.11-197772</pub-id><?supplied-pmid 22186874?><pub-id pub-id-type="pmid">22186874</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>B. D.</given-names></name><name><surname>Stray-Gundersen</surname><given-names>J.</given-names></name></person-group> (<year>1997</year>). <article-title>&#x0201c;Living high-training low&#x0201d;: effect of moderate-altitude acclimatization with low-altitude training on performance</article-title>. <source>J. Appl. Physiol.</source>
<volume>83</volume>, <fpage>102</fpage>&#x02013;<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1152/jappl.1997.83.1.102</pub-id><?supplied-pmid 9216951?><pub-id pub-id-type="pmid">9216951</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Up-regulation of hypoxia-inducible factor-1alpha enhanced the cardioprotective effects of ischemic postconditioning in hyperlipidemic rats</article-title>. <source>Acta Biochim Biophys Sin</source>
<volume>46</volume>, <fpage>112</fpage>&#x02013;<lpage>118</lpage>. <pub-id pub-id-type="doi">10.1093/abbs/gmt132</pub-id><?supplied-pmid 24389644?><pub-id pub-id-type="pmid">24389644</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieberman</surname><given-names>P.</given-names></name><name><surname>Protopapas</surname><given-names>A.</given-names></name><name><surname>Reed</surname><given-names>E.</given-names></name><name><surname>Youngs</surname><given-names>J. W.</given-names></name><name><surname>Kanki</surname><given-names>B. G.</given-names></name></person-group> (<year>1994</year>). <article-title>Cognitive defects at altitude</article-title>. <source>Nature</source>
<volume>372</volume>:<fpage>325</fpage>. <pub-id pub-id-type="doi">10.1038/372325a0</pub-id><?supplied-pmid 7969487?><pub-id pub-id-type="pmid">7969487</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippl</surname><given-names>F. J.</given-names></name><name><surname>Neubauer</surname><given-names>S.</given-names></name><name><surname>Schipfer</surname><given-names>S.</given-names></name><name><surname>Lichter</surname><given-names>N.</given-names></name><name><surname>Tufman</surname><given-names>A.</given-names></name><name><surname>Otto</surname><given-names>B.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Hypobaric hypoxia causes body weight reduction in obese subjects</article-title>. <source>Obesity</source>
<volume>18</volume>, <fpage>675</fpage>&#x02013;<lpage>681</lpage>. <pub-id pub-id-type="doi">10.1038/oby.2009.509</pub-id><?supplied-pmid 20134417?><pub-id pub-id-type="pmid">20134417</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lizamore</surname><given-names>C. A.</given-names></name><name><surname>Hamlin</surname><given-names>M. J.</given-names></name></person-group> (<year>2017</year>). <article-title>The use of simulated altitude techniques for beneficial cardiovascular health outcomes in nonathletic, sedentary, and clinical populations: a literature review</article-title>. <source>High Alt. Med. Biol.</source>
<volume>18</volume>, <fpage>305</fpage>&#x02013;<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1089/ham.2017.0050</pub-id><?supplied-pmid 28846046?><pub-id pub-id-type="pmid">28846046</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>London</surname><given-names>G. M.</given-names></name><name><surname>Zins</surname><given-names>B.</given-names></name><name><surname>Pannier</surname><given-names>B.</given-names></name><name><surname>Naret</surname><given-names>C.</given-names></name><name><surname>Berthelot</surname><given-names>J. M.</given-names></name><name><surname>Jacquot</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>1989</year>). <article-title>Vascular changes in hemodialysis patients in response to recombinant human erythropoietin</article-title>. <source>Kidney Int.</source>
<volume>36</volume>, <fpage>878</fpage>&#x02013;<lpage>882</lpage>. <pub-id pub-id-type="doi">10.1038/ki.1989.274</pub-id><?supplied-pmid 2615194?><pub-id pub-id-type="pmid">2615194</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundby</surname><given-names>C.</given-names></name><name><surname>Calbet</surname><given-names>J. A. L.</given-names></name><name><surname>Sander</surname><given-names>M.</given-names></name><name><surname>Van Hall</surname><given-names>G.</given-names></name><name><surname>Mazzeo</surname><given-names>R. S.</given-names></name><name><surname>Stray-Gundersen</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Exercise economy does not change after acclimatization to moderate to very high altitude</article-title>. <source>Scand. J. Med. Sci. Sport.</source>
<volume>17</volume>, <fpage>281</fpage>&#x02013;<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0838.2006.00530.x</pub-id><?supplied-pmid 17501869?><pub-id pub-id-type="pmid">17501869</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magalh&#x000e3;es</surname><given-names>J.</given-names></name><name><surname>Falc&#x000e3;o-Pires</surname><given-names>I.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>I. O.</given-names></name><name><surname>Lumini-Oliveira</surname><given-names>J.</given-names></name><name><surname>Marques-Aleixo</surname><given-names>I.</given-names></name><name><surname>Dos Passos</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Synergistic impact of endurance training and intermittent hypobaric hypoxia on cardiac function and mitochondrial energetic and signaling</article-title>. <source>Int. J. Cardiol.</source>
<volume>168</volume>, <fpage>5363</fpage>&#x02013;<lpage>5371</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2013.08.001</pub-id><?supplied-pmid 24012275?><pub-id pub-id-type="pmid">24012275</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Magalh&#x000e3;es</surname><given-names>J.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>I. O.</given-names></name><name><surname>Lumini-Oliveira</surname><given-names>J.</given-names></name><name><surname>Marques-Aleixo</surname><given-names>I.</given-names></name><name><surname>Passos</surname><given-names>E.</given-names></name><name><surname>Rocha-Rodrigues</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Modulation of cardiac mitochondrial permeability transition and apoptotic signaling by endurance training and intermittent hypobaric hypoxia</article-title>. <source>Int. J. Cardiol.</source>
<volume>173</volume>, <fpage>40</fpage>&#x02013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2014.02.011</pub-id><?supplied-pmid 24602319?><pub-id pub-id-type="pmid">24602319</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manimmanakorn</surname><given-names>A.</given-names></name><name><surname>Manimmanakorn</surname><given-names>N.</given-names></name><name><surname>Taylor</surname><given-names>R.</given-names></name><name><surname>Draper</surname><given-names>N.</given-names></name><name><surname>Billaut</surname><given-names>F.</given-names></name><name><surname>Shearman</surname><given-names>J. P.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Effects of resistance training combined with vascular occlusion or hypoxia on neuromuscular function in athletes</article-title>. <source>Eur. J. Appl. Physiol.</source>
<volume>113</volume>, <fpage>1767</fpage>&#x02013;<lpage>1774</lpage>. <pub-id pub-id-type="doi">10.1007/s00421-013-2605-z</pub-id><?supplied-pmid 23412543?><pub-id pub-id-type="pmid">23412543</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marquez</surname><given-names>J. L.</given-names></name><name><surname>Rubinstein</surname><given-names>S.</given-names></name><name><surname>Fattor</surname><given-names>J. A.</given-names></name><name><surname>Shah</surname><given-names>O.</given-names></name><name><surname>Hoffman</surname><given-names>A. R.</given-names></name><name><surname>Friedlander</surname><given-names>A. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Cyclic hypobaric hypoxia improves markers of glucose metabolism in middle-aged men</article-title>. <source>High Alt. Med. Biol.</source>
<volume>14</volume>, <fpage>263</fpage>&#x02013;<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1089/ham.2012.1057</pub-id><?supplied-pmid 24028640?><pub-id pub-id-type="pmid">24028640</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marticorena</surname><given-names>E. A.</given-names></name></person-group> (<year>1993</year>). <article-title>Monta&#x000f1;ismo m&#x000e9;dico: Rehabilitaci&#x000f3;n de pacientes coronarios con by-pass</article-title>. <source>Rev. Peru. Cardiol.</source>
<volume>19</volume>, <fpage>25</fpage>&#x02013;<lpage>29</lpage>.</mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marticorena</surname><given-names>E. A.</given-names></name><name><surname>Marticorena</surname><given-names>J. A.</given-names></name><name><surname>Gutierrez</surname><given-names>I.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>V.</given-names></name><name><surname>Fern&#x000e1;ndez-D&#x000e1;vila</surname><given-names>L.</given-names></name><name><surname>Oyola</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2001</year>). <article-title>Factor relajante del endotelio (ON) en rehabilitaci&#x000f3;n coronaria con c&#x000e1;mara hipob&#x000e1;rica</article-title>. <source>Rev. Peru. Cardiol.</source>
<volume>27</volume>, <fpage>148</fpage>&#x02013;<lpage>149</lpage>. Avavilable online at: <ext-link ext-link-type="uri" xlink:href="http://sisbib.unmsm.edu.pe/bvrevistas/cardiologia/anteriores.htm">http://sisbib.unmsm.edu.pe/bvrevistas/cardiologia/anteriores.htm</ext-link></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mateika</surname><given-names>J. H.</given-names></name><name><surname>El-Chami</surname><given-names>M.</given-names></name><name><surname>Shaheen</surname><given-names>D.</given-names></name><name><surname>Ivers</surname><given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>Intermittent hypoxia: a low-risk research tool with therapeutic value in humans: Fig. 1</article-title>. <source>J. Appl. Physiol.</source>
<volume>118</volume>, <fpage>520</fpage>&#x02013;<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00564.2014</pub-id><?supplied-pmid 25549763?><pub-id pub-id-type="pmid">25549763</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meehan</surname><given-names>R. T.</given-names></name></person-group> (<year>1987</year>). <article-title>Immune suppression at high altitude</article-title>. <source>Ann. Emerg. Med.</source>
<volume>16</volume>, <fpage>974</fpage>&#x02013;<lpage>979</lpage>. <pub-id pub-id-type="doi">10.1016/S0196-0644(87)80743-6</pub-id><?supplied-pmid 3307557?><pub-id pub-id-type="pmid">3307557</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meehan</surname><given-names>R.</given-names></name><name><surname>Duncan</surname><given-names>U.</given-names></name><name><surname>Neale</surname><given-names>L.</given-names></name><name><surname>Taylor</surname><given-names>G.</given-names></name><name><surname>Muchmore</surname><given-names>H.</given-names></name><name><surname>Scott</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>1988</year>). <article-title>Operation Everest II: alterations in the immune system at high altitudes</article-title>. <source>J. Clin. Immunol.</source>
<volume>8</volume>, <fpage>397</fpage>&#x02013;<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1007/BF00917156</pub-id><?supplied-pmid 2460489?><pub-id pub-id-type="pmid">2460489</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Milledge</surname><given-names>J. S.</given-names></name></person-group> (<year>2003</year>). <article-title>Altitude deterioration</article-title>, in <source>Health and Height</source> (<publisher-loc>Barcelona</publisher-loc>: <publisher-name>Publicacions Universitat de Barcelona</publisher-name>), <fpage>173</fpage>&#x02013;<lpage>180</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://www.publicacions.ub.edu/ficha.aspx?cod=06036">http://www.publicacions.ub.edu/ficha.aspx?cod=06036</ext-link></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millet</surname><given-names>G. P.</given-names></name><name><surname>Debevec</surname><given-names>T.</given-names></name><name><surname>Brocherie</surname><given-names>F.</given-names></name><name><surname>Malatesta</surname><given-names>D.</given-names></name><name><surname>Girard</surname><given-names>O.</given-names></name></person-group> (<year>2016</year>). <article-title>Therapeutic use of exercising in hypoxia : promises and limitations</article-title>. <source>Front. Physiol.</source>
<volume>7</volume>:<fpage>224</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2016.00224</pub-id><?supplied-pmid 27375500?><pub-id pub-id-type="pmid">27375500</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millet</surname><given-names>G. P.</given-names></name><name><surname>Faiss</surname><given-names>R.</given-names></name><name><surname>Pialoux</surname><given-names>V.</given-names></name></person-group> (<year>2012</year>). <article-title>Point: Counterpoint: Hypobaric hypoxia induces/does not induce different responses from normobaric hypoxia</article-title>. <source>J. Appl. Physiol.</source>
<volume>112</volume>, <fpage>1783</fpage>&#x02013;<lpage>1784</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00067.2012</pub-id><?supplied-pmid 22267386?><pub-id pub-id-type="pmid">22267386</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Millet</surname><given-names>G. P.</given-names></name><name><surname>Faiss</surname><given-names>R.</given-names></name><name><surname>Pialoux</surname><given-names>V.</given-names></name></person-group> (<year>2013</year>). <article-title>Evidence for differences between hypobaric and normobaric hypoxia is conclusive</article-title>. <source>Exerc. Sport Sci. Rev.</source>
<volume>41</volume>:<fpage>133</fpage>. <pub-id pub-id-type="doi">10.1097/JES.0b013e318271a5e1</pub-id><?supplied-pmid 23524575?><pub-id pub-id-type="pmid">23524575</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Najean</surname><given-names>Y.</given-names></name><name><surname>Moynot</surname><given-names>A.</given-names></name><name><surname>Deschryver</surname><given-names>F.</given-names></name><name><surname>Zins</surname><given-names>B.</given-names></name><name><surname>Naret</surname><given-names>C.</given-names></name><name><surname>Jacquot</surname><given-names>C.</given-names></name><etal/></person-group>. (<year>1989</year>). <article-title>Kinetics of erythropoiesis in dialysis patients receiving recombinant erythropoietin treatment</article-title>. <source>Nephrol. Dial. Transplant</source>
<volume>4</volume>, <fpage>350</fpage>&#x02013;<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1093/oxfordjournals.ndt.a091889</pub-id><?supplied-pmid 2505185?><pub-id pub-id-type="pmid">2505185</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarrete-Opazo</surname><given-names>A.</given-names></name><name><surname>Alcayaga</surname><given-names>J.</given-names></name><name><surname>Sep&#x000fa;lveda</surname><given-names>O.</given-names></name><name><surname>Rojas</surname><given-names>E.</given-names></name><name><surname>Astudillo</surname><given-names>C.</given-names></name></person-group> (<year>2017a</year>). <article-title>Repetitive intermittent hypoxia and locomotor training enhances walking function in incomplete spinal cord injury subjects: a randomized, triple-blind, placebo-controlled clinical trial</article-title>. <source>J. Neurotrauma</source>
<volume>34</volume>, <fpage>1803</fpage>&#x02013;<lpage>1812</lpage>. <pub-id pub-id-type="doi">10.1089/neu.2016.4478</pub-id><?supplied-pmid 27329506?><pub-id pub-id-type="pmid">27329506</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarrete-Opazo</surname><given-names>A.</given-names></name><name><surname>Mitchell</surname><given-names>G. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Therapeutic potential of intermittent hypoxia: a matter of dose</article-title>. <source>Am. J. Physiol. Regul. Integr. Comp. Physiol.</source>
<volume>307</volume>, <fpage>R1181</fpage>&#x02013;<lpage>R1197</lpage>. <pub-id pub-id-type="doi">10.1152/ajpregu.00208.2014</pub-id><?supplied-pmid 25231353?><pub-id pub-id-type="pmid">25231353</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarrete-Opazo</surname><given-names>A.</given-names></name><name><surname>Dougherty</surname><given-names>B. J.</given-names></name><name><surname>Mitchell</surname><given-names>G. S.</given-names></name></person-group> (<year>2017b</year>). <article-title>Enhanced recovery of breathing capacity from combined adenosine 2A receptor inhibition and daily acute intermittent hypoxia after chronic cervical spinal injury</article-title>. <source>Exp. Neurol.</source>
<volume>287</volume>, <fpage>93</fpage>&#x02013;<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2016.03.026</pub-id><?supplied-pmid 27079999?><pub-id pub-id-type="pmid">27079999</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarrete-Opazo</surname><given-names>A.</given-names></name><name><surname>Vinit</surname><given-names>S.</given-names></name><name><surname>Dougherty</surname><given-names>B. J.</given-names></name><name><surname>Mitchell</surname><given-names>G. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Daily acute intermittent hypoxia elicits functional recovery of diaphragm and inspiratory intercostal muscle activity after acute cervical spinal injury</article-title>. <source>Exp. Neurol.</source>
<volume>266</volume>, <fpage>1</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2015.02.007</pub-id><?supplied-pmid 25687551?><pub-id pub-id-type="pmid">25687551</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>M. E.</given-names></name><name><surname>Rejeski</surname><given-names>W. J.</given-names></name><name><surname>Blair</surname><given-names>S. N.</given-names></name><name><surname>Duncan</surname><given-names>P. W.</given-names></name><name><surname>Judge</surname><given-names>J. O.</given-names></name><name><surname>King</surname><given-names>A. C.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association</article-title>. <source>Med. Sci. Sports Exerc.</source>
<volume>39</volume>, <fpage>1435</fpage>&#x02013;<lpage>1445</lpage>. <pub-id pub-id-type="doi">10.1249/mss.0b013e3180616aa2</pub-id><?supplied-pmid 17762378?><pub-id pub-id-type="pmid">17762378</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netzer</surname><given-names>N. C.</given-names></name><name><surname>Chytra</surname><given-names>R.</given-names></name><name><surname>K&#x000fc;pper</surname><given-names>T.</given-names></name></person-group> (<year>2008</year>). <article-title>Low intense physical exercise in normobaric hypoxia leads to more weight loss in obese people than low intense physical exercise in normobaric sham hypoxia</article-title>. <source>Sleep Breath.</source>
<volume>12</volume>, <fpage>129</fpage>&#x02013;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1007/s11325-007-0149-3</pub-id><?supplied-pmid 18057976?><pub-id pub-id-type="pmid">18057976</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noguchi</surname><given-names>C. T.</given-names></name><name><surname>Asavaritikrai</surname><given-names>P.</given-names></name><name><surname>Teng</surname><given-names>R.</given-names></name><name><surname>Jia</surname><given-names>Y.</given-names></name></person-group> (<year>2007</year>). <article-title>Role of erythropoietin in the brain</article-title>. <volume>64</volume>, <fpage>159</fpage>&#x02013;<lpage>171</lpage>
<pub-id pub-id-type="doi">10.1016/j.critrevonc.2007.03.001</pub-id><?supplied-pmid 17482474?><pub-id pub-id-type="pmid">17482474</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nummela</surname><given-names>A.</given-names></name><name><surname>Rusko</surname><given-names>H.</given-names></name></person-group> (<year>2000</year>). <article-title>Acclimatization to altitude and normoxic training improve 400-m running performance at sea level</article-title>. <source>J. Sports Sci.</source>
<volume>18</volume>, <fpage>411</fpage>&#x02013;<lpage>419</lpage>. <pub-id pub-id-type="doi">10.1080/02640410050074340</pub-id><?supplied-pmid 10902676?><pub-id pub-id-type="pmid">10902676</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>N&#x000fa;&#x000f1;ez-Espinosa</surname><given-names>C.</given-names></name><name><surname>Douziech</surname><given-names>A.</given-names></name><name><surname>R&#x000ed;os-Kristj&#x000e1;nsson</surname><given-names>J. G.</given-names></name><name><surname>Rizo</surname><given-names>D.</given-names></name><name><surname>Torrella</surname><given-names>J. R.</given-names></name><name><surname>Pag&#x000e8;s</surname><given-names>T.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Effect of intermittent hypoxia and exercise on blood rheology and oxygen transport in trained rats</article-title>. <source>Respir. Physiol. Neurobiol.</source>
<volume>192</volume>, <fpage>112</fpage>&#x02013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.resp.2013.12.011</pub-id><?supplied-pmid 24373840?><pub-id pub-id-type="pmid">24373840</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohta</surname><given-names>A. A.</given-names></name><name><surname>Diwanji</surname><given-names>R.</given-names></name><name><surname>Kini</surname><given-names>R.</given-names></name><name><surname>Subramanian</surname><given-names>M.</given-names></name><name><surname>Ohta</surname><given-names>A. A.</given-names></name><name><surname>Sitkovsky</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title><italic>In vivo</italic> T cell activation in lymphoid tissues is inhibited in the oxygen-poor microenvironment</article-title>. <source>Front. Immunol.</source>
<volume>2</volume>:<fpage>27</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2011.00027</pub-id><?supplied-pmid 22566817?><pub-id pub-id-type="pmid">22566817</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oliver</surname><given-names>S. J.</given-names></name><name><surname>Macdonald</surname><given-names>J. H.</given-names></name><name><surname>Harper Smith</surname><given-names>A. D.</given-names></name><name><surname>Lawley</surname><given-names>J. S.</given-names></name><name><surname>Gallagher</surname><given-names>C. a</given-names></name><name><surname>Di Felice</surname><given-names>U.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>High altitude impairs <italic>in vivo</italic> immunity in humans</article-title>. <source>High Alt. Med. Biol.</source>
<volume>14</volume>, <fpage>144</fpage>&#x02013;<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1089/ham.2012.1070</pub-id><?supplied-pmid 23795734?><pub-id pub-id-type="pmid">23795734</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostadal</surname><given-names>B.</given-names></name><name><surname>Kolar</surname><given-names>F.</given-names></name></person-group> (<year>2007</year>). <article-title>Cardiac adaptation to chronic high-altitude hypoxia: beneficial and adverse effects</article-title>. <source>Respir. Physiol. Neurobiol.</source>
<volume>158</volume>, <fpage>224</fpage>&#x02013;<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1016/j.resp.2007.03.005</pub-id><?supplied-pmid 17442631?><pub-id pub-id-type="pmid">17442631</pub-id></mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ost&#x000e1;dal</surname><given-names>B.</given-names></name><name><surname>Kol&#x000e1;r</surname><given-names>F.</given-names></name><name><surname>Pelouch</surname><given-names>V.</given-names></name><name><surname>Bass</surname><given-names>A.</given-names></name><name><surname>Sam&#x000e1;nek</surname><given-names>M.</given-names></name><name><surname>Proch&#x000e1;zka</surname><given-names>J.</given-names></name></person-group> (<year>1989</year>). <article-title>The effect of chronic hypoxia on the developing cardiopulmonary system</article-title>. <source>Biomed. Biochim. Acta</source>
<volume>48</volume>, <fpage>S58</fpage>&#x02013;<lpage>62</lpage>. <?supplied-pmid 2525033?><pub-id pub-id-type="pmid">2525033</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panisello</surname><given-names>P.</given-names></name><name><surname>Torrella</surname><given-names>J. R.</given-names></name><name><surname>Esteva</surname><given-names>S.</given-names></name><name><surname>Pag&#x000e9;s</surname><given-names>T.</given-names></name><name><surname>Viscor</surname><given-names>G.</given-names></name></person-group> (<year>2008</year>). <article-title>Capillary supply, fibre types and fibre morphometry in rat tibialis anterior and diaphragm muscles after intermittent exposure to hypobaric hypoxia</article-title>. <source>Eur. J. Appl. Physiol.</source>
<volume>103</volume>, <fpage>203</fpage>&#x02013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1007/s00421-008-0691-0</pub-id><?supplied-pmid 18270729?><pub-id pub-id-type="pmid">18270729</pub-id></mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panisello</surname><given-names>P.</given-names></name><name><surname>Torrella</surname><given-names>J. R.</given-names></name><name><surname>Pag&#x000e9;s</surname><given-names>T.</given-names></name><name><surname>Viscor</surname><given-names>G.</given-names></name></person-group> (<year>2007</year>). <article-title>Capillary supply and fiber morphometry in rat myocardium after intermittent exposure to hypobaric hypoxia</article-title>. <source>High Alt. Med. Biol.</source>
<volume>8</volume>, <fpage>322</fpage>&#x02013;<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1089/ham.2007.1030</pub-id><?supplied-pmid 18081508?><pub-id pub-id-type="pmid">18081508</pub-id></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos-Campo</surname><given-names>D. J.</given-names></name><name><surname>Mart&#x000ed;nez-S&#x000e1;nchez</surname><given-names>F.</given-names></name><name><surname>Esteban-Garc&#x000ed;a</surname><given-names>P.</given-names></name><name><surname>Rubio-Arias</surname><given-names>J. A.</given-names></name><name><surname>Clemente-Suarez</surname><given-names>V. J.</given-names></name><name><surname>Jim&#x000e9;nez-D&#x000ed;az</surname><given-names>J. F.</given-names></name></person-group> (<year>2015</year>). <article-title>The effects of intermittent hypoxia training on hematological and aerobic performance in triathletes</article-title>. <source>Acta Physiol. Hung.</source>
<volume>102</volume>, <fpage>409</fpage>&#x02013;<lpage>418</lpage>. <pub-id pub-id-type="doi">10.1556/036.102.2015.4.8</pub-id><?supplied-pmid 26690033?><pub-id pub-id-type="pmid">26690033</pub-id></mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos-Campo</surname><given-names>D. J.</given-names></name><name><surname>Scott</surname><given-names>B. R.</given-names></name><name><surname>Alcaraz</surname><given-names>P. E.</given-names></name><name><surname>Rubio-Arias</surname><given-names>J. A.</given-names></name></person-group> (<year>2018</year>). <article-title>The efficacy of resistance training in hypoxia to enhance strength and muscle growth: a systematic review and meta-analysis</article-title>. <source>Eur. J. Sport Sci.</source>
<volume>18</volume>, <fpage>92</fpage>&#x02013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1080/17461391.2017.1388850</pub-id><?supplied-pmid 29045191?><pub-id pub-id-type="pmid">29045191</pub-id></mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathat</surname><given-names>C.</given-names></name><name><surname>Richalet</surname><given-names>J. P.</given-names></name><name><surname>Herry</surname><given-names>J. P.</given-names></name><name><surname>Larmignat</surname><given-names>P.</given-names></name></person-group> (<year>1992</year>). <article-title>Detection of high-risk subjects for high altitude diseases</article-title>. <source>Int. J. Sports Med.</source> 13 (<issue>Suppl. 1</issue>), <fpage>S76</fpage>&#x02013;<lpage>S78</lpage>. <pub-id pub-id-type="doi">10.1055/s-2007-1024602</pub-id><?supplied-pmid 1483801?><pub-id pub-id-type="pmid">1483801</pub-id></mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rey</surname><given-names>S.</given-names></name><name><surname>Semenza</surname><given-names>G. L.</given-names></name></person-group> (<year>2010</year>). <article-title>Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling</article-title>. <source>Cardiovasc. Res.</source>
<volume>86</volume>, <fpage>236</fpage>&#x02013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvq045</pub-id><?supplied-pmid 20164116?><pub-id pub-id-type="pmid">20164116</pub-id></mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynafarje</surname><given-names>B. D.</given-names></name><name><surname>Marticorena</surname><given-names>E.</given-names></name></person-group> (<year>2002</year>). <article-title>Bioenergetics of the heart at high altitude: environmental hypoxia imposes profound transformations on the myocardial process of ATP synthesis</article-title>. <source>J. Bioenerg. Biomembr.</source>
<volume>34</volume>, <fpage>407</fpage>&#x02013;<lpage>412</lpage>. <pub-id pub-id-type="doi">10.1023/A:1022597523483</pub-id><?supplied-pmid 12678432?><pub-id pub-id-type="pmid">12678432</pub-id></mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ricart</surname><given-names>A.</given-names></name><name><surname>Casas</surname><given-names>H.</given-names></name><name><surname>Casas</surname><given-names>M.</given-names></name><name><surname>Pag&#x000e9;s</surname><given-names>T.</given-names></name><name><surname>Palacios</surname><given-names>L.</given-names></name><name><surname>Rama</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2000</year>). <article-title>Acclimatization near home? Early respiratory changes after short-term intermittent exposure to simulated altitude</article-title>. <source>Wilderness Environ. Med.</source>
<volume>11</volume>, <fpage>84</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1580/1080-6032(2000)011[0084:ANHERC]2.3.CO;2</pub-id><?supplied-pmid 10921357?><pub-id pub-id-type="pmid">10921357</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richalet</surname><given-names>J. P.</given-names></name><name><surname>Bittel</surname><given-names>J.</given-names></name><name><surname>Herry</surname><given-names>J. P.</given-names></name><name><surname>Savourey</surname><given-names>G.</given-names></name><name><surname>Le Trong</surname><given-names>J. L.</given-names></name><name><surname>Auvert</surname><given-names>J. F.</given-names></name><etal/></person-group>. (<year>1992</year>). <article-title>Use of a hypobaric chamber for pre-acclimatization before climbing Mount Everest</article-title>. <source>Int. J. Sports Med.</source>
<volume>13</volume> (<issue>Suppl. 1</issue>), <fpage>S216</fpage>&#x02013;<lpage>S220</lpage>. <pub-id pub-id-type="doi">10.1055/s-2007-1024644</pub-id><?supplied-pmid 1483780?><pub-id pub-id-type="pmid">1483780</pub-id></mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richalet</surname><given-names>J. P.</given-names></name><name><surname>Souberbielle</surname><given-names>J. C.</given-names></name><name><surname>Antezana</surname><given-names>A. M.</given-names></name><name><surname>D&#x000e9;chaux</surname><given-names>M.</given-names></name><name><surname>Le Trong</surname><given-names>J. L.</given-names></name><name><surname>Bienvenu</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>1994</year>). <article-title>Control of erythropoiesis in humans during prolonged exposure to the altitude of 6,542 m</article-title>. <source>Am. J. Physiol.</source>
<volume>266</volume>, <fpage>R756</fpage>&#x02013;<lpage>R764</lpage>. <pub-id pub-id-type="doi">10.1152/ajpregu.1994.266.3.R756</pub-id><?supplied-pmid 8160868?><pub-id pub-id-type="pmid">8160868</pub-id></mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richalet</surname><given-names>J.-P.</given-names></name><name><surname>Gore</surname><given-names>C. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Live and/or sleep high:train low, using normobaric hypoxia</article-title>. <source>Scand. J. Med. Sci. Sports</source>
<volume>18</volume> (<issue>Suppl. 1</issue>), <fpage>29</fpage>&#x02013;<lpage>37</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0838.2008.00830.x</pub-id><?supplied-pmid 22267386?><pub-id pub-id-type="pmid">18665950</pub-id></mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richalet</surname><given-names>J.-P.</given-names></name><name><surname>Lhuissier</surname><given-names>F. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Aging, tolerance to high altitude, and cardiorespiratory response to hypoxia</article-title>. <source>High Alt. Med. Biol.</source>
<volume>16</volume>:<fpage>117</fpage>&#x02013;<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1089/ham.2015.0030</pub-id><?supplied-pmid 25946570?><pub-id pub-id-type="pmid">25946570</pub-id></mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizo-Roca</surname><given-names>D.</given-names></name><name><surname>Bonet</surname><given-names>J. B.</given-names></name><name><surname>Inal</surname><given-names>B.</given-names></name><name><surname>R&#x000ed;os-Kristj&#x000e1;nsson</surname><given-names>J. G.</given-names></name><name><surname>Pag&#x000e8;s</surname><given-names>T.</given-names></name><name><surname>Viscor</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Contractile activity is necessary to trigger intermittent hypobaric hypoxia-induced fibre size and vascular adaptations in skeletal muscle</article-title>. <source>Front. Physiol.</source>
<volume>9</volume>:<fpage>481</fpage>
<pub-id pub-id-type="doi">10.3389/FPHYS.2018.00481</pub-id><pub-id pub-id-type="pmid">29780328</pub-id></mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizo-Roca</surname><given-names>D.</given-names></name><name><surname>R&#x000ed;os-Kristj&#x000e1;nsson</surname><given-names>J. G.</given-names></name><name><surname>N&#x000fa;&#x000f1;ez-Espinosa</surname><given-names>C.</given-names></name><name><surname>Santos-Alves</surname><given-names>E.</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>I. O.</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>2017a</year>). <article-title>Intermittent hypobaric hypoxia combined with aerobic exercise improves muscle morphofunctional recovery after eccentric exercise to exhaustion in trained rats</article-title>. <source>J. Appl. Physiol.</source>
<volume>122</volume>, <fpage>580</fpage>&#x02013;<lpage>592</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.00501.2016</pub-id><?supplied-pmid 27765844?><pub-id pub-id-type="pmid">27765844</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizo-Roca</surname><given-names>D.</given-names></name><name><surname>R&#x000ed;os-Kristj&#x000e1;nsson</surname><given-names>J. G.</given-names></name><name><surname>N&#x000fa;&#x000f1;ez-Espinosa</surname><given-names>C.</given-names></name><name><surname>Santos-Alves</surname><given-names>E.</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>J.</given-names></name><name><surname>Ascens&#x000e3;o</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2017b</year>). <article-title>Modulation of mitochondrial biomarkers by intermittent hypobaric hypoxia and aerobic exercise after eccentric exercise in trained rats</article-title>. <source>Appl. Physiol. Nutr. Metab.</source>
<volume>42</volume>, <fpage>683</fpage>&#x02013;<lpage>693</lpage>. <pub-id pub-id-type="doi">10.1139/apnm-2016-0526</pub-id><?supplied-pmid 28177702?><pub-id pub-id-type="pmid">28177702</pub-id></mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez</surname><given-names>F. A.</given-names></name><name><surname>Casas</surname><given-names>H.</given-names></name><name><surname>Casas</surname><given-names>M.</given-names></name><name><surname>Pag&#x000e9;s</surname><given-names>T.</given-names></name><name><surname>Rama</surname><given-names>R.</given-names></name><name><surname>Ricart</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>1999</year>). <article-title>Intermittent hypobaric hypoxia stimulates erythropoiesis and improves aerobic capacity</article-title>. <source>Med. Sci. Sports Exerc.</source>
<volume>31</volume>, <fpage>264</fpage>&#x02013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1097/00005768-199902000-00010</pub-id><?supplied-pmid 10063816?><pub-id pub-id-type="pmid">10063816</pub-id></mixed-citation></ref><ref id="B143"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez</surname><given-names>F. A.</given-names></name><name><surname>Iglesias</surname><given-names>X.</given-names></name><name><surname>Feriche</surname><given-names>B.</given-names></name><name><surname>Calder&#x000f3;n-Soto</surname><given-names>C.</given-names></name><name><surname>Chaverri</surname><given-names>D.</given-names></name><name><surname>Wachsmuth</surname><given-names>N. B.</given-names></name><etal/></person-group>. (<year>2015</year>). <article-title>Altitude Training in Elite Swimmers for Sea Level Performance (Altitude Project)</article-title>. <source>Med. Sci. Sports Exerc.</source>
<volume>47</volume>, <fpage>1965</fpage>&#x02013;<lpage>1978</lpage>. <pub-id pub-id-type="doi">10.1249/MSS.0000000000000626</pub-id><?supplied-pmid 25628173?><pub-id pub-id-type="pmid">25628173</pub-id></mixed-citation></ref><ref id="B144"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez</surname><given-names>F. A.</given-names></name><name><surname>Truijens</surname><given-names>M. J.</given-names></name><name><surname>Townsend</surname><given-names>N. E.</given-names></name><name><surname>Gore</surname><given-names>C. J.</given-names></name><name><surname>Levine</surname><given-names>B. D.</given-names></name><name><surname>Truijens</surname><given-names>M. J.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Performance of runners and swimmers after four weeks of intermittent hypobaric hypoxic exposure plus sea level training</article-title>. <source>J. Appl. Physiol.</source>
<volume>103</volume>, <fpage>1523</fpage>&#x02013;<lpage>1535</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.01320.2006</pub-id><?supplied-pmid 17690191?><pub-id pub-id-type="pmid">17690191</pub-id></mixed-citation></ref><ref id="B145"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez</surname><given-names>F. A.</given-names></name><name><surname>Ventura</surname><given-names>J. L.</given-names></name><name><surname>Casas</surname><given-names>M.</given-names></name><name><surname>Casas</surname><given-names>H.</given-names></name><name><surname>Pag&#x000e9;s</surname><given-names>T.</given-names></name><name><surname>Rama</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2000</year>). <article-title>Erythropoietin acute reaction and haematological adaptations to short, intermittent hypobaric hypoxia</article-title>. <source>Eur. J. Appl. Physiol.</source>
<volume>82</volume>, <fpage>170</fpage>&#x02013;<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1007/s004210050669</pub-id><?supplied-pmid 10929210?><pub-id pub-id-type="pmid">10929210</pub-id></mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ross</surname><given-names>H. H.</given-names></name><name><surname>Sandhu</surname><given-names>M. S.</given-names></name><name><surname>Cheung</surname><given-names>T. F.</given-names></name><name><surname>Fitzpatrick</surname><given-names>G. M.</given-names></name><name><surname>Sher</surname><given-names>W. J.</given-names></name><name><surname>Tiemeier</surname><given-names>A. J.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title><italic>In vivo</italic> intermittent hypoxia elicits enhanced expansion and neuronal differentiation in cultured neural progenitors</article-title>. <source>Exp. Neurol.</source>
<volume>235</volume>, <fpage>238</fpage>&#x02013;<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1016/j.expneurol.2012.01.027</pub-id><?supplied-pmid 22366327?><pub-id pub-id-type="pmid">22366327</pub-id></mixed-citation></ref><ref id="B147"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salpeter</surname><given-names>S. R.</given-names></name><name><surname>Buckley</surname><given-names>N. S.</given-names></name><name><surname>Ormiston</surname><given-names>T. M.</given-names></name><name><surname>Salpeter</surname><given-names>E. E.</given-names></name></person-group> (<year>2006</year>). <article-title>Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths</article-title>. <source>Ann. Intern. Med.</source>
<volume>144</volume>, <fpage>904</fpage>&#x02013;<lpage>912</lpage>. <pub-id pub-id-type="doi">10.7326/0003-4819-144-12-200606200-00126</pub-id><?supplied-pmid 16754916?><pub-id pub-id-type="pmid">16754916</pub-id></mixed-citation></ref><ref id="B148"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>A. M. J.</given-names></name><name><surname>Borrani</surname><given-names>F.</given-names></name></person-group> (<year>2018</year>). <article-title>Effects of intermittent hypoxic training performed at high hypoxia level on exercise performance in highly trained runners</article-title>. <source>J. Sports Sci.</source>
<volume>36</volume>, <fpage>2045</fpage>&#x02013;<lpage>2052</lpage>. <pub-id pub-id-type="doi">10.1080/02640414.2018.1434747</pub-id><?supplied-pmid 29394148?><pub-id pub-id-type="pmid">29394148</pub-id></mixed-citation></ref><ref id="B149"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saugy</surname><given-names>J. J.</given-names></name><name><surname>Schmitt</surname><given-names>L.</given-names></name><name><surname>Hauser</surname><given-names>A.</given-names></name><name><surname>Constantin</surname><given-names>G.</given-names></name><name><surname>Cejuela</surname><given-names>R.</given-names></name><name><surname>Faiss</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2016</year>). <article-title>Same Performance Changes after Live High-Train Low in Normobaric vs</article-title>. <source>Hypobaric Hypoxia. Front. Physiol.</source>
<volume>7</volume>:<fpage>138</fpage>. <pub-id pub-id-type="doi">10.3389/fphys.2016.00138</pub-id><?supplied-pmid 27148076?><pub-id pub-id-type="pmid">27148076</pub-id></mixed-citation></ref><ref id="B150"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savourey</surname><given-names>G.</given-names></name><name><surname>Launay</surname><given-names>J.-C.</given-names></name><name><surname>Besnard</surname><given-names>Y.</given-names></name><name><surname>Guinet</surname><given-names>A.</given-names></name><name><surname>Travers</surname><given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>Normo- and hypobaric hypoxia: are there any physiological differences?</article-title>
<source>Eur. J. Appl. Physiol.</source>
<volume>89</volume>, <fpage>122</fpage>&#x02013;<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1007/s00421-002-0789-8</pub-id><?supplied-pmid 12665974?><pub-id pub-id-type="pmid">12665974</pub-id></mixed-citation></ref><ref id="B151"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schommer</surname><given-names>K.</given-names></name><name><surname>Wiesegart</surname><given-names>N.</given-names></name><name><surname>Menold</surname><given-names>E.</given-names></name><name><surname>Haas</surname><given-names>U.</given-names></name><name><surname>Lahr</surname><given-names>K.</given-names></name><name><surname>Buhl</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Training in normobaric hypoxia and its effects on acute mountain sickness after rapid ascent to 4559 m</article-title>. <source>High Alt. Med. Biol.</source>
<volume>11</volume>, <fpage>19</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1089/ham.2009.1019</pub-id><?supplied-pmid 20367484?><pub-id pub-id-type="pmid">20367484</pub-id></mixed-citation></ref><ref id="B152"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schultze-Werninghaus</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>Should asthma management include sojourns at high altitude?</article-title>
<source>Chem. Immunol. Allergy</source>
<volume>91</volume>, <fpage>16</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1159/000090227</pub-id><?supplied-pmid 16354946?><pub-id pub-id-type="pmid">16354946</pub-id></mixed-citation></ref><ref id="B153"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schultze-Werninghaus</surname><given-names>G.</given-names></name></person-group> (<year>2008</year>). <article-title>[Effects of high altitude on bronchial asthma]</article-title>. <source>Pneumologie</source>
<volume>62</volume>, <fpage>170</fpage>&#x02013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1055/s-2007-1016442</pub-id><?supplied-pmid 18320497?><pub-id pub-id-type="pmid">18320497</pub-id></mixed-citation></ref><ref id="B154"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serebrovska</surname><given-names>T. V.</given-names></name><name><surname>Portnychenko</surname><given-names>A. G.</given-names></name><name><surname>Drevytska</surname><given-names>T. I.</given-names></name><name><surname>Portnichenko</surname><given-names>V. I.</given-names></name><name><surname>Xi</surname><given-names>L.</given-names></name><name><surname>Egorov</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Intermittent hypoxia training in prediabetes patients: Beneficial effects on glucose homeostasis, hypoxia tolerance and gene expression</article-title>. <source>Exp. Biol. Med. (Maywood).</source>
<volume>242</volume>, <fpage>1542</fpage>&#x02013;<lpage>1552</lpage>. <pub-id pub-id-type="doi">10.1177/1535370217723578</pub-id><?supplied-pmid 28758418?><pub-id pub-id-type="pmid">28758418</pub-id></mixed-citation></ref><ref id="B155"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serebrovska</surname><given-names>T. V.</given-names></name><name><surname>Serebrovska</surname><given-names>Z. O.</given-names></name><name><surname>Egorov</surname><given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>Fitness and therapeutic potential of intermittent hypoxia training: a matter of dose</article-title>. <source>Fiziol. Zh.</source>
<volume>62</volume>, <fpage>78</fpage>&#x02013;<lpage>91</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="https://fz.kiev.ua/journals/2016_V.62/2016_3/2016_3-78-91.pdf">https://fz.kiev.ua/journals/2016_V.62/2016_3/2016_3-78-91.pdf</ext-link><?supplied-pmid 29569889?><pub-id pub-id-type="pmid">29569889</pub-id></mixed-citation></ref><ref id="B156"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serebrovskaya</surname><given-names>T. V.</given-names></name><name><surname>Manukhina</surname><given-names>E. B.</given-names></name><name><surname>Smith</surname><given-names>M. L.</given-names></name><name><surname>Downey</surname><given-names>H. F.</given-names></name><name><surname>Mallet</surname><given-names>R. T.</given-names></name></person-group> (<year>2008</year>). <article-title>Intermittent hypoxia: cause of or therapy for systemic hypertension?</article-title>
<source>Exp. Biol. Med. (Maywood).</source>
<volume>233</volume>, <fpage>627</fpage>&#x02013;<lpage>650</lpage>. <pub-id pub-id-type="doi">10.3181/0710-MR-267</pub-id><?supplied-pmid 18408145?><pub-id pub-id-type="pmid">18408145</pub-id></mixed-citation></ref><ref id="B157"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serebrovskaya</surname><given-names>T. V.</given-names></name><name><surname>Swanson</surname><given-names>R. J.</given-names></name><name><surname>Kolesnikova</surname><given-names>E. E.</given-names></name></person-group> (<year>2003</year>). <article-title>Intermittent hypoxia: mechanisms of action and some applications to bronchial asthma treatment</article-title>. <source>J. Physiol. Pharmacol.</source>
<volume>54</volume> (<issue>Suppl. 1</issue>), <fpage>35</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.318/0710-MR-</pub-id><?supplied-pmid 15886409?><pub-id pub-id-type="pmid">15886409</pub-id></mixed-citation></ref><ref id="B158"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serebrovskaya</surname><given-names>T. V</given-names></name></person-group> (<year>2002</year>). <article-title>Intermittent hypoxia research in the former Soviet Union and the Commonwealth of Independent States: history and review of the concept and selected applications</article-title>. <source>High Alt. Med. Biol.</source>
<volume>3</volume>, <fpage>205</fpage>&#x02013;<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1089/15270290260131939</pub-id><?supplied-pmid 12162864?><pub-id pub-id-type="pmid">12162864</pub-id></mixed-citation></ref><ref id="B159"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>H. U.</given-names></name><name><surname>Grotzer</surname><given-names>M.</given-names></name><name><surname>Nikolaizik</surname><given-names>W. H.</given-names></name><name><surname>Blaser</surname><given-names>K.</given-names></name><name><surname>Sch&#x000f6;ni</surname><given-names>M. H.</given-names></name></person-group> (<year>1994</year>). <article-title>High altitude climate therapy reduces peripheral blood T lymphocyte activation, eosinophilia, and bronchial obstruction in children with house-dust mite allergic asthma</article-title>. <source>Pediatr. Pulmonol.</source>
<volume>17</volume>, <fpage>304</fpage>&#x02013;<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1002/ppul.1950170507</pub-id><?supplied-pmid 8058424?><pub-id pub-id-type="pmid">8058424</pub-id></mixed-citation></ref><ref id="B160"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>I.</given-names></name><name><surname>Chohan</surname><given-names>I. S.</given-names></name><name><surname>Lal</surname><given-names>M.</given-names></name><name><surname>Khanna</surname><given-names>P. K.</given-names></name><name><surname>Srivastava</surname><given-names>M. C.</given-names></name><name><surname>Nanda</surname><given-names>R. B.</given-names></name><etal/></person-group>. (<year>1977</year>). <article-title>Effects of high altitude stay on the incidence of common diseases in man</article-title>. <source>Int. J. Biometeorol.</source>
<volume>21</volume>, <fpage>93</fpage>&#x02013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1007/BF01553705</pub-id><?supplied-pmid 334677?><pub-id pub-id-type="pmid">334677</pub-id></mixed-citation></ref><ref id="B161"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steiner</surname><given-names>C.</given-names></name></person-group> (<year>2009</year>). <article-title>[Atopic dermatitis and psoriasis: what is the benefit of in-patient high altitude climate therapy?]</article-title>. <source>Praxis (Bern. 1994).</source>
<volume>98</volume>, <fpage>1373</fpage>&#x02013;<lpage>1376</lpage>. <pub-id pub-id-type="doi">10.1024/1661-8157.98.23.1373</pub-id><?supplied-pmid 19918730?><pub-id pub-id-type="pmid">19918730</pub-id></mixed-citation></ref><ref id="B162"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stray-Gundersen</surname><given-names>J.</given-names></name><name><surname>Levine</surname><given-names>B. D.</given-names></name></person-group> (<year>1999</year>). <article-title>&#x0201c;Living high and training low&#x0201d; can improve sea level performance in endurance</article-title>
<source>athletes</source>. <volume>33</volume>, <fpage>150</fpage>&#x02013;<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1136/bjsm.33.3.150</pub-id></mixed-citation></ref><ref id="B163"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stray-Gundersen</surname><given-names>J.</given-names></name><name><surname>Chapman</surname><given-names>R. F.</given-names></name><name><surname>Levine</surname><given-names>B. D.</given-names></name></person-group> (<year>2001</year>). <article-title>&#x0201c;Living high-training low&#x0201d; altitude training improves sea level performance in male and female elite runners</article-title>. <source>J. Appl. Physiol.</source>
<volume>91</volume>, <fpage>1113</fpage>&#x02013;<lpage>1120</lpage>. <pub-id pub-id-type="doi">10.1152/jappl.2001.91.3.1113</pub-id><?supplied-pmid 11509506?><pub-id pub-id-type="pmid">11509506</pub-id></mixed-citation></ref><ref id="B164"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Streeter</surname><given-names>K. A.</given-names></name><name><surname>Sunshine</surname><given-names>M. D.</given-names></name><name><surname>Patel</surname><given-names>S.</given-names></name><name><surname>Gonzalez-Rothi</surname><given-names>E. J.</given-names></name><name><surname>Reier</surname><given-names>P. J.</given-names></name><name><surname>Baekey</surname><given-names>D. M.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Intermittent hypoxia enhances functional connectivity of midcervical spinal interneurons</article-title>. <source>J. Neurosci.</source>
<volume>37</volume>, <fpage>8349</fpage>&#x02013;<lpage>8362</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0992-17.2017</pub-id><?supplied-pmid 28751456?><pub-id pub-id-type="pmid">28751456</pub-id></mixed-citation></ref><ref id="B165"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sy</surname><given-names>D. Q.</given-names></name><name><surname>Thanh Binh</surname><given-names>M. H.</given-names></name><name><surname>Quoc</surname><given-names>N. T.</given-names></name><name><surname>Hung</surname><given-names>N. V.</given-names></name><name><surname>Quynh Nhu</surname><given-names>D. T.</given-names></name><name><surname>Bao</surname><given-names>N. Q.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Prevalence of asthma and asthma-like symptoms in Dalat Highlands, Vietnam</article-title>. <source>Singapore Med. J.</source>
<volume>48</volume>, <fpage>294</fpage>&#x02013;<lpage>303</lpage>. Available online at: <ext-link ext-link-type="uri" xlink:href="http://smj.sma.org.sg/4804/4804a4.pdf">http://smj.sma.org.sg/4804/4804a4.pdf</ext-link><?supplied-pmid 17384875?><pub-id pub-id-type="pmid">17384875</pub-id></mixed-citation></ref><ref id="B166"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thanigaimani</surname><given-names>S.</given-names></name><name><surname>McLennan</surname><given-names>E.</given-names></name><name><surname>Linz</surname><given-names>D.</given-names></name><name><surname>Mahajan</surname><given-names>R.</given-names></name><name><surname>Agbaedeng</surname><given-names>T. A.</given-names></name><name><surname>Lee</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2017</year>). <article-title>Progression and reversibility of stretch induced atrial remodeling: characterization and clinical implications</article-title>. <source>Prog. Biophys. Mol. Biol.</source>
<volume>130</volume>, <fpage>376</fpage>&#x02013;<lpage>386</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbiomolbio.2017.07.010</pub-id><?supplied-pmid 28734850?><pub-id pub-id-type="pmid">28734850</pub-id></mixed-citation></ref><ref id="B167"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tin'kov</surname><given-names>A. N.</given-names></name><name><surname>Aksenov</surname><given-names>V. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Effects of intermittent hypobaric hypoxia on blood lipid concentrations in male coronary heart disease patients</article-title>. <source>High Alt. Med. Biol.</source>
<volume>3</volume>, <fpage>277</fpage>&#x02013;<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1089/152702902320604250</pub-id><?supplied-pmid 12396881?><pub-id pub-id-type="pmid">12396881</pub-id></mixed-citation></ref><ref id="B168"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Truijens</surname><given-names>M. J.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>F. A.</given-names></name><name><surname>Townsend</surname><given-names>N. E.</given-names></name><name><surname>Stray-Gundersen</surname><given-names>J.</given-names></name><name><surname>Gore</surname><given-names>C. J.</given-names></name><name><surname>Levine</surname><given-names>B. D.</given-names></name></person-group> (<year>2008</year>). <article-title>The effect of intermittent hypobaric hypoxic exposure and sea level training on submaximal economy in well-trained swimmers and runners</article-title>. <source>J. Appl. Physiol.</source>
<volume>104</volume>, <fpage>328</fpage>&#x02013;<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1152/japplphysiol.01324.2006</pub-id><?supplied-pmid 18048583?><pub-id pub-id-type="pmid">18048583</pub-id></mixed-citation></ref><ref id="B169"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trumbower</surname><given-names>R. D.</given-names></name><name><surname>Hayes</surname><given-names>H. B.</given-names></name><name><surname>Mitchell</surname><given-names>G. S.</given-names></name><name><surname>Wolf</surname><given-names>S. L.</given-names></name><name><surname>Stahl</surname><given-names>V. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Effects of acute intermittent hypoxia on hand use after spinal cord trauma: a preliminary study</article-title>. <source>Neurology</source>
<volume>89</volume>, <fpage>1904</fpage>&#x02013;<lpage>1907</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000004596</pub-id><?supplied-pmid 28972191?><pub-id pub-id-type="pmid">28972191</pub-id></mixed-citation></ref><ref id="B170"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>Y.-W.</given-names></name><name><surname>Yang</surname><given-names>Y.-R.</given-names></name><name><surname>Sun</surname><given-names>S. H.</given-names></name><name><surname>Liang</surname><given-names>K.-C.</given-names></name><name><surname>Wang</surname><given-names>R.-Y.</given-names></name></person-group> (<year>2013</year>). <article-title>Post ischemia intermittent hypoxia induces hippocampal neurogenesis and synaptic alterations and alleviates long-term memory impairment</article-title>. <source>J. Cereb. Blood Flow Metab.</source>
<volume>33</volume>, <fpage>764</fpage>&#x02013;<lpage>773</lpage>. <pub-id pub-id-type="doi">10.1038/jcbfm.2013.15</pub-id><?supplied-pmid 23443175?><pub-id pub-id-type="pmid">23443175</pub-id></mixed-citation></ref><ref id="B171"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turban</surname><given-names>K.</given-names></name><name><surname>Spengler</surname><given-names>L.</given-names></name></person-group> (<year>1906</year>). <article-title>Resultate der Asthmabehandlung im Hochgebirge</article-title>. <source>Jahresbericht der Schweiz Balneol. Gesellschaft</source>
<volume>2</volume>:<fpage>72</fpage>.</mixed-citation></ref><ref id="B172"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valle</surname><given-names>M.</given-names></name><name><surname>del</surname><given-names>P.</given-names></name><name><surname>Garc&#x000ed;a-Godos</surname><given-names>F.</given-names></name><name><surname>Woolcott</surname><given-names>O. O.</given-names></name><name><surname>Marticorena</surname><given-names>J. M.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>V.</given-names></name><etal/></person-group>. (<year>2006</year>). <article-title>Improvement of myocardial perfusion in coronary patients after intermittent hypobaric hypoxia</article-title>. <source>J. Nucl. Cardiol.</source>
<volume>13</volume>, <fpage>69</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.nuclcard.2005.11.008</pub-id><?supplied-pmid 16464719?><pub-id pub-id-type="pmid">16464719</pub-id></mixed-citation></ref><ref id="B173"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Woude</surname><given-names>H. J.</given-names></name><name><surname>Winter</surname><given-names>T. H.</given-names></name><name><surname>Aalbers</surname><given-names>R.</given-names></name></person-group> (<year>2001</year>). <article-title>Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists</article-title>. <source>Thorax</source>
<volume>56</volume>, <fpage>529</fpage>&#x02013;<lpage>535</lpage>. <pub-id pub-id-type="doi">10.1136/thorax.56.7.529</pub-id><?supplied-pmid 11413351?><pub-id pub-id-type="pmid">11413351</pub-id></mixed-citation></ref><ref id="B174"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Velzen</surname><given-names>E.</given-names></name><name><surname>van den Bos</surname><given-names>J. W.</given-names></name><name><surname>Benckhuijsen</surname><given-names>J. A.</given-names></name><name><surname>van Essel</surname><given-names>T.</given-names></name><name><surname>de Bruijn</surname><given-names>R.</given-names></name><name><surname>Aalbers</surname><given-names>R.</given-names></name></person-group> (<year>1996</year>). <article-title>Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma</article-title>. <source>Thorax</source>
<volume>51</volume>, <fpage>582</fpage>&#x02013;<lpage>584</lpage>. <pub-id pub-id-type="doi">10.1136/thx.51.6.582</pub-id><?supplied-pmid 8693437?><pub-id pub-id-type="pmid">8693437</pub-id></mixed-citation></ref><ref id="B175"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viru&#x000e9;s-Ortega</surname><given-names>J.</given-names></name><name><surname>Garrido</surname><given-names>E.</given-names></name><name><surname>Javierre</surname><given-names>C.</given-names></name><name><surname>Kloezeman</surname><given-names>K. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Human behaviour and development under high-altitude conditions</article-title>. <source>Dev. Sci.</source>
<volume>9</volume>, <fpage>400</fpage>&#x02013;<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1111/j.1467-7687.2006.00505.x</pub-id><?supplied-pmid 16764613?><pub-id pub-id-type="pmid">16764613</pub-id></mixed-citation></ref><ref id="B176"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viscor</surname><given-names>G.</given-names></name><name><surname>Javierre</surname><given-names>C.</given-names></name><name><surname>Pag&#x000e8;s</surname><given-names>T.</given-names></name><name><surname>Ventura</surname><given-names>J.-L.</given-names></name><name><surname>Ricart</surname><given-names>A.</given-names></name><name><surname>Martin-Henao</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2009</year>). <article-title>Combined intermittent hypoxia and surface muscle electrostimulation as a method to increase peripheral blood progenitor cell concentration</article-title>. <source>J. Transl. Med.</source>
<volume>7</volume>:<fpage>91</fpage>. <pub-id pub-id-type="doi">10.1186/1479-5876-7-91</pub-id><?supplied-pmid 19874615?><pub-id pub-id-type="pmid">19874615</pub-id></mixed-citation></ref><ref id="B177"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viscor</surname><given-names>G.</given-names></name><name><surname>Ricart</surname><given-names>A.</given-names></name><name><surname>Pag&#x000e8;s</surname><given-names>T.</given-names></name><name><surname>Corral</surname><given-names>L.</given-names></name><name><surname>Javierre</surname><given-names>C. F.</given-names></name><name><surname>Ventura</surname><given-names>J. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Intermittent hypoxia for obstructive sleep apnea?</article-title>
<source>High Alt. Med. Biol.</source>
<volume>15</volume>, <fpage>520</fpage>&#x02013;<lpage>521</lpage>. <pub-id pub-id-type="doi">10.1089/ham.2014.1060</pub-id><?supplied-pmid 25361383?><pub-id pub-id-type="pmid">25361383</pub-id></mixed-citation></ref><ref id="B178"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vocks</surname><given-names>E.</given-names></name><name><surname>Schuh</surname><given-names>A.</given-names></name><name><surname>Liebich</surname><given-names>C.</given-names></name><name><surname>Topperzer</surname><given-names>U.</given-names></name><name><surname>Ring</surname><given-names>J.</given-names></name></person-group> (<year>1999</year>). <article-title>High altitude stay and plasma cortisol level in psoriasis</article-title>. <source>Phys. Medizin Rehabil. Kurortmedizin</source>
<volume>9</volume>, <fpage>197</fpage>&#x02013;<lpage>201</lpage>. <pub-id pub-id-type="doi">10.1055/s-2008-1061805</pub-id></mixed-citation></ref><ref id="B179"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G. L.</given-names></name><name><surname>Semenza</surname><given-names>G. L.</given-names></name></person-group> (<year>1993</year>). <article-title>General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia</article-title>. <source>Proc. Natl. Acad. Sci.U.S.A.</source>
<volume>90</volume>, <fpage>4304</fpage>&#x02013;<lpage>4308</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.90.9.4304</pub-id><?supplied-pmid 8387214?><pub-id pub-id-type="pmid">8387214</pub-id></mixed-citation></ref><ref id="B180"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>M.</given-names></name></person-group> (<year>1954</year>). <article-title>High altitude deterioration</article-title>. <source>Proc. R. Soc. London. Ser. B Biol. Sci.</source>
<volume>143</volume>, <fpage>40</fpage>&#x02013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.2307/83018</pub-id><?supplied-pmid 13224649?><pub-id pub-id-type="pmid">13224649</pub-id></mixed-citation></ref><ref id="B181"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>West</surname><given-names>J. B.</given-names></name><name><surname>Schoene</surname><given-names>R. B.</given-names></name><name><surname>Luks</surname><given-names>A. M.</given-names></name><name><surname>Milledge</surname><given-names>J. S.</given-names></name></person-group> (<year>2013</year>). <source>High Altitude Medicine and Physiology. 5th Edn.</source>
<publisher-loc>Boca Raton, FL</publisher-loc>: <publisher-name>CRC Press/Taylor &#x00026; Francis Group</publisher-name></mixed-citation></ref><ref id="B182"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wiesner</surname><given-names>S.</given-names></name><name><surname>Haufe</surname><given-names>S.</given-names></name><name><surname>Engeli</surname><given-names>S.</given-names></name><name><surname>Mutschler</surname><given-names>H.</given-names></name><name><surname>Haas</surname><given-names>U.</given-names></name><name><surname>Luft</surname><given-names>F. C.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Influences of normobaric hypoxia training on physical fitness and metabolic risk markers in overweight to obese subjects</article-title>. <source>Obesity</source>
<volume>18</volume>, <fpage>116</fpage>&#x02013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1038/oby.2009.193</pub-id><?supplied-pmid 19543214?><pub-id pub-id-type="pmid">19543214</pub-id></mixed-citation></ref><ref id="B183"><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Wilber</surname><given-names>R. L.</given-names></name></person-group> (<year>2004</year>). <source>Altitude training and Athletic Performance</source>. <publisher-loc>Champaign, IL</publisher-loc>: <publisher-name>Human Kinetics</publisher-name>.</mixed-citation></ref><ref id="B184"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilber</surname><given-names>R. L.</given-names></name><name><surname>Stray-Gundersen</surname><given-names>J.</given-names></name><name><surname>Levine</surname><given-names>B. D.</given-names></name></person-group> (<year>2007</year>). <article-title>Effect of hypoxic &#x0201c;dose&#x0201d; on physiological responses and sea-level performance</article-title>. <source>Med. Sci. Sports Exerc.</source>
<volume>39</volume>, <fpage>1590</fpage>&#x02013;<lpage>1599</lpage>. <pub-id pub-id-type="doi">10.1249/mss.0b013e3180de49bd</pub-id><?supplied-pmid 17805093?><pub-id pub-id-type="pmid">17805093</pub-id></mixed-citation></ref><ref id="B185"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wille</surname><given-names>M.</given-names></name><name><surname>Gatterer</surname><given-names>H.</given-names></name><name><surname>Mairer</surname><given-names>K.</given-names></name><name><surname>Philippe</surname><given-names>M.</given-names></name><name><surname>Schwarzenbacher</surname><given-names>H.</given-names></name><name><surname>Faulhaber</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Short-term intermittent hypoxia reduces the severity of acute mountain sickness</article-title>. <source>Scand. J. Med. Sci. Sport.</source>
<volume>22</volume>, <fpage>79</fpage>&#x02013;<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0838.2012.01499.x</pub-id><?supplied-pmid 22853822?><pub-id pub-id-type="pmid">22853822</pub-id></mixed-citation></ref><ref id="B186"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q.</given-names></name><name><surname>Yu</surname><given-names>K. X.</given-names></name><name><surname>Ma</surname><given-names>Q. S.</given-names></name><name><surname>Liu</surname><given-names>Y. N.</given-names></name></person-group> (<year>2015</year>). <article-title>Effects of intermittent hypobaric hypoxia preconditioning on the expression of neuroglobin and Bcl-2 in the rat hippocampal CA1 area following ischemia-reperfusion</article-title>. <source>Genet. Mol. Res.</source>
<volume>14</volume>, <fpage>10799</fpage>&#x02013;<lpage>10807</lpage>. <pub-id pub-id-type="doi">10.4238/2015.September.9.18</pub-id><?supplied-pmid 26400308?><pub-id pub-id-type="pmid">26400308</pub-id></mixed-citation></ref><ref id="B187"><mixed-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Xi</surname><given-names>L.</given-names></name><name><surname>Serebrovskaya</surname><given-names>T. V</given-names></name></person-group> (eds) (<year>2012</year>). <source>Intermittent Hypoxia and Human Diseases</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Springer</publisher-name>.</mixed-citation></ref><ref id="B188"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>B.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Zhao</surname><given-names>D.</given-names></name><name><surname>Jiang</surname><given-names>R.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2008</year>). <article-title>Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/reperfusion injury in the rat</article-title>. <source>Stroke</source>
<volume>39</volume>, <fpage>2362</fpage>&#x02013;<lpage>2369</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.107.507939</pub-id><?supplied-pmid 18583563?><pub-id pub-id-type="pmid">18583563</pub-id></mixed-citation></ref><ref id="B189"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Jiang</surname><given-names>X.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Gao</surname><given-names>M.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Hypoxia-induced astrocytes promote the migration of neural progenitor cells via vascular endothelial factor, stem cell factor, stromal-derived factor-1alpha and monocyte chemoattractant protein-1 upregulation</article-title>
<source>in vitro. Clin. Exp. Pharmacol. Physiol.</source>
<volume>34</volume>, <fpage>624</fpage>&#x02013;<lpage>631</lpage>. <pub-id pub-id-type="doi">10.1111/j.1440-1681.2007.04619.x</pub-id><?supplied-pmid 17581219?><pub-id pub-id-type="pmid">17581219</pub-id></mixed-citation></ref><ref id="B190"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yangzong Nafstad</surname><given-names>P.</given-names></name><name><surname>Madsen</surname><given-names>C.</given-names></name><name><surname>Bjertness</surname><given-names>E.</given-names></name></person-group> (<year>2006</year>). <article-title>Childhood asthma under the north face of Mount Everest</article-title>. <source>J. Asthma</source>
<volume>43</volume>, <fpage>393</fpage>&#x02013;<lpage>398</lpage>. <pub-id pub-id-type="doi">10.1080/02770900600710326</pub-id><?supplied-pmid 16801145?><pub-id pub-id-type="pmid">16801145</pub-id></mixed-citation></ref><ref id="B191"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Mei</surname><given-names>Y.</given-names></name><name><surname>Guo</surname><given-names>Y.</given-names></name></person-group> (<year>2008</year>). <article-title>The protection of Bcl-2 overexpression on rat cortical neuronal injury caused by analogous ischemia/reperfusion <italic>in vitro</italic></article-title>. <source>Neurosci. Res.</source>
<volume>62</volume>, <fpage>140</fpage>&#x02013;<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1016/j.neures.2008.07.002</pub-id><?supplied-pmid 18723055?><pub-id pub-id-type="pmid">18723055</pub-id></mixed-citation></ref><ref id="B192"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>K.</given-names></name><name><surname>Zhao</surname><given-names>T.</given-names></name><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>K.</given-names></name><name><surname>Zhu</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2014a</year>). <article-title>Notch1 mediates postnatal neurogenesis in hippocampus enhanced by intermittent hypoxia</article-title>. <source>Neurobiol. Dis.</source>
<volume>64</volume>, <fpage>66</fpage>&#x02013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2013.12.010</pub-id><?supplied-pmid 24368168?><pub-id pub-id-type="pmid">24368168</pub-id></mixed-citation></ref><ref id="B193"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S.</given-names></name><name><surname>Guo</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Ma</surname><given-names>H.</given-names></name><name><surname>Fu</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2016a</year>). <article-title>Chronic intermittent hybobaric hypoxia protects against cerebral ischemia via modulation of mitoKATP</article-title>. <source>Neurosci. Lett.</source>
<volume>635</volume>, <fpage>8</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2016.10.025</pub-id><?supplied-pmid 27760384?><pub-id pub-id-type="pmid">27760384</pub-id></mixed-citation></ref><ref id="B194"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Dey</surname><given-names>S.</given-names></name><name><surname>Alnaeeli</surname><given-names>M.</given-names></name><name><surname>Suresh</surname><given-names>S.</given-names></name><name><surname>Rogers</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2014b</year>). <article-title>Erythropoietin action in stress response, tissue maintenance and metabolism</article-title>. <source>Int. J. Mol. Sci.</source>
<volume>15</volume>, <fpage>10296</fpage>&#x02013;<lpage>10333</lpage>. <pub-id pub-id-type="doi">10.3390/ijms150610296</pub-id><?supplied-pmid 24918289?><pub-id pub-id-type="pmid">24918289</pub-id></mixed-citation></ref><ref id="B195"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Yan</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>H.</given-names></name></person-group> (<year>2016b</year>). <article-title>Role of hypoxia Inducible Factor 1 in hyperglycemia-exacerbated blood-brain barrier disruption in ischemic stroke</article-title>. <source>Neurobiol. Dis.</source>
<volume>95</volume>, <fpage>82</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2016.07.012</pub-id><?supplied-pmid 27425889?><pub-id pub-id-type="pmid">27425889</pub-id></mixed-citation></ref><ref id="B196"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>S.</given-names></name><name><surname>Yi</surname><given-names>T.</given-names></name><name><surname>Liu</surname><given-names>R.</given-names></name><name><surname>Bian</surname><given-names>C.</given-names></name><name><surname>Qi</surname><given-names>X.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><etal/></person-group>. (<year>2012</year>). <article-title>Proteomics identification of annexin A2 as a key mediator in the metastasis and proangiogenesis of endometrial cells in human adenomyosis</article-title>. <source>Mol. Cell. Proteomics</source>
<volume>11</volume>:<fpage>M112</fpage>.017988. <pub-id pub-id-type="doi">10.1074/mcp.M112.017988</pub-id><?supplied-pmid 22493182?><pub-id pub-id-type="pmid">22493182</pub-id></mixed-citation></ref><ref id="B197"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Wu</surname><given-names>L.-Y.</given-names></name><name><surname>Ding</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2005</year>). <article-title>Neurogenesis in the adult rat brain after intermittent hypoxia</article-title>. <source>Brain Res.</source>
<volume>1055</volume>, <fpage>1</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2005.04.075</pub-id><?supplied-pmid 16098951?><pub-id pub-id-type="pmid">16098951</pub-id></mixed-citation></ref><ref id="B198"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimna</surname><given-names>A.</given-names></name><name><surname>Kurpisz</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Hypoxia-inducible factor-1 in physiological and pathophysiological angiogenesis: applications and therapies</article-title>. <source>Biomed Res. Int.</source>
<volume>2015</volume>:<fpage>549412</fpage>. <pub-id pub-id-type="doi">10.1155/2015/549412</pub-id><?supplied-pmid 26146622?><pub-id pub-id-type="pmid">26146622</pub-id></mixed-citation></ref></ref-list></back></article>